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Abstract
The focus o f this descriptive-comparative study was to investigate the relationships between
potential access (race, age, socioeconomic status (SES), and the means of discovery of
breast cancer), realized access (the length o f time between discovery o f breast abnormality
and diagnosis o f breast cancer, and the length o f time between diagnosis and initiation of
breast cancer treatment), and stage at diagnosis of breast cancer, in African American and
Caucasian women, receiving care within an equal economic access health care system. The
research questions were answered through secondary analysis, using data obtained from the
tumor registry records of 62 African American and 573 Caucasian women diagnosed with
breast cancer within the Department o f Defense Military Health System, from January 1,
1988 through December 31, 1997. Descriptive statistics were used to describe the sample
and the study variables; and independent samples chi-square tests, t-tests, Mann Whitney U
tests, analysis o f variance, multiple regression, and logistic regression were used to analyze
the data. Results indicate that, when compared to Caucasian women, African American
women: (a) were diagnosed at a significantly later stage o f breast cancer, (b) were
significantly younger at the time o f diagnosis, (c) were from a significantly lower SES, (d)
had a significantly higher percentage o f incidental breast self exam (BSE) discovered breast
abnormalities, and (e) had a significantly lower percentage o f mammogram discovered
breast abnormalities. Women with breast abnormalities discovered by incidental BSE were
almost six times more likely to be diagnosed in late stage breast cancer than women with
mammogram discovered breast abnormalities. There were no significant differences noted
between African American and Caucasian women in length o f time between discovery and
diagnosis, and length of time between diagnosis and treatment.
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CHAPTER 1
INTRODUCTION
Breast cancer is a major medical problem affecting the quality of life of all
American women. Second to lung cancer as the leading cause of cancer death in women
in the United States, breast cancer occurs in American women more often than any other
type of cancer. From 1993 through 1995, calculated over a life time, one in every 18
women developed invasive cancer of the lungs and bronchus, while one in every 8 women
developed cancer o f the breast (Landis et al., 1999). In 1999, approximately 175,000
American women will be newly diagnosed with breast cancer, and an estimated 43,300
will die of this invasive disease (Landis, Murray, Bolden, & Wingo, 1999).
Healthy People 2000. published in 1990, set three broad goals for all Americans:
increasing the span o f healthy life, reducing health disparities, and achieving access to
preventive services (Department o f Health and Human Services [DHHS], 1990). Healthy
People 2000 set a specific goal o f reducing breast cancer death rates from an age adjusted
baseline of 22.9 per 100,000 women in 1987, to no more than 20.6 per 100,000 women by
the year 2000. In addition, Healthy People 2000 acknowledged a disparity in breast cancer
death rates between White women and women o f color; and targeted women of color for
increased preventive services relating to breast cancer (DHHS, 1990).
The United States Bureau of Census reported (as cited in Parker, Davis, Wingo,
Ries, & Heath, 1998), that in 1990, White Americans constituted about 84 percent o f the
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United States population. African Americans made up approximately 12 percent o f the
population; and Hispanics constituted about 9 percent. Asian and Pacific Islanders
comprised about 3 percent o f the United States population in 1990. Composition o f this
group included Chinese, Filipino, Hawaiian, Japanese, Korean, and Vietnamese
Americans. Native Americans made up about 0.8 percent of the United States population
in 1990, and included American Indians and Alaska Natives. From 1990 to 1995, the age
adjusted breast cancer incidence rates for women in the United States, by race and
ethnicity per 100,000 were: (a) 113.2 for White women, (b) 99.0 for African American
women, (c) 71.4 for Asian/Pacific Islander women, (d) 69.3 for Hispanic women, and (e)
31.9 for American Indian women. However, the age adjusted breast cancer mortality
rates for women by race and ethnicity per 100,000 from 1990 to 1995 were: (a) 31.5 for
African American women, (b) 26.0 for White women, (c) 15.3 for Hispanic women, (d)
11.7 for American Indian women, and (e) 11.6 for Asian/Pacific Islander women (Landis
et al., 1999). Even though White women have the highest incidence of breast cancer in the
United States and the mortality rate cited above for White women is well above the
Healthy People 2000 goal o f 20.6 per 100,000 women, the breast cancer mortality rate in
African American women is higher than the mortality rate in White women, and in all
other groups of women o f color.
Because o f this disparity in mortality rate between African American and White
women, and because African American women comprise the largest ethnic minority group
in the United States, current research examining breast cancer disparity between White
women and women o f color has focused primarily on African American women. From
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1989 to 1993, age adjusted breast cancer mortality rates in the United States for White
women decreased by approximately she percent, while breast cancer mortality rates rose
about one percent for African American women (National Cancer Institute [NCI], 1996).
Hence, breast cancer impacts achievement of the Healthy People 2000 goal o f increasing
the span o f healthy life for all American women; however, the disproportionate influence
of breast cancer mortality on the lives of African American women threatens to also
impede achievement o f the Healthy People 2000 goal o f reduced disparities in health care.
Delayed diagnosis is consistently cited as the cause o f the disparity in breast cancer
mortality between White women and African American women (Bedell, Wood, Lezotte,
Sedlacek, & Orleans, 1995; Hunter et al., 1993; Long, 1993; Mandelblatt, Andrews, Kao,
Wallace & Kemer, 1995; Simon & Severson, 1996; Thompson, Montano, Mahloch,
Mullen, & Taylor, 1997). From 1989 to 1994, 50 percent o f the African American
women diagnosed with breast cancer presented with localized tumors, as compared to 62
percent o f the White women diagnosed; and the five year breast cancer survival rate for
White women was 87 percent as compared to 71 percent for African American women
(Landis et al., 1999).
Access barriers have been identified as the primary cause of diagnosis delay
(Ansell, Lacey, Whitman, Chen, & Phillips, 1994; Ayanian, Kohler, Abe, & Epstein, 1993;
Lauver, Coyle & Panchmatia, 1995). Studies exploring access as a barrier to cancer care
and screening have defined access primarily in terms o f availability o f care, or in relation to
economic factors and health insurance coverage (Ayanian et al., 1993; Mandelblatt,
Andrews, Kao, Wallace, & Kemer, 1995; Mandelblatt, Andrews, Kemer, Zauber, &
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Burnett, 1991; Michels, Taplin, Carter, & Kugler; 1995; Zaloznik, 1995, 1997). As a
result, providing economic access to breast health care has become the primary focus for:
increasing African American women’s participation in breast cancer screening programs,
eliminating delayed diagnosis, and decreasing breast cancer mortality in African American
women.
The Department o f Defense (DoD) Military Health System (MHS) provides
“equal” health care access to all active duty and retired members of the Armed Forces, and
their family members (Assistant Secretary o f Defense for Health Affairs [ASDHA],
1996a). Race and socioeconomic status are not a factor in determining who will receive
care. Thus, if economic access to care is the primary factor creating delayed diagnosis of
breast cancer, there should be no significant difference in stage at diagnosis o f breast
cancer between White women and African American women receiving care within the
MHS.
Statement o f the Problem
Research is needed to describe the relationship between access and stage at
diagnosis for women being treated for breast cancer inside the MHS. The 1996 National
Defense Authorization Act allocated 25 million dollars for breast cancer prevention and
treatment within the DoD MHS (Assistant Secretary o f Defense for Health Affairs
[ASDHA], 1996b). The result of this legislation was twofold: development o f the DoD
Breast Cancer Prevention, Diagnosis, and Education Initiative; and movement o f breast
cancer prevention, diagnosis, and treatment to the forefront o f DoD MHS health
promotion and disease prevention strategies. Thus, the overall objective o f the D oD’s
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breast cancer initiative was “to ensure awareness of, and easy access to, superior medical
and diagnostic technology and follow-up care for the early detection and optimum
treatment o f breast cancer in active duty women and women beneficiaries” (ASDHA,
1996b, p.2). Within the DoD MHS there are varying levels o f rank and therefore varying
levels of socioeconomic strata. Economic access to health care, however, is purported to
be “equal” despite rank or socioeconomic status. Therefore, the disparity in breast cancer
stage at diagnosis between White women and African American women in the larger
population, attributed to lack of economic access to breast health care, is expected to be
nonexistent inside the DoD MHS. Furthermore, the existence o f government funding for
breast health care in the MHS could lead policy makers and providers o f health care to
conclude that “ ...easy access to, superior medical and diagnostic technology and follow-up
care for the early detection and optimum treatment o f breast cancer..” exists for all
women receiving breast health care in the MHS.
The year 2000 is rapidly approaching and breast cancer continues to attack all
American women. Successful achievement o f the Healthy People 2000 goal o f reduced
disparity in breast cancer mortality is contingent upon a reduced mortality rate in African
American women. If economic access to breast health care is the key to combating breast
cancer mortality and eliminating stage at diagnosis disparity between White women and
women o f color, then all such legislation and policy issuance should focus on providing
economic access to breast health care for all women. However, if significant disparity
exists in breast cancer stage at diagnosis between White women and women o f color in an
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“equal” access system, then economic access must be eliminated as the primary cause of
the disparity, and other contributors to delayed diagnosis must be identified.
Purpose o f the Study
The purpose of this study was to describe the relationship between access and
stage at diagnosis o f breast cancer in African American and Caucasian women being
diagnosed with breast cancer within the DoD MHS. Relationships between stage at
diagnosis of breast cancer and age, socioeconomic status, the means o f discovery of breast
cancer, the length of time between discovery of breast abnormality and diagnosis of breast
cancer, and the length of time between diagnosis and initiation o f breast cancer treatment,
were explored to provide relevant knowledge concerning the interrelationships between
these variables in women receiving care within the MHS.
African American women and White women were the focus o f this research study.
The term African American women is used interchangeably with the term Black women in
the health care literature; therefore these terms were used interchangeably in this study.
The term Caucasian women is used interchangeably with the term White women in the
health care literature; therefore these terms were also used interchangeably in this study.
Specific Aims
The specific aims of this study were to:
1) Describe the age and socioeconomic status (defined as rank) o f women identifying
their race as Caucasian or African American and being diagnosed with breast cancer at
Naval Medical Center San Diego from January 1, 1988 to December 31, 1997.
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2) Describe the means of discovery o f breast cancer (breast self exam, clinical breast
exam, mammogram) in women identifying their race as Caucasian or African American
and being diagnosed with breast cancer at Naval Medical Center San Diego from January
1, 1988 to December 31, 1997.
3) Identify the length of time in days between discovery o f breast lump, mass, or
abnormality and diagnosis of breast cancer, and between diagnosis o f breast cancer and
initiation o f treatment, in women identifying their race as Caucasian or African American
and being diagnosed with breast cancer at Naval Medical Center San Diego from January
1, 1988 to December 31, 1997.
4) Identify the stage at diagnosis o f breast cancer in women identifying their race as
Caucasian or African American and being diagnosed with breast cancer at Naval Medical
Center San Diego from January 1, 1988 to December 31, 1997.
5) Compare the relationship between age, socioeconomic status, race and the means o f
discovery o f breast cancer, length o f time before diagnosis, length o f time between
diagnosis and initiation of treatment, and stage at diagnosis in women identifying their race
as Caucasian and being diagnosed with breast cancer at Naval Medical Center San Diego
from January 1, 1988 to December 31, 1997 with the relationship between age,
socioeconomic status, race, and the means o f discovery o f breast cancer, length o f time
before diagnosis, length of time between diagnosis and initiation o f treatment, and stage at
diagnosis in women identifying their race as African American and being diagnosed with
breast cancer at Naval Medical Center San Diego from January 1, 1988 to December 31,
1997.
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Conceptual Framework
The conceptual framework for this study was based on the Aday/Andersen
Framework for the Study of Access (Aday & Andersen, 1974). The Aday/Andersen
access model was initially applied directly in a national survey o f access to medical care
conducted in 1976 (Aday, Andersen, Fleming, 1980). This model has subsequently
provided the framework for numerous community surveys o f access to medical care
(Aday, 1985; Aday, et al., 1993; Andersen, Giachello, & Aday, 1986; Northam, 1996;
Urrutia-Rojas & Aday, 1991), and studies evaluating the impact o f access barriers on
health care (Aday, Andersen, Loevy, & Kremer, 1984; Champion & Menon, 1997;
Guidry, Aday, Zhang, & Winn, 1997; Guidry, et al., 1996; Miller & Champion, 1997).
The Aday/ Andersen framework defines access as “ ...those dimensions which
describe the potential and actual entry o f a given population group to the health care
delivery system” (Aday, Fleming, & Andersen, 1984, p. 13). Health care policy is
characterized as the starting point for access in this model since improved access is
considered to be a primary goal o f most health care policies (Aday & Andersen, 1974).
Indicators o f potential access are identified as characteristics o f the health care delivery
system and the population at risk, while indicators o f actual or realized access are
identified as utilization and satisfaction. More specifically, the likelihood o f an individual’s
entering the health care delivery system is purported to be influenced by the structure of
the system, and the nature of the needs, wants, and resources brought to the care-seeking
process by potential consumers o f health care; and the realization o f entrance into the
health care delivery system is demonstrated by a population’s reported rates o f utilization,
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and through their subjective evaluation o f the health care services they obtain (Aday,
Fleming, & Andersen, 1984).
In conceptualizing potential access, characteristics o f the health care delivery
system are operationalized as the availability and organization o f health care resources
(Aday, Andersen, & Fleming, 1980). Health care resources include health care personnel,
structures in which the health care is delivered, the education provided, and equipment and
materials used in providing the care. Characteristics of the population at risk are
operationalized as predisposing, enabling, and need-oriented. Predisposing characteristics
include such variables as age, sex, race, and values concerning health and illness, and
describe the “propensity” of individuals to use health care services. Enabling
characteristics include such variables as income, insurance coverage, and geographic
location in relation to the health care services, and describe the “means” individuals have
at their disposal for the use of services. The need for health care may be either perceived
by the individual or determined by the health care delivery system, and refers to the most
immediate initiator o f health care service use, the illness level (Aday, Andersen, &
Fleming, 1980).
Realized access is conceptualized by characteristics o f the utilization o f services
and consumer satisfaction (Aday, Andersen, & Fleming, 1980). Utilization o f health care
services can be objectively measured and is operationalized by evaluation of the type of
services utilized, the site of the health care encounter, the purpose o f the utilization of
services, and the time interval involved with utilization of services. The time interval can
be evaluated in terms of whether or not an individual entered the health care system within
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a given period o f time, by the number of visits within a given period o f time, or by the
degree o f coordination o f services associated with a particular illness. Consumer
satisfaction is operationalized as a subjective measure of the consumer’s attitudes toward
the health care delivery system and their satisfaction with their experiences with the health
care delivery system (Aday, Andersen, & Fleming, 1980).
This study did not investigate all o f the variables described by Aday and Andersen
(1974). Data were collected regarding the age, race, and socioeconomic status o f the
population at risk. Variables characterizing the event initiating utilization o f specialized
breast health care services were evaluated. Aspects of utilization o f health care services
were also evaluated. A schematic model o f the variables selected for inclusion in this
study is presented in Figure 1. The arrows depict the flow o f influence theorized by the
investigator to exist between potential and realized access, and stage at diagnosis o f breast
cancer. This conceptual model also provided the framework for the literature review
presented in chapter two.
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Figure 1. Framework for the Study of Access to Breast Health Care for Women in the Military Health System
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Research Questions
1. What are the relationships between age, race, socioeconomic status, the means
of discovery of breast cancer, and stage at diagnosis of breast cancer in women identifying
their race as Caucasian or African American, and being diagnosed with breast cancer at
Naval Medical Center San Diego from January 1, 1988 to December 31, 1997.
2. What are the relationships between the length of time between discovery and
diagnosis o f breast cancer, and the length o f time between diagnosis and initiation o f
treatment o f breast cancer, and stage at diagnosis o f breast cancer in women identifying
their race as Caucasian or African American, and being diagnosed with breast cancer at
Naval Medical Center San Diego from January 1, 1988 to December 31, 1997.
3. To what extent do the variables age, race, socioeconomic status, and the
means o f discovery o f breast cancer predict the length o f time between discovery and
diagnosis o f breast cancer, and the length of time between diagnosis and initiation of
treatment o f breast cancer, in women identifying their race as Caucasian or African
American, and being diagnosed with breast cancer at Naval Medical Center San Diego
from January 1, 1988 to December 31, 1997.
4. To what extent do the variables age, race, socioeconomic status, and the means
of discovery o f breast cancer predict stage at diagnosis o f breast cancer in women
identifying their race as Caucasian or African American, and being diagnosed with breast
cancer at Naval Medical Center San Diego from January 1, 1988 to December 31, 1997.
5 . To what extent do the variables length o f time between discovery and diagnosis
of breast cancer, and length o f time between diagnosis and initiation o f treatment o f breast
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cancer, predict stage at diagnosis of breast cancer in women identifying their race as
Caucasian or African American, and being diagnosed with breast cancer at Naval Medical
Center San Diego from Januaiy 1, 1988 to December 31, 1997.
Importance o f the Study
Addressing the problem of access by focusing principally on availability o f care,
economic barriers, and health insurance coverage, excludes the impact o f other aspects of
access, and assumes that economic access to care translates into utilization o f health care
services (Bashshur, Homan, & Smith, 1994; Facione & Facione, 1997; Friedman, 1994;
Guidry et al., 1996; Pearlman, Rakowski, Ehrich, & Clark, 1996).
Steiner (1991), states:
Access to health care is more than the mere availability o f physicians and county
hospitals or clinics to serve the medically indigent within a certain geographic area;
it is the availability of services that are financially accessible to the patient; it is the
availability of effective cancer prevention and early detection educational
messages that are culturally sensitive and meaningful to the patient population; and
it is the availability of acceptable, appropriate, and comprehensive early detection
and treatment services in an environment that is concerned about the needs of the
person, treats the person with dignity, provides care in a timely fashion, and
provides quality, culturally sensitive care (p. 1736 ).
The success o f health care service availability in decreasing morbidity and mortality
associated with cancer depends on actual utilization o f services (Mandelblatt et al., 1993);
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and utilization o f cancer screening services is guided by a perception o f their necessity and
appropriateness, as well as their availability.
The existing nursing research on African American women’s access to breast
health programs has been inadequate in its provision of knowledge o f factors influencing
African American women’s participation in breast health care (Bibb, 1997). This
inadequacy presents a practice problem for the discipline of nursing, since the primary
purpose o f nursing research is to improve nursing practice (Bunting & Campbell, 1994;
Hunt, 1996); and nursing’s involvement in African American women’s participation in
breast health programs is crucial if breast cancer mortality is to be reduced. “Research
based knowledge is incorporated into one’s critical thinking about identified practice
problems and changes are made in the individual’s personal professional practice on the
basis of this knowledge” (Crane, 1995). Therefore, continuing to focus current research
on testing availability of care and health care insurance, as an exclusive determinant of
African American’s women participation in breast cancer screening programs, could
impede nursing’s progress in improving access to breast health care.
Research is used to generate and test theory (Chinn & Kramer, 1995), and existing
research on access has generated evidence o f additional delineators o f access to breast
health care which should be examined. This study provides an opportunity to examine the
relationship between other aspects o f access and utilization o f breast health care services
within an “equal” economic access health care delivery system; and to provide a
knowledge base for the formation o f hypotheses to be tested in future breast health care
research focused on women of color.
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Definition o f Terms
Economic access: the availability of health care and health insurance coverage (Aday,
Andersen, Fleming, 1980), as indicated by a woman’s eligibility to receive care in the
MHS being indicated on the Tumor Registry medical record.
Potential access:
Age: the age o f the woman at the time o f diagnosis as indicated on the Tumor
Registry medical record.
Race: the classification of an individual based on physical characteristics.
1. Black woman is defined as any woman identified as non-Hispanic black or
African American on the Tumor Registry medical record.
2. White woman is defined as any woman identified as non-Hispanic White or
Caucasian on the Tumor Registry medical record.
Socioeconomic Status fSESV the active duty rank o f the woman or military
sponsor entitling the woman to receive health care within the MHS (Clark & Thompson,
1994), as indicated on the Tumor Registry medical record.
1.

Enlisted ranks are defined as E l (enlisted at the first level of rank) through

E9 (enlisted at the ninth level of rank).
2.

Officer ranks are defined as Chief Warrant Officer (CWO) and 01

(commissioned officer at the first level o f rank) through 010 (commissioned officer at the
tenth level o f rank).
3.

Junior Enlisted ranks are defined as E l through E5.

4.

Senior Enlisted ranks are defined as E6 through E9.
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5.

Junior Officer ranks are defined as CWO through 04.

6.

Senior Officer ranks are defined as 0 5 through Ol 0

Means of discovery of breast cancer: The means of discovery o f a breast lump,
mass, or abnormality that initiated the woman’s utilization o f specialized breast health
services and resulted in the diagnosis of breast cancer. Indicated on the Tumor Registry
medical record as one o f the following means:
1.

Intentional breast self exam (BSE): discovered by the woman while

routinely examining her own breasts.
2.

Incidental BSE: incidentally or accidentally discovered by the woman or

significant other.
3.

Routine clinical breast exam (CBE): discovered by a provider o f health care

within the MHS or other health care delivery system during a routine breast health care
exam.
4.

Secondary CBE: discovered by a provider o f health care within the MHS

or other health care delivery system during a physical exam for purposes other than
routine breast health care.
5.

Routine mammogram: discovered during performance o f routine clinical

mammogram.
6.

Secondary mammogram: discovered during a clinical mammogram

performed as a result of a complaint of a medical condition other than breast related.
Realized access:
Utilization o f services measured by:
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Length o f time between discovery and diagnosis - the length o f time in days
between discovery o f breast lump, mass, or abnormality and diagnosis o f breast cancer, as
indicated on the Tumor Registry medical record.
Length o f time between diagnosis and treatment - the length o f time in days
between diagnosis o f breast cancer and initiation o f treatment o f breast cancer (excision of
lump, mastectomy, chemotherapy, or radiation therapy), as indicated on the Tumor
Registry medical record.
Stage at diagnosis o f breast cancer: refers to the grouping of patients according to the
extent o f their disease as indicated on their Tumor Registry medical record. This grouping
is defined in accordance with the classifications outlined for clinical staging o f breast
cancer in the American Joint Committee On Cancer (AJCQ Cancer Staging Manual
(1997). Staging is based on classification o f the primary tumor (T), regional lymph nodes
(N), and distant metastasis (M). A summary o f these classifications is presented in tables
1, 2, and 3. Table 4 summarizes the clinical staging o f breast cancer at diagnosis, using
the TNM classifications.
Stage classifications for this study are defined as:
1.

In situ:

Stage 0

2.

Stage 1:

Stage I

3.

Stage 2:

Stages HA and IIB

4.

Stage 3:

Stages IIIA and DIB

5.

Stage 4:

Stage IV

6.

Earlv stage: In situ and stage 1; Late stage:
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Table 1

AJCC Primary Tumor (T) Classification

TX

Primary tumor cannot be assessed

TO

No evidence o f primary tumor

Tis

Carcinoma in situ

T1

Tumor 2 cm or less in greatest dimension

T2

Tumor more than 2 cm but not more than 5 cm in greatest dimension

T3

Tumor more than 5 cm in greatest dimension

T4

Tumor o f any size with direct extension to chest wall or skin.

Table 2

AJCC Lvmph Nodes fND Classification

NX

Regional lymph nodes cannot be assessed

NO

No regional lymph node metastasis

N1

Metastasis to moveable ipsilateral axillary lymph node(s)

N2

Metastasis to ipsilateral axillary lymph node(s) fixed to one another or to other structures

N3

Metastasis to ipsilateral internal mammary lymph node(s)

Table 3

AJCC Distant Metastasis (TVO Classification

MX

Distant metastasis cannot be assessed

MO

No distant metastasis

Ml

Distant metastasis
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Table 4

AJCC Clinical Staging o f Breast Cancer

Stage

Primary Tumor

Regional Lymph Nodes

Distant Metastasis

Stage 0

Tis

NO

MO

Stage I

T1

NO

MO

Stage HA

TO

N1

MO

T1

N1

MO

T2

NO

MO

T2

N1

MO

T3

NO

MO

TO

N2

MO

T1

N2

MO

T2

N2

MO

T3

N1

MO

T3

N2

MO

T4

Any N

MO

Any T

N3

MO

Any T

Any N

Ml

Stage UB

Stage IDA

Stage IH B

Stage IV
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Assumptions
The assumptions on which this study was based include:
1. All information contained in the Tumor Registry medical record is accurate and
reflects information included in the woman’s hospital medical record.
2. Health care resources within the MHS are adequate in terms o f the availability
of health care personnel, equipment, and educational services.
3. All women entitled to receive health care within the MHS have “equal”
economic access to breast health care services.
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CHAPTER II
REVIEW OF THE LITERATURE
The literature pertaining to breast cancer mortality disparity between African
American and Caucasian women was critically reviewed for its relevance to this study.
This chapter presents a review o f research studies and findings that support the
relationship between the study variables: economic access, age, race, SES, the means of
discovery o f breast cancer, delay in diagnosis o f breast cancer, delay in treatment of breast
cancer, and stage at diagnosis of breast cancer. Studies included in this review tend to
address multiple aspects of this study’s variables. For instance, age, race, and SES are
included as demographic variables in many o f the studies reviewed, and the means of
discovery o f breast cancer (BSE, CBE, mammogram) is frequently included as a variable
in studies examining delay in diagnosis and treatment of breast cancer. Therefore, for
organizational purposes, the following subsections are arranged based on the major
variable examined in the research study under review, as it relates to stage at diagnosis of
breast cancer, and breast cancer mortality disparity between African American and
Caucasian women.
Economic Access and Stage at Diagnosis of Breast Cancer
Studies exploring access as a barrier to cancer care and screening have defined
access primarily in terms o f economic access and in relation to health care insurance
coverage. Many o f these studies have focused on access to care created by federally,
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state, and locally financed health care programs, resulting from implementation o f health
care policy. “Improved access to care is an important goal o f much o f health policy”
(Aday & Andersen, 1974, p. 212). However, barriers to access may occur at the health
care delivery system level or at a personal level; and an individual’s ability and willingness
to participate in health care determines access, as well as the economic availability of
health care (Aday, et al., 1993; Bashshur, Homan, Smith, 1994; DeBaca, 1994; Facione,
Dodd, Holzemer, & Meleis, 1997; Facione & Facione, 1997; Friedman, 1994; Guidry,
Aday, Zhang, & Winn, 1997; Guidry, et al., 1996; Katz, Hislop, Thomas, & Larson, 1993;
Lauver & Ho, 1993; Lierman, 1988; Northam, 1996; Powell, Schwartz, & Hussain,
1995). In this study, economic access to health care was controlled for by examining
participation in breast health care by women eligible to receive care within the MHS. The
studies included in this section of the review examine the relationship between health
insurance coverage, demographic characteristics o f the individual seeking care, and stage
at diagnosis o f breast cancer.
In examining the relationship between health insurance coverage and clinical
outcomes among women with breast cancer, Ayanian, Kohler, Abe, and Epstein (1993)
studied the state cancer registry records o f 4675 women, 35 to 64 years o f age, diagnosed
with breast cancer in New Jersey between 1985 and 1987. The findings o f this study
reported that 88.3 percent of the women with private insurance were White, 70.8 percent
of those uninsured were White, and 64.4 percent o f those with Medicaid were White. The
researchers compared the stage o f breast cancer at diagnosis among uninsured and
Medicaid patients with the stage at diagnosis o f disease among privately insured patients
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and found that uninsured women (P< 0.001) and women covered by Medicaid (P= 0.01)
presented with significantly more advanced disease than those women who were privately
insured. Stratification o f the population according to age revealed that significantly more
advanced disease was present among uninsured women 50 to 64 years o f age (P< 0.001)
and those covered by Medicaid who were 35 to 49 years of age (P= 0.02), than among
those women with private health insurance coverage, in the same age groups. An
evaluation of stage specific survival by type of insurance coverage found that survival was
worse for uninsured (P< 0.001) and Medicaid (P< 0.001) patients with local disease, than
for privately insured patients. Survival was also worse for uninsured (P< 0.001) and
Medicaid (P< 0.001) patients with regional disease than for privately insured patients, but
there was no difference among the comparison groups for distant disease. The results of
this study support that women without health care insurance and with Medicaid coverage
presented with more advanced disease than did women with private health insurance.
After using multivariate analysis to estimate the adjusted risk of death among uninsured
and Medicaid patients, when compared to those who were privately insured, the
researchers found that uninsured and Medicaid patients had a greater adjusted risk of
death. In addition, those women who were uninsured or with Medicaid, had poorer
survival with local and regional disease than did those with private health care insurance;
and association between survival and type o f insurance coverage was identified.
Chaulk, Kazandjian, and Pipesh (1995) conducted a retrospective analysis using
hospital discharge data from 1989 through 1993 to explore racial differences in breast
cancer illness, comorbidity, and mortality in Maryland’s unique hospital all-payer rate
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setting system. The all-payer rate setting system has been shown to constrain economic
incentives in the decision to hospitalize and provide services once hospitalized. In a
sample o f 14,016 women (11,231 White, 2487 Black, and 298 other racial origin), the
researchers found that despite the presence o f the all payer system, Black women
hospitalized for breast cancer were more likely to be severely ill than white women. The
findings o f the study also demonstrated that more Black women died (2 .3% or 58 o f
2487) between 1989 and 1993, than did White women (1.4 % or 161 o f 11,231). In
addition, a relationship between the type of insurance coverage and the severity o f the
illness was also found to be present and was irrespective o f race. The percent o f women
insured by Medicare was 44.9, 44.5 percent had private insurance, 4.3 percent were
enrolled in a Health Maintenance Organization (HMO), and 2.5 percent were uninsured.
Medicaid recipients were significantly more ill than Medicare enrollees, privately insured
women, or women insured by an HMO. The researchers did not control for education,
care seeking behavior, or geographic access to services, and the discharge data reviewed
for the study did not indicate whether or when breast cancer screening was performed on
the women in the study. This study also demonstrated a relationship between the type o f
health care insurance coverage and stage at diagnosis o f disease.
Mandelblatt, Andrews, Kao, Wallace and Kemer (1995) used data from the New
York state department o f health tumor registry to examine the impact o f demographic
variable such as age, race, ethnicity, and type of reporting hospital; and social context
variables such as area o f residence, socioeconomic status and access to screening
mammography, on breast cancer stage at diagnosis among New York women between
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1980 and 1985. Chi-square and t-tests were used to assess the relationship between the
demographic variables and each stage. Late stage (stages 2, 3, and 4) breast cancer was
found to occur at a significantly higher proportion among women 50 to 64 years o f age
(54.7%) than among women 20 to 49 years o f age (50.9 % ) and women 65 and older
(50.5%) (P< 0.0001). Late stage disease occurred at the highest proportion in African
American women (59.2%), followed by Hispanic women (54.6 %), and White women
(50.4%) (P< 0.001). Women diagnosed in public hospitals had a higher proportion o f late
stage disease (63.7 %) than did women diagnosed in nonpublic hospitals (51.1 %). Three
logistic regression models were used to evaluate the impact of demographic variables,
social context variables, and both class of variables combined, on the outcome o f having
breast cancer diagnosed in a late stage, compared to an early stage. Women diagnosed in
public hospitals were 45 percent more likely to be diagnosed at a later stage than women
diagnosed in other types o f hospitals (P< 0.0001); and African American women were 34
percent more likely to be diagnosed at a later stage than White women (P< 0.0001). The
odds o f having late stage disease were 28 percent higher for women living in areas with
the lowest socioeconomic status ranking, when compared with women living in an area o f
the highest socioeconomic status ranking. Mammography capacity was a significant
independent predictor o f stage at diagnosis of breast cancer (P= 0.016).
Zaloznik (1995) conducted a retrospective review o f DoD MHS breast cancer
cases recorded in the DoD Automated Tumor Registry (ACTUR), from 1976 to 1992, to
determine if there were any differences in stage at diagnosis of breast cancer or survival
between Caucasian and African American women being diagnosed in the MHS. Zaloznik
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examined a total o f 6414 (89.58% of total) records o f Caucasians and 746 (10.41% of
total) records o f African Americans. The subjects were stratified according to age at
diagnosis, race, and stage at diagnosis, and the researcher found that there were no
statistically significant differences in stage at presentation between Caucasian and African
American women. Caucasian women had significantly (P = < 0.0001) more tumors < 1.0
centimeters than did African American women. African American women had more
tumors that measured 2.1 to 3.0 centimeters in size. The median age for diagnosis o f
breast cancer in African American women was 50, as compared to age 58 in Caucasian
women. Twenty-four percent of the African American women studied were less than 40
years old at presentation, compared to nine percent o f the Caucasian women (P=<
0.0001). Even though the findings of this study did not report a significant difference in
the stage at diagnosis o f breast cancer between African American and Caucasian women,
significant differences were reported in tumor size and age at diagnosis. This study did
not evaluate the effect o f socioeconomic status or geographic location of the treatment
facility on stage at diagnosis, nor did it look at care seeking or screening behaviors.
Wojcik, Spinks, and Optenberg (1998) conducted a retrospective review o f 6577
DoD MHS central tumor registry records to evaluate the effects of age, stage o f cancer at
diagnosis, tumor size, grade, lymph node involvement, waiting time between diagnosis and
first treatment, marital status, military dependent status, alcohol usage, tobacco usage, and
family history on breast cancer survival. The 5879 White (89.4% of the total) and 698
African American (10.6% o f the total) women included in the study ranged in age from 19
to 97 years, and were diagnosed with breast cancer between 1975 and 1994.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Chi-square analysis and t-tests were used to compare the characteristics o f the
African American and White women. The Cox proportional hazards model and several
multiple regression models were applied to examine the effects of the independent
variables on survival status. Almost 90 percent o f the women in the study were civilian
spouses o f active duty service members or military retirees, and 4.9 percent o f the women
were active duty members themselves. Within the group of African American women,
10.3 percent were on active duty when diagnosed with breast cancer as compared to 4.3
percent within the group of White women. The mean age at the time o f diagnosis for
African American women was 50 years as compared to 57.1 years for the White women;
and 22.8 percent o f the African American women were diagnosed with breast cancer at
less than 40 years o f age, as compared to 9.2 percent of the White women. Wojcik, et al.
found statistically significant (p = 0.0001) differences in overall survival between the
African American and White women. The mortality rate among African American women
was 24.77 percent as compared with 18.08 percent for White women. Tumor stage at the
time of diagnosis appeared to be the strongest predictor of death from ail causes. The risk
of death for women with tumors diagnosed at stage 3 was 6.55 times higher than for
women diagnosed at stage 0. African American women had significantly larger tumors
than White women (2.53 centimeters as compared to 2.28 centimeters, p = 0.013); and
48.86 percent of the African American women were diagnosed at stages 2 and 3 as
compared to 38.65 percent of the White women. The waiting time from diagnosis to
treatment was significantly shorter for African American women (21.15 days) than for
White women (29.51 days; p = 0.0024).
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Despite the significant difference in survival status between African American and
White women within the DoD MHS, Wojcik, et al. found that the five year risk o f death
for African American women receiving care in the DoD (1.37), when compared with
White women, was less than the relative risk reported in the Surveillance, Epidemiology,
and End Results (SEER) Program of the National Cancer Institute (1.86). The survival
rate for White women receiving care within the DoD was comparable to rates reported in
SEER. Based on these study findings, the researchers surmised that ready access to
medical facilities improves survival for African American women, and support that even
though ready access is necessary for receipt o f definitive medical care, it is not a sufficient
condition for equalizing survival rates between African American and Caucasian women.
Wojcik, et al. did not examine the effects of socioeconomic status or means o f discovery
on stage at diagnosis or survival status, and suggest that other explanations may
contribute to diagnosis o f African American women at younger ages and later stages o f
breast cancer.
The studies presented above support the existence o f a relationship between
economic access and stage at diagnosis o f breast cancer. The studies also identify
differences in stage at diagnosis of breast cancer relative to the type o f health care
insurance coverage, irrespective to race. Even when access to care was provided though
health insurance or public policy as a result o f local, state, or federal health care funding,
diagnosis delay occurred. Existence of economic access to health care did not always
result in early diagnosis o f breast cancer, and other factors such as age, race, and SES
were found to influence breast cancer diagnosis outcomes.
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Even though the studies presented above examined the impact of age, race, and
SES on stage at diagnosis o f breast cancer, and the type o f health care insurance being
utilized, the studies did not address the influence o f the means o f discovery o f breast
cancer (BSE, CBE, mammogram), or delays in diagnosis o f breast cancer, on stage at
diagnosis in women with economic access to health care.
Potential Access and Stage at Diagnosis o f Breast Cancer
The availability and organization o f resources within a health care delivery system,
and the characteristics o f the desires, needs, and resources that a potential consumer
brings to the care seeking process, influence the probability o f an individual’s entry into
the health care system (Aday, Fleming, & Andersen, 1984; Andersen, Giachello, & Aday,
1986; Berk & Schur, 1998; Guidry, et al., 1996). Therefore, potential access is
characterized by: predisposing factors such as age, sex, race, religion, and values
concerning health and illness; enabling factors such as income, insurance coverage, and
attributes of the community in which the individual lives; and need factors such as illness
level and the need for health care services as perceived by the individual or health care
delivery system (Aday & Andersen, 1974; Aday, Andersen, & Fleming, 1980). Because
the setting for this study was the MHS, the assumption was made that health insurance
coverage was available and equal for all eligible military beneficiaries. Nevertheless,
factors such as age, race, SES, and the event initiating breast health care differ among
individuals receiving care in the MHS, and may cause varying levels of potential access
within an equal access system. Therefore, the following section presents a review o f the
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literature o f the relationship between variables of potential access identified for inclusion in
this study, and stage at diagnosis o f breast cancer.

The single most important risk factor for breast cancer in women is age, although
race and ethnicity modify the effect o f age on the risk o f developing breast cancer (Vogel,
1996). The purpose of this review, however, is to explore the relationship between age
and stage at diagnosis of breast cancer. Age is represented as a demographic variable in
most of the studies presented in this chapter. Therefore, this section of the literature
review will focus on studies in which age was the major variable of the study in examining
its relationship to stage at diagnosis o f breast cancer.
Newman and Alfonso (1997) evaluated stage at diagnosis of breast cancer
distribution, relative to age, in women treated for breast cancer between 1990 and 1995 at
the Long Island College Hospital in Brooklyn, New York. For the purposes of this study,
the researchers conducted a retrospective review o f tumor registry data, hospital and
physician office records, and pathology reports on 283 White patients and 143 Black
patients. The two groups of women were stratified according to age and women 50 years
and older were designated as the older patient population, and women younger than 50
years were designated as the younger population. SES was estimated by access to
primary care management through the outpatient public clinic as compared to access to
private medical care. Chi-square analysis was used to determine statistical significance.
Newman and Alfonso found that the mean age at diagnosis for White women was 63 years
compared to 56 years for Black women; and that approximately one fifth o f the White
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women were diagnosed at less than 50 years of age compared to one third o f the Black
women (P = 0.008). Black women were diagnosed with in situ breast cancer in 8.6
percent o f the cases, and stage 1 cancer in 23.7 percent o f the cases, while White women
were diagnosed with in situ breast cancer in 10.4 percent o f the cases and stage 1 breast
cancer in 37.2 percent o f the cases (P = 0.004). Stage 3 and 4 cancers were diagnosed at a
significantly higher rate in Black women (27.3 percent) when compared to White women
(18.6 percent) (P = 0.049).
Stage 2, 3, and 4 breast cancer was diagnosed at a proportion of 64.6 percent in
the younger population o f women as compared to 55.8 percent in the older population.
There were no notable differences in the distribution o f stage at diagnosis o f breast cancer
in the older patient population. In the younger population, in situ breast cancer was
diagnosed in 22 percent o f the Black women as compared to 6.4 percent o f the White
women; and stage 0 and 1 breast cancer was diagnosed at a significantly lower rate in
Black women at 21.3 percent, when compared to 49.0 percent in White women (P =
0.004). Stage 3 disease occurred at the highest proportion in the younger Black women.
Stage 0 and 1 breast cancers occurred at a proportion of 38.1 percent in younger Black
women as compared to 21.3 percent in older Black women (P = 0.049).
Black women were diagnosed through the hospital’s public health clinic in 9.7
percent (14 o f 144) o f the cases as compared to 1.3 percent (3 o f 239) of the White
women, but over 90 percent o f both groups of women had access through the private
practice setting. The stage at diagnosis o f breast cancer distribution for Black women o f
all ages was similar among the public clinic patients and private practice setting patients.
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Stage 0 breast cancer was diagnosed in 9 .7 percent of the Black women receiving care in
the private setting, zero percent was diagnosed in women receiving care in the public
setting. Stage 1 and 2 breast cancers were diagnosed in 63.7 percent o f the Black women
receiving care in the private setting as compared to 64.3 percent in the public setting.
Stage 3 and 4 cancers were diagnosed in 26.6 percent o f the Black women receiving care
in the private setting as compared to 35.7 percent in the public setting.
The study presented above confirms that there is a higher incidence of late stage
breast cancer diagnosed in Black women when compared to White women. The study
also confirms that late stage breast cancer is diagnosed at a higher rate in younger Black
women when compared to older Black women and White women o f all ages. However,
these race related variances do not appear to be associated with the type o f health care
coverage since the majority o f the Black women in the study had access to and used
private medical care; and the distribution of stage at diagnosis o f breast cancer in Black
women receiving care through the public clinic was similar to the distribution of those
receiving care through the private practice setting. This study did not examine the
influence o f care seeking behaviors on stage at diagnosis o f breast cancer.
Race
Most o f the arguments for biological contributions to the disparity in breast cancer
death rates are based on race. However, there is growing consensus in the health care
literature to support that human races are not biological entities, and that racial
classification in the United States is determined by social and political parameters (Hahn &
Stroup, 1994; Herman, 1996; Roach & Alexander, 1995). In addition, the concept o f race
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has been purported to be socially meaningful, but of limited biological significance; and the
factors creating the breast cancer mortality disparity have been argued to be not as much
biological as they are cultural, social, geographical, and structural (Adams, 1995; BayneSmith, 1996; Frank-Stromborg & Olsen, 1993; Freeman, 1997; Kato & Mann, 1996;
Williams, Lauizzo-Mourey, & Warren, 1994). The studies presented in the following
section integrate examination of the relationship between cultural, social, structural, and
biological perspectives of race, and stage at diagnosis of breast cancer in African
American and Caucasian women.
Coates et al. (1990) examined the effects o f nutritional status on breast cancer
survival differences among 469 Black and 1491 White women diagnosed with breast
cancer in Georgia between 1975 and 1979. Nutritional status variables included height
measured in meters, weight measured in kilograms, and serum albumin, hemoglobin, and
lymphocyte counts. Demographic, medical, and clinical characteristics such as: age in
years, marital status, education in years, menopausal status at diagnosis, prior history of
cancer, family history of cancer, history of breast self examination, number o f lymp nodes
involved, type o f treatment (surgery, radiation therapy, hormone therapy, chemotherapy),
occupational status o f the patient’s household, stage at diagnosis o f breast cancer, tumor
histology, time between the recognition o f symptoms and the first medical consultation,
and time between the first medical consultation and diagnosis were also included in the
analysis. This study employed several statistical tests. Stage and race specific median
body mass indices, lymphocyte counts, and levels o f serum albumin and hemoglobin were
compared to assess associations between race and nutritional status indicators. Odds
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ratios and corresponding approximate 95 percent confidence intervals were used to
evaluate the associations between race and the nutritional status indicators, and between
race and other suspected prognostic factors identified through the research literature.
Univariate survival analyses, with the Kaplan-Meier product estimation procedure, were
performed to assess the relationship between suspected prognostic factors and survival
from breast cancer. The Wilcoxon test statistic was used to assess statistical significance
of differences between survival curves. The prognostic effect of race was evaluated using
the Cox proportional hazards regression approach with adjustments made for nutritional
status variables and other confounding prognostic factors.
Coates et al. found that Black women in this study were more likely to be younger,
unmarried, less educated, and of a low occupational status than White women. Black
women were less likely to have a personal history o f breast cancer than were White
women; and Black women were less likely to perform BSE than were White women.
Black women tended to have a longer time between recognition of symptoms and seeking
medical care; and Black women tended to have more advanced disease and lymph node
involvement, and were more likely to present with nipple bleeding and ulceration, at the
time of diagnosis, than were White women. Because Black women were more likely to
present with advanced, inoperable disease, when compared to White women, the
percentage o f Black women not undergoing surgery was elevated. When data were
adjusted for stage at diagnosis of breast cancer, socioeconomic status, and other
prognostic factors mentioned above, poorer survival rates were demonstrated in Black
women when compar ed to White women. There was a strong association between race
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and three o f the four nutritional status measures. Lower levels o f serum albumin and
hemoglobin and higher relative body weight were more common among Black women
than among White women, and were independently associated with poorer survival.
Approximately 76 percent of the White women in the study survived five years as
compared to 57 percent o f the Black women. The black-to-white hazard rate ratio among
women with stage 3 disease was 1.61. Adjustment for demographic, medical, and clinical
characteristics among women with stage 3 disease reduced the black-white difference in
mortality rates in these women to a ratio rate o f 1.54. However, simultaneous adjustment
for all four o f the nutritional status variables reduced the rate ratio to 1.14, resulting in a
74 percent reduction in excess risk for Black women.
The results o f this study support that differences in the nutritional status of Black
and White women may contribute to differences in survival. Black women were more
likely to have lower serum albumin and hemoglobin levels than White women, and were
more likely to be overweight. These differences were associated with poorer survival
rates, and in women with stage 3 disease, adjustment for these nutritional status indicators
explained three fourths o f the excess risk o f mortality among the Black women in this
study. Serum albumin, commonly used as an indicator of nutritional status, reflects
protein calorie nutrition intake. However, serum albumin is also a reflection o f disease
status in various illnesses (Coates et al., 1990). The researchers in this study
acknowledged that the lower serum albumin levels in the Black women in this study could
be a reflection o f nutritional status or a reflection o f the extent o f the disease within stage.
Decreased serum hemoglobin levels can reflect malnutrition or may result from the
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presence o f disease, including breast cancer. Therefore, the associations found between
decreased serum albumin and hemoglobin levels could be indicative o f either nutritional
status or disease severity. This study’s findings about the poorer survival rates among
overweight Black women with breast cancer are consistent with other research studies
(Coates et al., 1990); however, it is not clear if the association noted between obesity and
stage at diagnosis is a reflection o f masking o f signs and symptoms o f breast cancer due to
being overweight or hormonal mechanisms.
Jones, Kasi, Cumen, Owens, and Dubrow (1997) also evaluated the effect of
obesity on poorer stage at diagnosis outcomes for Black women when compared to White
women. In conducting a retrospective review o f 145 Black women and 177 White women
diagnosed with breast cancer in Connecticut between January 1987 and March 1989, these
researchers examined the extent to which the observed racial differences in stage at
diagnosis o f breast cancer could be explained by racial differences in severe obesity. Odds
ratios and their 95 percent confidence interval and logistic regression were used to test for
significant associations between race, obesity, and stage at diagnosis. Jones et al. found
that severe obesity was associated with both race and stage at diagnosis o f breast cancer.
Severe obesity was more likely to occur in Black women (26 percent) than in White
women (7 percent); and severe obesity was significantly associated with diagnosis of
breast cancer in stage 2 or greater. After adjustment for severe obesity, the risk of
diagnosis o f breast cancer at a later stage was reduced by 33 percent in Black women as
compared to White women. The findings o f this study concluded that severe obesity may
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play an important role in explaining the higher prevalence of late stage diagnosis o f breast
cancer in Black women.
Hunter et al. (1993) obtained data from the National Cancer Institute’s
Black/White Survival Study for the period 1985 to 1986 and evaluated the relationship
between selected demographic, lifestyle, health care access, antecedent medical experience
factors, and stage at diagnosis o f breast cancer in 649 Black and 573 White women. The
women included in the study were newly diagnosed with primary breast cancer between
January 1, 1985 and December 31, 1986; ranged in age from 20 to 79; and resided in one
of the following areas: Atlanta, Georgia; New Orleans, Louisiana; or the San FranciscoOakland, California area. Approximately 70 percent o f the Black breast cancer cases
were randomly selected from each metropolitan area, and a sample of White breast
cancer cases was matched by age groups to adjust for the tendency for the Black women
to be younger than the White women at the time o f diagnosis. Adjustment of the patient
selection rates resulted in a slight imbalance in the race distribution in the study, 53
percent Black women and 47 percent White women. Hunter et al. collected data from
medical records, review o f histology slides, and patient interviews. Demographic factors
included marital status, education, and total family income. Lifestyle factors included
smoking history and body mass index. Antecedent medical experience factors included
history o f BSE and CBE during the six years prior to breast cancer diagnosis; length o f
time from the woman’s recognition of a symptom to the first visit to a physician for that
symptom; and current medical conditions that the women had at the time o f admission to
the hospital for a diagnosis o f breast cancer. Access to medical care factors included the
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type of health insurance and usual source of medical care. Stage at diagnosis was
classified according to the tumor-lymph node-metastases (TNM) system for breast cancer
based on post surgical pathologic evaluation criteria o f the American Joint Committee on
Cancer (Stages: in situ, I, II, HI, and IV).
Hunter et al. evaluated the differences in breast cancer stage at diagnosis and the
distribution of the factors mentioned above, between the Black and White women
included in this study by using chi-square tests for independence, and chi-square test for
trend, where appropriate. Log-linear models were used to evaluate the relationship
between each factor and stage at diagnosis separately in the groups o f Black and White
women. Logistic regression models were used to examine explanatory factors that
showed a statistically significant association with stage at diagnosis in both groups of
women. The researchers found a highly significant association between race and stage at
diagnosis (P < .00005). Black women had a more advanced stage o f disease at diagnosis.
There were no significant differences in age adjusted race-stage relationship by
metropolitan area. Women younger than 50 years old with in situ disease were
significantly more likely to be White, while those with stage III or IV were significantly
more likely to be Black. There was no statistically significant difference in stage at
diagnosis observed in women 65 to 79 years o f age. Black women were more likely than
White women (P < .001) to have less than a high school education, be overweight, and
have a lower total family income. Black women were also more frequently never married
and more often current smokers, and had a greater history of existing medical conditions.
In addition, a greater proportion of Black women, than White women, were found to
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either have no insurance or have public assisted health care, with their usual source o f
medical care being the hospital outpatient clinic, emergency room, or public clinic. The
majority o f the women in both groups reported practicing BSE and participating in CBE;
and the length o f time from recognition o f symptoms to seeking medical consultation was
equal in both races. A recent history o f CBE was significantly associated with lower stage
disease in both groups (Black women, P < .01; White women, P < .04); and a history o f
delay between recognition of symptoms and medical consultation was positively related to
a higher stage at diagnosis in both races (P < .00005). Limited access to health care, usual
source o f medical care, larger body mass index, and history o f low mammography use
factors w ere associated with a higher stage at diagnosis o f breast cancer only in the Black
women in the study. Lower income was associated marginally with higher stage o f disease
only in the White women in the study (P = .06); and less education was associated
marginally with higher stage o f disease at diagnosis only in the Black women in the study
(P = .07).
The Black women in this study were diagnosed at a higher stage of disease than
the White women. In the Black women, access to health care, lifestyle, and antecedent
medical experience were factors found to be associated with higher stage at diagnosis; and
in the White women in this study, SES tended to have more influence on higher stage at
diagnosis o f breast cancer. Women with higher total family income, and medical care
through private physicians or private medical clinics were found to present with lower
stage of disease, suggesting that higher stage at diagnosis is related to poorer access to
health care and lower SES. However, this association is social, and perhaps
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environmental, but there are no data in this study to support that it is biological. The racestage association observed in this study is complex and supports that there are multiple
factors influencing differences between stage at diagnosis in the Black and White women
included in this study. Hunter et al. evaluated factors associated with race, age, SES, the
means o f discovery o f breast cancer, and treatment and diagnosis delay. However, the
evaluation was conducted across three metropolitan areas with varying social, political,
and environmental climates; and in access systems that have the potential to vary in health
care availability, quality, and promptness. Even though this study is systematic and
comprehensive in its evaluation o f factors associated with differences in stage at diagnosis
o f breast cancer between Black and White women, studies systematically evaluating the
influence o f these factors on stage at diagnosis of breast cancer in an equal economic
access system are needed.
Eley et al. (1994) used data from the National Cancer Institute’s Black/White
Cancer Survival Study for the period o f 1985 to 1986 to examine the impact of recognized
prognostic factors on the observed poorer breast cancer survival rate in Black women
when compared to White women. The study included 612 Black and 518 White women,
age 20 to 79 from three different geographic areas. The sampling design was based on
random sampling of Black subjects and frequency matching o f White subjects by age
groups. Data were derived from personal interviews with the women, abstracts o f the
hospital records, and a central pathology review of biology and surgical specimens in
exploring the impact of stage at diagnosis, histopathologic characteristics of the tumor,
treatment, concurrent medical conditions, socioeconomic status, and usual source of care,
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on survival differences. Frequency tables and chi-square test were used to examine
bivariate relationships between race and the variables mentioned above. Cox proportional
hazards regression was used to asses the impact of the variables mentioned above on racial
differences in survival after diagnosis o f breast cancer. After controlling for age and
geographic area, Eley et al. found that the risk of dying from breast cancer was 2.2 times
greater for Black women than for White women and concluded that approximately 75
percent o f the racial difference in survival was explained by the prognostic factors
explored in the study (stage at diagnosis, histopathologic characteristics of the tumor,
treatment, concurrent medical conditions, SES, usual source of medical care, marital
status, occupation, poverty index). Approximately 40 percent o f the difference in the
survival rate was explained by a more advanced stage of the disease in the Black women.
After controlling for stage and tumor pathology, information about treatment did not
explain the survival difference. Racial differences in stage at diagnosis of breast cancer
appeared to be largely influenced by social and demographic factors.
Simon and Severson (1996) examined racial differences in survival of breast cancer
in 8622 White and 1880 African American women diagnosed with breast cancer in the
Detroit metropolitan area between 1988 and 1992. This retrospective analysis was
conducted using medical and demographic data obtained from the Metropolitan Detroit
Cancer Surveillance System. Demographic data included age at diagnosis, race, marital
status at diagnosis, and census derived socioeconomic rank. Clinical variables included
tumor size, stage at diagnosis, histologic type and histologic grade. Factors relating to the
characteristics of the hospital in which each woman received their first course o f cancer
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related surgery included the number o f beds in the hospital, presence o f a residency
training program, and the proportion o f Medicaid and/or Medicare patients discharged
from each hospital. The chi-square test was used to assess differences between age,
marital status, socioeconomic census rank, tumor size, stage at diagnosis, histologic type
and grade o f the tumor, number o f beds in the hospital, presence of residency training,
proportion o f Medicaid and/or Medicare discharges, and race. The relative risk o f death
from any cause in African American women, when compared to White women, was
estimated using Cox proportional hazards regression.
Simon and Severson found that the African American women in this study were
more likely to be younger than the White women, when diagnosed with breast cancer. In
addition, African American women were more likely to live in a census tract with a lower
socioeconomic census rank than were White women. African American women were
found to present at a more advanced stage, with larger tumors, and a higher tumor
histologic grade. When examining local (confined to the breast) and regional (spread
beyond the breast by direct extension or to regional lymph nodes) stage disease, the
researchers found that White women had a significantly better survival than did African
American women (log rank, P = 0.0001). Although not significantly different within
remote (direct extension or metastases to organs other than regional or distant lymph
nodes) stage disease, White women seemed to have better survival rates than did African
American women (log rank, P = 0.3). There was a significant difference in survival
between African American women and White women in the first four years after
diagnosis, however there was no significant difference in women who lived longer than
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four years. There was a significant interaction between age at diagnosis and race (P =
0.005). Fifty percent o f the variation in survival between African American and White
women was accounted for by adjusting for age, marital status, socioeconomic census rank,
stage at diagnosis, characteristics o f the tumor, number o f beds in the hospital of
treatment, presence o f residency training, and the proportion o f Medicaid and/or Medicare
discharges.
Roach et al. (1997) evaluated the prognostic significance o f race and survival in
stage 2 breast cancer in 185 African American, 1325 White, 12 Oriental, and 34 other
[race] women treated with adjuvant chemotherapy in the Cancer and Leukemia Group B
(CALGB) trial 8541. Retrospective analysis was conducted using data from the CALGB
database. Women included in the CALGB trial had: (a) Histologically confirmed stage 2
breast cancer with no or minimal symptoms; (b) clear margins following radical, modified,
or breast conserving surgery; (c) chemotherapy preceded by dissection o f level one and
two lymph nodes; (d) chemotherapy followed by external beam irradiation consisting o f 50
Gy to the entire breast and 1.5 Gy boost to the area of incision; (e) initial chemotherapy
including CAF (cyclophosphamide, doxorubicin, fluorouracil); (f) tamoxifen added in
women who were perimenopausal, or who were postmenopausal with positive estrogen
receptors; and (g) chemotherapy prescribed based on actual body weight. Women
included in the CALGB 8541 trial were randomly assigned to receive either a high dose,
standard dose, or low dose intensity o f chemotherapy; and were stratified according to
type of breast management, menopausal status, number of lymph nodes involved, and
estrogen receptor status.
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In this study, differences in disease free survival and overall survival were assessed.
“Disease free survival was defined as the time from randomization to a documented
relapse or death without a relapse. Overall survival was defined as the time from
randomization to death from any cause” (Roach et al., 1997, p 108). The proportional
hazards model for multivariate analyses, the log rank test, and the stratified log rank test
for univariate analyses were used to assess differences in disease free and overall survival.
African American women were found to be slightly more likely to be estrogen
receptor positive (34 percent) than were White women (26 percent) (P = 0.03). Ninety
percent o f the African American women were more likely to have had a mastectomy when
compared to White women (84 percent) (P = 0.03). African American women tended to
be younger (median 46 years) than White women (median 50 years) (P < 0.01); and
African American women tended to have tumors somewhat larger (median 3.0
centimeters) than White women (median 2.5 centimeters) (P < 0.01). When compared to
White women, African American women tended to have more delays in treatment (P =
0.01); had a 1.35 (P = 0.04) times higher risk of death; and were 1.24 (P = 0.09) times as
likely to fail treatment. However, after adjusting for prognostic factors such as dose,
intensity o f chemotherapy, number o f positive lymph nodes, estrogen receptor status, and
age, these researchers found that race was not an independent prognostic factor for overall
survival or disease free survival. Roach et al. concluded that they could not
“mechanistically” explain the existence of significant biologic breast cancer cause and
effect factors related to skin color and that “ ...efforts directed at early detection of breast
cancer in African American women are likely to have greater impact on improving their
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survival than efforts directed at identifying a biologic basis for their lower survival” (p.
111).

Krieger, Van Den Eeden, Zava, and Okamoto (1997) assessed the distributions of
breast cancer prognostic biomarkers by race and ethnicity in 48 White, 44 Black, and 43
Asian women diagnosed with breast cancer within a large health maintenance organization
in the San Francisco area between 1966 and 1990. The study was based on tumor
samples obtained from a random sample o f 50 White, 50 Black, and 50 Asian women
selected for inclusion in a nested case control study examining the relationship between
exposure to organochlorines and risk o f breast cancer. Women were included in this study
based on self identified race and ethnicity, diagnosis o f breast cancer at least sue months
after receiving a multiphasic examination at the health maintenance organization, and prior
to December 31, 1990, and the researchers’ ability to locate tumor blocks (archival
paraffin-embedded tumor biopsy specimens).
A multiphasic self administered questionnaire, supplemented by a physical
examination provided data on the women’s sociodemographic, reproductive, and
anthropometric characteristics. Data were obtained through medical record chart review
pertaining to the women’s age and parity; menopausal status at the time o f diagnosis;
tumor characteristics such as stage, grade, laterality, size, and lymph node involvement;
and surgical assession number for each cases’ tumor block. The researchers reviewed
pathology reports to determine which blocks should be analyzed for tumor markers; and
immunohistochemistry on thin sections ( 4 - 5 microns) prepared from paraffin blocks was
used to determine biomarkers. The stage o f a breast tumor was categorized as local,
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regional, or distant; and tumor size was categorized as < 20 millimeters or > 20
millimeters.
Odds ratios and their 95 percent confidence interval and univariate analyses were
used to assess sociodemographic, reproductive, anthropometric, and breast cancer tumor
characteristic distributions overall and by race and ethnicity. Multivariate logistic
regression was used to adjust for place of birth, menopausal status, and age at diagnosis,
and to compare tumor characteristic and socioeconomic distributions by race and
ethnicity. Approximately 66 percent o f the women studied were diagnosed with local
disease. Forty percent had tumors that measured < 20 millimeters, and 44 percent o f the
women studied had lymph node involvement. There were no notable differences in tumor
stage and lymph node involvement across racial and ethnic and socioeconomic groups.
When compared to White women, and after adjusting for age at diagnosis, menopausal
status, place of birth, and socioeconomic status, Black women were 3 .5 times more likely
to have breast tumors > 20 millimeters; and Asian women were 3.7 times more likely to
have tumors > 20 millimeters. After adjusting for age at diagnosis, menopausal status, and
place of birth, there was no notable differences in tumor size by socioeconomic status,
however tumor size tended to be larger in women who had completed four or more years
of college. Approximately 70 percent of the tumors found in all three racial and ethnic
groups were estrogen receptor positive; and there were no clear patterns o f differences in
distribution of breast cancer molecular prognostic markers by socioeconomic class.
Therefore, disparities in breast cancer mortality rates between the racial and ethnic groups
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evaluated in this study could not be explained solely by differential distributions o f
molecular breast cancer prognostic biomarkers.
The studies presented above identify multiple factors influencing the disparity in
stage at diagnosis and mortality between African American and Caucasian women. These
studies also support the premise that race is not biological, but rather social, cultural,
and/or structural. Delayed diagnosis of breast cancer has been shown to occur at a higher
rate in the African American women in the studies presented above; however, diagnosis
delay has also been shown to be associated with social, cultural, and structural constructs
such as SES, educational level, type of health insurance coverage, and obesity. Several of
the studies in this section evaluated the relationship between stage at diagnosis o f breast
cancer, and many o f the variables proposed to be examined in this study. Age, race, SES,
preventive health practices such as BSE, CBE, and mammograms, as well delays related
to the diagnosis and treatment of breast cancer, and their relationship to stage at diagnosis
outcomes in African American and Caucasian women have been systematically examined .
In many instances, the findings were inconclusive. Late stage at diagnosis was repeatedly
demonstrated to be associated with African American women. Young African American
women, in particular, were found to have more advanced disease and larger tumors.
However, many o f the African American women in the studies presented above were from
low SES; and it is not clear if these differences between the African American and White
women in these studies are associated with race, health insurance coverage, or SES.
Studies examining access as a multifaceted concept are needed to help provide knowledge
and understanding this phenomena.
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Socioeconomic Status
The major factor related to late stage at diagnosis is low socioeconomic status,
which has been demonstrated to result in diminished resources and lack o f access to health
care services (Freeman & Wasfie, 1989; Griffin, 1994;). The studies presented in this
section evaluate the impact o f SES on access to breast health care and stage at diagnosis
of breast cancer.
Wells and Horm (1992) examined the influence o f race and socioeconomic factors
on stage at diagnosis o f breast cancer in cases of invasive breast cancer in 17,949 White
women and 2838 Black women, reported through the U. S. National Cancer Institutes
Surveillance Epidemiology and End Results (SEER) program in the San FranciscoOakland, Detroit, and Atlanta metropolitan area from 1978 to 1982. In situ cases of
breast cancer were also available for analysis in this study, 917 among White women and
126 cases among Black women. The researchers chose the median family income strata to
ensure that each race group contained enough persons for meaningful analysis; and racespecific indicators o f median education and family income were used because Whites and
Blacks residing in the same census tract areas were found to have different education
and/or income distributions. The Spearman rank correlation coefficient was computed to
test the relationship between stage at diagnosis of breast cancer and income and education.
The study findings revealed that Black women were diagnosed at a later stage than White
women; and that there were 45.7 percent of the Black women diagnosed in localized or in
situ stages compared to 52.1 percent of the White women. Eleven percent o f the Black
women were diagnosed with breast cancer that had metastasized into the distant stage
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compared to seven percent o f the White women. The study findings also revealed a less
advanced stage with increasing educational level or income among both Black and White
women (P < .001). Black women in the lowest educational and income strata had a
poorer stage o f disease at presentation than did White women; and Black women in the
upper educational and upper income strata had a slightly better stage of disease at
diagnosis than White women. Both Black and White women in the upper education and
income strata were found to have a higher incidence o f breast cancer. This increase in
incidence was attributed to the higher incidence rates of in situ and localized breast cancer
in this group o f women. Incidence o f breast cancer in the distant stage was found to
decrease with increasing education and income; and the differences between education and
income factors influence on stage at diagnosis o f breast cancer was found to be more
striking in Black women.
Wagner and Schatzkin (1994) used several sources o f existing data to determine
temporal trends in breast cancer mortality in American women by age, race, and
socioeconomic status from 1969 through 1989. County level socioeconomic data relating
to the median family income and percentage of persons in a household 25 years o f age or
older with a high school education, were obtained from the area resource file for the 1970
and 1980 census years. Mortality data was obtained from the compressed mortality file
and was also county based. Mortality data on White women was available separately for
1968 through 1989; and on Black women separately for 1979 through 1989. Detailed
death records obtained from the mortality files o f the National Center for Health Statistics
and population estimates provided by the National Cancer Institute were used to obtain
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mortality data for Black women from 1969 through 1972. The study findings revealed
that from 1969 through 1972 to 1987 through 1989, mortality climbed 21.4 percent for
Black women age 25 to 44; 38.3 percent for Black women age 45 to 65; and 54.3 percent
for Black women over age 64. For White women, in the same time period, mortality
declined 14.4 percent among younger women and 5.1 percent among middle aged women;
but mortality increased by 14.7 percent for older White women. The researchers also
found that breast cancer mortality increasing among both race groups, had risen more
rapidly in the lower socioeconomic strata counties. In women 45 to 64, breast cancer
mortality was supported to be declining in women in higher socioeconomic strata counties
and rising in lower socioeconomic strata. In women 25 to 44 years of age, breast cancer
mortality was demonstrated to be decreasing in both higher and lower socioeconomic
strata counties, but at a higher rate of decrease in higher socioeconomic strata counties.
Franzini, Williams, Franklin, Singletary and Theriault (1997) examined the effects
of race and SES on survival in 964 White, 205 Hispanic, and 163 Black women treated for
breast cancer at the University of Texas M. D. Anderson Cancer Center from 1987 to
1991. Demographic information including race and ethnicity, age at diagnosis, and ability
to pay for health care, was collected on the women included in this study at registration.
The clinical variables examined in this study included stage o f disease at diagnosis,
histology, treatment administered in the first four months, and participation in a clinical
research protocol. Racial differences in demographic, disease, and treatment
characteristics were assessed using odds ratios and their corresponding 95 percent
confidence intervals. The Mantel-Cox test was used to assess differences in the survival

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

51

curves between subgroups; and the independent effects o f race, age, stage, treatment,
SES, and histology on survival was assessed using the multivariate Cox proportional
hazards model, after adjusting for the effects o f all other factors included in the model.
Overall there was no notable difference in the age distribution between Black and White
women but Hispanic women were diagnosed at younger ages. Black and Hispanic women
were less likely to be in high SES groups, and Black women tended to be poorer
economically when compared to Hispanic women. When compared to White women,
early stage disease was less prevalent among Hispanic and Black women. Black women
tended to have more distant metastasis when compared with Hispanic women and a higher
percentage o f Hispanic women had disease that involved lymph nodes. The differences in
treatment by either race or SES were negligible when adjustments were made by stage o f
breast cancer at diagnosis. Histological type did not differ by race. There were significant
(P = 0.0005) differences in survival by race. The differences continued to be significant
across race (P = 0.02) when stratified by stage, but differences in survival by race were
eliminated when both stage at diagnosis and SES were controlled for (P =15). Women in
lower SES had significantly poorer survival (P < 0.0001). Adjusting for stage at diagnosis
(P = 0.003)and for stage and race (P = 0.008) did not eliminate these significant survival
differences. Race and histology were not significant independent predictors of survival;
however, age, stage at diagnosis, protocol participation, treatment choices, and SES were
all found to be significant independent predictors of survival (P < 0.05). When the
relationship between race and SES was investigated, the excess risk for Black women was
found to be 98 percent when compared to White women. The excess risk decreased to
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non-significance at 34 percent in Black women when all prognostic variables were
controlled. Prognostic variables explained 66 percent of the unadjusted excess risk in
Black women in this study; stage at diagnosis explained 38 percent, and SES explained 45
percent.
Heck, Wagner, Schatzkin, Deveas, & Breen (1997) assessed the relationship
between socioeconomic status and breast cancer mortality by examining educational
levels on death certificates of women dying between 1989 and 1993. Death certificates o f
women 25 years or older, whose death certificate listed breast cancer as the underlying
cause o f death were included in the study. Ethnic groups were categorized as Hispanic,
non Hispanic White, non Hispanic Black, and non Hispanic Asian. Educational levels
were categorized as 0 through 8 years, 9 through 11 years, 12 years, 13 through 15 years,
and 16 or more years o f education. Data were collected by review o f death certificates
and analyzed using the SAS program. The researchers found that women with fewer than
12 years of education had lower mortality rates than women with at least twelve years;
and the highest rate o f breast cancer mortality was found among women with 12 years o f
education and among those with 16 years or more of education. Asian women in this
study had the lowest age adjusted mortality rates, while Black non Hispanic women had
the highest rates, followed by White non Hispanic women. Within each non White
population o f this study, the mortality rate for breast cancer increased with greater
education through 12 years. The mortality rate for non Hispanic Black women with 16 or
more years o f education was similar to that of women with 12 years, but lower than that
of women with 13 to 15 years. The non Hispanic White women included in this study did
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not demonstrate a strong positive gradient o f mortality by educational level. The findings
o f this study are interesting and vary from findings relating to educational level presented
earlier in this section. In addition, the assumption was made that educational level was an
appropriate measure o f SES and that the educational level o f the decedent as listed on the
death certificate was accurate. However, the results of this study support the inclusion o f
SES as a variable in this study.
The studies presented above support a significant relationship between low SES
and delayed diagnosis of breast cancer. Other factors such as age, educational level, stage
at diagnosis o f breast cancer, tumor characteristics, and treatment modalities, were also
found to be significant predictors o f breast cancer outcomes. In Black women high
educational levels were associated with both early stage at diagnosis and high mortality.
Delayed diagnosis o f breast cancer was demonstrated to be more prevalent in African
American women when compared to White women; but since low SES seemed to be more
prevalent in the African American women than in the White women included in these
studies, it is not clear if the poorer outcomes in African American women are associated
with race, SES, or a combination o f the two. Nevertheless, there is strong support for the
inclusion o f SES in this study as a variable o f potential access
Means o f Discovery o f Breast Cancer
The American Cancer Society and the National Cancer Institute recommend three
strategies for early detection o f breast cancer: mammography, clinical breast exam (CBE),
and breast self exam (BSE). Mammography has been promoted as the optimal prevention
strategy for breast cancer, and its effectiveness as a screening procedure for detecting
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breast cancer at an early stage has been well documented in the literature (Champion &
Miller, 1996; Crooks & Neutens, 1993; Frazier, Jiles, & Mayberry, 1996; Long, 1993;
Miller & Champion, 1996; Thomas, Fox, Leake, & Roetzheim, 1996 ). Mammography
results have been estimated to be 75-90 percent effective in detection o f breast
abnormalities, and mammography used in conjunction with CBE has been proven to be
very effective. Although not recommended as the only breast cancer screening activity,
BSE has also been proven effective in discovery o f breast abnormalities.
BSE is a useful method because (a) most tumors are found by women themselves
either accidentally or during self examination; (b) retrospective data show that
patients diagnosed at earlier stages o f breast cancer were more likely to have
practiced regular BSE than patients diagnosed at later stages; (c) the cost benefit
ratio o f mammography may not be advantageous for women < 40 years of age
who have a lower incidence o f breast cancer than older women; (d) mammography
screening may not be readily available to all women, especially those in rural and
poor inner city locations; and [(e)] screening mammography is recommended every
1-2 years for women > 50, thus creating a need for BSE practice between
mammographies (Han, Baumann, & Cimprich, 1996, p. 197).
Therefore, mammography conducted in conjunction with CBE and BSE is the
recommended approach for effective breast cancer screening and early diagnosis o f breast
cancer.
The relationship between breast cancer survival and early stage at diagnosis is weB
documented in the literature (Chu et al., 1996; Harris, Lippman, Veronesi, Willett, 1992;
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Kirkwood, Lotze, & Yasko, 1996; McPherson, Swenson, Jolitz, & Murray, 1997:
Pederson & Trigg, 1995; Phillips, 1991). Early detection and treatment o f breast cancer
is extremely important, and breast cancer diagnosis initiated by breast cancer screening
activities (BSE, CBE, or mammography), is more likely to be diagnosed in an earlier
stage than breast cancer discovered incidentally or secondary to some other medical
condition. Numerous studies have looked concurrently and individually at African
American and Caucasian women’s participation in breast cancer screening, and have
identified access, cultural, social, personal, and economic barriers to participation in breast
screening activities and breast health care programs (Adderley-Kelly & Green, 1997;
Bakker, Lightfoot, Steggles, & Jackson, 1998; Bowen, Hickman, Powers, 1997; Brown &
Williams, 1994; Burnett, Steakley, & Tefft, 1995; Champion, 1992; Champion & Miller,
1996; Champion & Menon, 1997; Champion & Scott, 1997; Crane, Kaplan, Bastani, &
Scrimshaw, 1996; Crooks & Neutens, 1993; Duke, Gordom-Sosby, Reynolds, & Gram,
1994; Erwin, Spatz, Turturro, 1992; Frazier, Jiles, & Mayberry, 1996; Glenn & Moore,
1990; Han, Bauman, Cimprich, 1996; Hoffman-Goetz & Mills, 1997; Kurtz, Given,
Given, & Kurtz, 1993; Lerman, Rimer, Trock, Balshem, & Engstrom, 1990; Lierman,
Young, Kasprzyk, & Benoliel, 1990; Lierman, Young, Powell-Cope, Georgiadou, &
Benoliel, 1994; Mandelblatt, et al., 1993; Miller & Champion, 1996, 1997; Miller &
Hailey, 1994; Morgan & Levin, 1995; Nemcek, 1990; Olsen & Frank-Stromborg, 1994;
Olson & Morse, 1996; Patterson, Helvie, Joynt, Roubidoux, & Strawderman, 1998;
Persson, Svensson, & Ek, 1997; Phillips & Wilbur, 1995; Sensiba & Stewart, 1995;
Tessaro, Eng, & Smith, 1994; Thomas, Fox, Leake, & Roetzheim, 1996; Thompson,
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Montano, Mahloch, Mullen, & Taylor, 1997; Valdini & Cargill, 1997; Williams, Abbott,
& Taylor, 1997) . However, these studies have not examined the impact o f these barriers
on stage at diagnosis or breast cancer mortality. The studies listed above focused on
uncovering reasons why women did or did not participate in breast health programs, and
on identifying intervention strategies to increase involvement in breast cancer screening
activities. Few studies have looked primarily at the relationship between participation in
breast cancer screening activities and stage at diagnosis of breast cancer; and even fewer
studies have examined the impact o f race o r economic access on this relationship. Several
studies have examined differences in participation in breast cancer screening by race,
secondary to exploring the relationship between race, SES, economic access, and stage at
diagnosis o f breast cancer (Franzini, Williams, Franklin, Singletary, & Theriault, 1997;
Eley et al., 1994; Hunter et al., 1993; Newman & Alfonso, 1997; Wells & Horm, 1992).
The results o f these studies were presented earlier in the literature review section.
Therefore, the following section includes studies which concurrently examine breast
cancer screening activities in African American and Caucasian women in relation to breast
cancer diagnosis and survival outcomes. Studies looking primarily at BSE or CBE and
their relationships to stage at diagnosis in African American and Caucasian women could
not be located. Examination of CBE practices was consistently included in studies
examining use o f mammography. Therefore, the following section is comprised o f studies
which examine all three screening activities, and studies focusing primarily on utilization of
CBE and mammography in samples composed o f African American and Caucasian
women.
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Vernon et al. (1992), used data from the 1987 American Cancer Society Texas
Breast Screening project to examine attitudes and behaviors related to breast cancer
screening in a multiethnic sample o f women. The study included a population o f 31,000
White, 1800 Hispanic, and 1100 Black women age 35 and older. There were more Black
(30 percent) and Hispanic (28 percent) women in the younger 35 to 39 age group than
White women (17 percent); and Black (16 percent)and Hispanic (16.4 percent) women
had proportionately more women in the lowest (< 13,000 annual household income)
income category, when compared to White women (8.6 percent). A higher proportion of
Hispanic women had less than a high school education (19.2 percent), when compared to
Black (9 percent) and White (7 percent) women. Vernon et al. used the chi-square test to
compare the frequency o f breast cancer screening behaviors across these groups o f women
and found that White women (33 percent) were more likely than Black (27 percent) and
Hispanic (24 percent) women to have had a mammogram prior to participating in the
screening project. Income level was associated with prior mammography only in the
White women, and educational level was not associated with prior mammography in any
of the ethnic groups. In all three groups, women who had prior CBE were more likely
than women who had not had prior CBE to report prior mammography. White and
Hispanic women who practiced BSE were more likely than women who did not practice
BSE to have had prior mammography. This pattern was also observed in the Black
women in this study but was not statistically significant (P = 0.078). In all groups, women
with a history o f breast cancer in their family were more likely to have had a mammogram
prior to the screening project than those without a history. The two most important
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reasons for not having had a prior mammogram given by the women in this study were
cost and lack o f physician referral. Lack o f physician referral ranked first for Black and
White women; and cost ranked first for Hispanic women. Cost, as a reason for not having
had a prior mammogram, was inversely associated with educational level in all three ethnic
groups.
In a descriptive study, Douglass, Bartolucci, Waterbor, and Sirles (1995),
administered the Breast Cancer Control and Health Beliefs Questionnaire to a group of
117 African American and 157 White women educators employed by a public school
system, to identify differences in health beliefs and practices regarding mammography,
CBE, and BSE. Women included in the study were recruited from a list o f randomly
selected schools, within a selected school system, within a selected state, based on current
employment as a professional educator, age 35 years or older, and no personal history of
breast cancer. The mean age of the sample was 47.62 for the African American women
and 44.71 for the White women. The SES score was calculated using Green’s two-factor
procedure, and the difference in scores for the two groups of women was not statistically
significant. The chi-square test was used to test for significant differences between the
two groups on frequency of use o f mammography, BSE, and CBE. The difference for the
frequency o f use o f mammogram and CBE was not statistically significant (P = 0.735; P =
0.083 respectively). The difference for BSE frequency approached significance (P =
0.058), with a larger proportion o f the African American (41 percent compared to 31
percent) women reporting performance o f BSE during the previous 12 months. Analysis
of variance was used in the calculation o f differences in health belief scores between the
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two groups. When compared with African American women, White women had a
significantly higher (P = 0.002) mean score for perceived barriers to mammography and
CBE (P =.05). The researchers looked at race as a predictor o f the use o f breast cancer
screening modalities using logistic regression, and found no significant differences (P =
0.50 - 0.99) in the ability of the health belief model to predict use o f mammography, CBE,
or BSE, according to race.
Michels, Carter, Taplin, and Kugler (1995) examined barriers to mammography
use in women eligible for military health care at Madigan Army Medical Center in
Washington state. Data were collected using a questionnaire developed by the
researchers. A random sample o f zip codes in the Madigan Medical Center service area
was obtained through the Defense Eligibility Enrollment Reporting System (DEERS) and
500 questionnaires were mailed to women 40 years or older, who had been randomly
selected based on tw o o f the digits in their social security numbers. A total o f 440 women
responded to the survey, and 309 o f those responding were eligible for inclusion in the
study. Chi-square, analysis of variance, and Pearson’s correlation were used to conduct
statistical analysis. The age of the respondents ranged from 41 to 89; 72.4 percent o f the
women were white, 10.7 percent African American, 15.9 percent Asian American, 3.7
percent Hispanic, and 1 percent were o f other ethnic origin. The proportion o f women
with less than a high school education was 22.6 percent, while the proportion o f women
with greater than a high school education was 13 percent. The proportion o f women with
annual income levels less than $10,000 was 19.6 percent, and the proportion with income
levels greater than $50,000 annually was 2.1 percent. A total o f 21.5 percent o f the
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women in the study had never had a mammogram; 39.2 percent had a mammogram within
the past year, 56.4 percent within the past two years, and more than five years had passed
since 10.8 percent o f the women in this study had had mammograms. Women with higher
income levels, with a higher risk factor for breast cancer, and with a higher perceived risk
of breast cancer were more likely to have participated regularly in mammography.
Women with a higher rate o f mammography participation were more likely to state that
their provider or the media recommended mammography. The researchers did not detect
any difference between women with higher participation and all other women in the study
based on age, race, education, insurance coverage for mammography, or military versus
civilian source o f care. Overall, 12.8 percent o f the women included in this study
participated in regular mammography, compared to 31 percent o f the women in the
general population.
Benedict, Williams, and Hoomani (1996) conducted a retrospective study of
women diagnosed with breast cancer to determine the means o f discovery according to
adherence to American Cancer Society (ACS) guidelines for BSE, CBE, and
mammography; and according to age, race, family history and educational level. A
questionnaire with demographic questions, questions about the women’s breast cancer
detection practices, and method o f discovery o f breast tumor was developed and mailed to
women from the mailing list of a breast cancer support group in Charleston, South
Carolina. O f the 190 questionnaires mailed, 188 were returned and 51 were selected for
inclusion in the study based on the time o f diagnosis fitting within a 1990 to 1992 time
frame. Nine o f the women included in the study were Black and 41 were White. The
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mean age at the time o f diagnosis for the Black women was 49.75 years as compared to
50.08 years for the White women. The mode o f highest educational level for the Black
women was “some college” (44%) as compared to “junior high school” (26.8%) for the
White women; and 22.2 percent of the Black women had a family history o f breast cancer
as compared to 19.5 percent o f the White women. Method o f discovery according to
stage at diagnosis was extracted from the questionnaires o f 20 women. O f the stage 1
cancers diagnosed in the women in this study (n=13), 61.5 (n=8) percent were discovered
by mammogram, as compared to 23.1 (n=3) percent by BSE, 7.7 (n=l) percent by
accident, and 7.7 (n= l) percent by another person. One-hundred percent of the stage 3
(n=2)cancers were discovered by BSE, and stage 4 (n=2) discoveries were equally divided
(50%) between BSE and CBE. Within the stage 2 (n=12)grouping, 58.3 (n=7) percent of
the discoveries occurred by BSE, 16.7 (n=2) percent by accident, and 16.7 (n=2) percent
by mammogram. O f the Black women included in the study, 11.1 percent of the cancers
were discovered by BSE, 33.3 percent by accident, and 55.6 percent by mammogram. Of
the White women in the study, 34.1 percent of the cancers were discovered by BSE, 7.35
percent by accident, 31.7 by mammogram, 7.3 percent by CBE, and 7.3 percent by
another person. Twenty-two of the Black women in the study had mammograms every 1
to 2 years before diagnosis, as compared to 56 percent o f the White women, and 55.6
percent of the Black women performed BSE in the 12 months prior to diagnosis as
compared to 51.2 percent o f the White women. Because o f the small sample size o f Black
women, and the unequal group size (Black and White women), inferential statistics were
not conducted.
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O’Malley, Earp, and Harris (1997) used data from the New Hanover Breast
Cancer Screening program, a National Cancer Institute Consortium project conducted
between 1987 and 1991 in two eastern North Carolina counties, to examine racial
differences in mammography use in Black and White women . The researchers obtained
data from a 1988 random digit dialing telephone survey o f 1214 women age 30 to 74
years. A total o f 948 Black and White women age 50 to 74 years were included in this
study. Chi-square tests, t tests, Wilcoxon rank sums, Kruskal-Wallis chi-square
approximations, and logistic regression analyses were used to compare attitudes and
characteristics by race and by mammography use. Approximately 90 percent of the
women included in this study were aware of mammography; 46 percent reported a prior
mammogram; and 32 percent reported having a mammogram in the past year. Black
women reported ever having had a mammogram (27 percent) approximately half as often
as White women (52 percent); and White women reported having had a physicians’
recommendation for mammography twice (52 percent) as often as the Black women (25
percent) in the study. When factors related to race and mammography use were
controlled for, the initial racial differences in mammography use were eliminated.
Physician recommendation alone accounted for 60 to 75 percent of the mammography use
differences by race.
In a cross sectional descriptive study, Dibble, Vanoni, and Miaskowski (1997)
examined women’s attitudes toward breast cancer screening procedures from ten sites in a
major metropolitan area in California. The study was conducted with a convenience
sample of 233 White, 127 African American, 118 Pacific Islanders, 61 Hispanic, and 58
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Asian American women age 18 years or older, recruited from public health centers, mobile
mammography vans, and hospital based radiology departments. Data were collected using
a demographic questionnaire and the Attitude Toward Breast Cancer Screening
Procedures Scale. Differences in women’s attitudes by ethnicity were calculated using
descriptive statistics, analysis of covariance, and the Tukey post hoc analysis procedure.
Mean scores o f the demographic characteristics of the sample were also calculated and
included in the data analysis. The mean age o f the participants was 53 years; 48 percent
were married or partnered; 81 percent had children; 62 percent were currently employed;
and 44 percent had an annual family income o f less than $20,000. The average years of
education was 13.9. Seventy-nine percent o f the women had had a previous mammogram;
and 4 percent had been previously diagnosed with breast cancer, while 23 percent had
experienced a lump in their breast. After controlling for age, education, number o f
pregnancies, marital status, income, employment status, previous mammogram, lump and
family history, significant differences by ethnicity (F = 6.65, P < .0001), in the scores on
the Attitude Toward Breast Cancer Screening Procedures Scale were detected. The
African American women in this study had the most positive attitude towards breast
cancer screening procedures.
Roberson (1997), compared breast cancer screening outcomes among 282 African
American and 1079 White women participating in a multistrategy cancer control
intervention in western New York. Data were collected from women who participated in
the intervention between mid 1994 and mid 1996 using a screening intake form. Data
collected included demographic information, as well as information regarding health
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practices, risk factors, screening status, and clinical findings. The mean age for African
American women included in the study was 50 years as compared to 56 years for White
women. Twelve or more years o f high school had been completed by 79 percent o f the
African American women, as compared to 82 percent o f the White women. Across both
groups, annual family incomes o f less than $15,000 were reported in 99 percent o f the
women studied. A significant difference in the health insurance status o f African American
and White women was noted (P < .001). Twenty-four percent of the African American
women reported Medicare and Medicaid as their primary source of health care insurance,
while 75 percent reported having no health insurance coverage. Twenty-five percent o f
the White women reported having Medicare and Medicaid as their source o f health care
insurance, and 53 percent reported having no insurance at all. Sixty-one percent o f the
White women in the study reported that they had a previous mammogram as compared to
53 percent o f the African American women (P < .002). Twenty four percent o f the White
women reported that they practiced BSE monthly as compared to 33 percent o f the
African American women included in this study (P < .009). Twelve percent o f the African
American women presented with breast abnormalities that were probably benign and
required short term follow-up, as compared to 11 percent o f the White women; and 6
percent o f the African American women were found to have breast abnormalities by
mammogram, as compared to 5 percent o f the White women in this study. This study was
limited in that it studied a sample of relatively low-income women. However, the study
found that women in this low income group, who participated in cancer control
interventions, were similar in educational and income levels. This study supported
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findings o f other studies presented above, in that the African American women, in this
study, were more likely to participate in BSE than were the White women. However, the
White women in this study were slightly more likely to have had a previous mammogram
than the African American women.
In the studies presented above, race was not a significant predictor of participation
in breast cancer screening programs. In two of the studies, African American women were
found to be more likely to participate in breast cancer screening than White women; and
African American women were found more likely to practice self exam than White
women. In another study, even though the percentage o f mammogram discovered breast
cancer was higher for the African American women than for the White women, African
American women were found to have had a lower percentage o f mammography screening
participation prior to breast cancer diagnosis, when compared to White women. Barriers
to accessing breast cancer screening were attributed to the individual as well as the health
care delivery system. In the study conducted on mammography use by women eligible for
care within the MHS, mammography rates were found to be lower than those in the
United States overall. Income level and cost of mammography were primary factors
associated with prior mammography use by the women in the studies presented above.
Physician referral was also demonstrated to be a major factor associated with
mammography use; and physician referral is associated with economic access to care.
Even though most o f the studies presented above did not present results relating to the
association between the particular means o f discovery o f breast cancer and stage at
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diagnosis o f breast cancer, there is support for inclusion o f this variable (the means o f
discovery o f breast cancer) in this study, as a measure o f potential access.
Realized Access and Stage at Diagnosis o f Breast Cancer
Evaluation o f the utilization o f health services by the consumer is a key factor in
examining health care access; and the willingness o f the consumer to seek care is crucial, if
potential access is to become realized access (Aday & Andersen, 1974; Aday, Andersen,
& Fleming, 1980; Aday, Fleming, & , Andersen, 1984). The disposition o f the consumer to
utilize services is influenced by economic access concerns and social and cultural
definitions o f health and illness; as well as, attitudes towards and knowledge of health care
(Adams, 1995; Bayne-Smith, 1996; Donnelly, 1995; Frank-Stromborg & Olsen, 1993;
Jennings, 1996; Kagawa-Singer, 1995. 1997; Olsen & Frank-Stromborg, 1993; Palos,
1994). As a result, economic access and realized access are not always synonymous, and
timeliness in the utilization of services, by the consumer, can become an important factor
in determining health care outcomes.
Women vary in their response to the discovery o f breast cancer symptoms . Some
women seek provider attention and treatment immediately upon discovery, and other
women delay diagnosis and treatment for greater than two years (Facione, 1993; Facione,
Dodd, Holzemer, & Meleis, 1997; Katz, Hislop, Thomas, & Larson, 1993; Lauver, 1992a,
1992b; Lauver & Angerame, 1993; Lauver & Ho, 1993; Lierman, 1988; Vernon, Tilley,
Neale, & Steinfeidt, 1985). The relationship between delayed diagnosis and treatment o f
breast cancer, and increased mortality, has been well established (Bedell, Wood, Lezotte,
Sedlacek, & Orleans, 1995; Hunter et al., 1993; Long, 1993; Mandelblatt, Andrews, Kao,
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Wallace & Kemer, 1995; Simon & Severson, 1996); and has been presented in earlier
sections o f this literature review. Therefore, the following section focuses on studies
examining factors associated with diagnosis and treatment delay o f breast cancer, in
samples including both African American and Caucasian women.
Diagnosis Delays
Coates et al. (1992) explored differences in the length o f time between symptom
recognition and initial medical consultation between 410 Black and 325 White women,
newly diagnosed with breast cancer in 1985 or 1986, from the Atlanta, New Orleans, and
San Francisco/Oakland areas. The researchers conducted in person interviews to obtain
information specific to race and recognition of breast cancer symptoms; and collected
retrospective data on symptoms, dates o f recognition, and initial medical consultation.
Tests used to conduct the statistical analyses included the Mantel-Cox test, Cox
proportional hazards regression analysis, and logistic regression analysis. Women who
had their breast cancer diagnosed prior to symptom recognition were more likely to have
been White and older; to have smaller, earlier stage, lower grade tumors; and to have lived
in the San Francisco/Oakland area. White women were more likely than Black women to
have obtained medical consultation on each day after the first three days following
symptom recognition; and 32 percent o f the Black women, compared to 40.3 percent o f
the White women had obtained medical consultation by the seventh day following
symptom recognition. The difference in the median symptom duration was o f borderline
significance (P = .06) at 16 days for Black women compared to 14 days for White women.
Even though Black women were two times more likely than White women (6.6 percent
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compared to 3.1 percent) to have stage IV breast cancer when diagnosed, and one and onhalf times more likely to have stage EH breast cancer when diagnosed than White women
(21.2 percent compared to 13.5 percent), the small racial difference in time between
recognition o f symptoms and initial medical consultation could not explain the racial
differences in stage or tumor size at diagnosis.
Lauver, Coyle, and Panchmatia (1995) assessed women’s reasons for and barriers
to seeking care for breast cancer symptoms in a multiethnic sample o f 138 women
recruited from a breast clinic in an urban teaching hospital providing care to the medically
indigent. The women included in the study varied in age from 19 to 76 years. Sixty-three
o f the participants were Caucasian, 71 were African American, and 4 were Asian and
Latina. Thirty-two percent o f the women had not finished high school as compared to
30.4 percent with a high school education. O f the women included in the study 22.5
percent had completed some college and 15.2 percent had finished college. The median
annual family income of the women was $12,000, with a range of $0 to $300,000. In
regard to health care insurance, 58.7 percent o f the women were covered by public
assistance; 26.8 percent by private insurance; 3.5 percent by private and public monies;
3.6 percent by Medicare; and 7.4 percent did not report a source o f health insurance
coverage. The researchers determined delay in seeking care by calculating the number of
days between the woman finding a breast change and the woman’s contact with the health
care delivery system, concerning the change, by telephone or in person. Twenty-three
percent o f the women were discovered to have delayed three months or longer. Thirtyeight percent o f the women sought care within one week of symptom discovery; 49
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percent within two weeks; 65 percent within six weeks; and 77 percent within three
months. Fifty percent of the women reported no barriers to seeking care for breast
changes, and sought care sooner (mean = 53 days, median =11 days) than those women
citing particular barriers to care (mean = 143 days, median = 32.5 days). The barrier most
commonly cited as interfering with care seeking was conflicting commitments (15.8
percent o f responses); followed by limited finances/insurance (11.8 percent); fear or
avoidance (9.9 percent); transportation problems (6.6 percent); lack o f knowledge of how
to access the system (3.3 percent); and other reasons (2.6 percent).
Caplan, Helzlsouer, Shapiro, Wesley, and Edwards (1996), examined reasons for
system delay in breast cancer diagnosis, from the initial medical consultation to
establishment o f a diagnosis, in women from the National Cancer Institute’s Black/White
Cancer Survival Study. There were 1,222 women eligible for inclusion in the Black/White
Study. Data collection methods for the study included medical record review, centralized
pathology review, and personal interview. The personal interview collected data on
previous health practices, symptom recognition, care seeking behaviors, dietary patterns,
personal health practices, attitudes toward the health care system, SES, and reasons for
delay. Women were included in this study based on a system delay o f four or more weeks
between the initial medical consultation for a breast cancer symptom, and diagnosis of
breast cancer. These inclusion criteria yielded a sample of 367 women. The Chi-square
test was used to compare the Black and White women regarding basic demographics,
symptom status, stage at diagnosis, and delay. Fifty-five percent o f the study sample was
Black, and most o f the study sample used a private physician as their primary source of
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care. The White women were significantly more likely than the Black women to be
asymptomatic at the time of initial presentation; and Black women were significantly more
likely than White women to have advanced disease. The median system delay for Black
women was 11 weeks as compared to 13 weeks for White women. Most women in both
groups (45 percent) attributed delay to the health care system, due to physician inaction or
difficulty scheduling appointments. When compared to White women, more Black women
attributed system delays to scheduling delays, rather than to physician inaction. Women
attributing delay in diagnosis to themselves (25 percent) tended to have more advanced
disease. The reason most often given for delay by both groups o f women was that the
problem was not important or urgent (37.6 percent); followed by the event o f a birthday,
holiday, or out o f town commitment (17.8 percent); competing health problems (14
percent); being too busy (12.7 percent); and fear (12.7 percent).

Seventeen percent o f

the women in the study attributed delay to both themselves and the health care delivery
system.
Even though the studies presented above primarily examined the length o f time
between discovery and initial contact with the health care delivery system, there is support
for the inclusion o f the length o f time between discovery of a breast abnormality and the
diagnosis o f breast cancer as a measure o f utilization of health care services, in this study.
Mean score diagnosis delays were comparable for African American and White women
with no significant differences being reported above. Reasons for delay were attributed to
characteristics o f both the individual and health care delivery system. Even though the
perception o f barriers was found to delay care seeking in one o f the studies presented
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above, the barrier most frequently cited in two of the studies in this section related to
characteristics o f the individual, rather than characteristic o f the health care delivery
system. Advanced disease was found to be higher in African American women than in
White women in one of the studies; however, there was no significant difference in mean
diagnosis delay scores between these two groups.
Treatment Delays
Bedell, Wood, Lezotte, Sedlacek and Orleans (1995) examined delay in diagnosis
and treatment o f breast cancer in 225 women diagnosed with breast cancer between
January 1, 1992 and December 31, 1993. The Colorado Central Cancer registry was used
to identify women and data were collected from the medical records at three sites: a
public hospital, a university hospital cancer center, and a private practice. Data were
abstracted from the records of 52 women from the public hospital, 83 women from the
university hospital, and 90 women from private practice, and included information on age
at diagnosis, race, insurance status, stage at diagnosis of breast cancer, the initial breast
cancer symptom, the date of the first medical consultation, the date o f the biopsy for
definitive diagnosis, and the date o f the initiation of treatment. The analysis o f the data
focused on the length of time in days between the first medical consultation and biopsy
for definitive breast cancer diagnosis, and the length of time in days between definitive
diagnosis and the initiation of treatment.

Sources for delay were divided into three

categories. System delay referred to delay resulting from routine practices o f the specific
health care delivery system, and included such sub-categories as scheduling delay or time
spent waiting for appointments; cancellation or postponement o f appointments; delay in
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reporting examination or test results to the provider; and delay attributed to lost or
unavailable records. Provider delay referred to delay relating to physician or other health
care provider behaviors, such as a work-up exceeding 14 days; a justifiable delay
occurring when evaluation had not revealed cancer but the case was being closely
followed; and misdiagnosis o f cancer symptoms. Patient delay referred to delay relating to
patient behaviors. Patient delay included sub-categories such as a prolonged period o f
decision making; refusal of further medical evaluation or treatment; concerns related to
finances; scheduling rearranged for the patient’s convenience; and the patient’s seeking a
second opinion. The Wilcoxon rank sum test and chi-square were used to conduct the
statistical analysis. The majority of the women from the public hospital were Hispanic.
African American women were seen more often at the public hospital than at the two
other sites combined; and nearly half o f the women at the public hospital and the
university hospital were uninsured. Five percent of the women from private practice were
uninsured; and all three sites had similar proportions of women with Medicaid or Medicare
as their source o f health care insurance. The ages of the women in this study ranged from
27 to 90 years with a mean age of 53.3. The diagnostic interval median was significantly
different among the three sites (P = 0.003). The diagnostic interval median at the public
hospital was 25 days, as compared to 14 days in private practice, and 24 days at the
university hospital. The treatment interval median was also significantly different among
the groups (P = 0.029), with a median o f 15 days in the public hospital, 10 days in private
practice, and 13 days at the university hospital. During the diagnostic interval, differences
in delay among the three groups was significant only for the system category (P = 0.038).
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There were longer intervals o f delay for the public hospital than for private practice (P =
0.036) or the university hospital (P = 0.018). However, during the treatment interval,
significant differences in delay among the three sights were found by system (P = 0.04)
and by patient (P = 0.019). There were no significant differences across the three sites in
the treatment interval, by provider. Patient caused delay, during the treatment interval,
occurred more often in private practice than at any other site. A major finding o f this
study was the significant difference observed in diagnosis delay between the public
hospital and private setting. Over 50 percent o f the diagnostic delay occurring in the
public hospital was attributed to system factors. Even though this finding is enlightening,
the researchers did not include stratification o f the sample by race in their report of
findings, nor did they evaluate the relationship between the diagnosis delay found in the
public hospital, and the stage o f diagnosis of those women receiving care in that particular
setting. Nevertheless, the study results support variance in breast cancer diagnosis and
treatment intervals, by type o f health care delivery setting. Even though it is not clear if
the difference in patient delay occurring in the public hospital is influenced by system
factors, source of health insurance coverage, or individual characteristics of the patient,
this study supports the inclusion of both diagnostic and treatment delays as measures o f
realized access.
Conclusion
The review of literature presented above supports the research design for this
study, and the inclusion o f each o f the variables in this study’s conceptual framework. In
addition, the review supports the relationship between economic access to breast health
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care and stage at diagnosis o f breast cancer. Variation in breast cancer outcomes was
found to be associated with the type o f health care insurance coverage; but even when
health care insurance was comparable within a study population, stage at diagnosis varied
by age, SES, the means of discovery o f breast cancer, and diagnosis and treatment delays.
Multiple factors are associated with stage at diagnosis o f breast cancer. These
factors are components of both potential and realized access. Age, race, and SES were
found to be related to stage at diagnosis and participation in breast cancer screening; and
participation in breast cancer screening was found to be related to utilization o f health care
services. Even though no studies could be located which specifically addressed the
relationship between participation in breast cancer screening and stage o f breast cancer at
diagnosis, the literature presented above supports that women who participate in breast
cancer screening activities are more likely to be diagnosed with early stage breast cancer
than those who do not. Diagnosis and treatment delays were found to be associated with
characteristics o f the health care delivery system, as well as characteristics o f the
individual. Therefore, the studies presented above support the relationship between
potential and realized access.
Many o f the studies presented above used existing data to conduct retrospective
analyses. Several o f the studies conducted retrospective analysis using the same data base.
Data from the National Cancer Institute’s Black/White Study was analyzed by several
different groups o f investigators. However, each group addressed a set o f different
research questions; and the variety o f inclusion criteria used created a unique sample for
each study. In addition, the sample sizes and statistical tests were appropriate for the
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research design and the questions being addressed. Therefore the results from the studies
using the Black/White Study database are felt to be valuable in supporting the existence o f
a relationship between the variables included in this study’s conceptual model.
Other studies collected data from a single health care institution, or from a specific
socioeconomic strata or educational level. Even though these data are limited in their
generalizability, the appropriateness o f the sample size and statistical tests, to the research
design, make the results o f these studies valuable to the construction o f the research
design o f this study.
Although several o f the studies included in this review examined the majority o f
the variables included in the conceptual model for this study, in aggregate, no one study
examined all o f the variables proposed for examination in this study, within an equal
economic access health care setting. Economic access barriers such as health care
insurance and availability o f health care resources were demonstrated to be related to
delayed diagnosis o f breast cancer. However, demographic characteristics, as well as
personal barriers to participation in breast cancer diagnosis and treatment were also found
to be related to stage at diagnosis. Even though the review o f literature offers support for
relationships between all o f the variables in this study’s conceptual model, the impact of
equal economic access on variables o f potential and realized access, and stage at diagnosis
o f breast cancer, is unclear.
In summary, the review o f literature presented above indicates that research is
needed to assess the relationship between access (economic, potential, and realized) and
stage at diagnosis o f breast cancer in women being treated for breast cancer inside the
MHS. Descriptive comparative studies conducted in settings in which health care
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insurance coverage is equal, and distribution of health care resources is adequate, are
needed to generate a better understanding o f the multiple factors influencing disparity in
stage at diagnosis between African American and Caucasian women. This knowledge can
lead to hypotheses development and testing for the purpose o f identifying appropriate
interventions to increase access to breast cancer screening for all American women.
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CHAPTER m
METHODOLOGY
The research design, the setting, the population, and the sample are described in
this chapter. The methods and procedures for data collection, as well as the data analysis
techniques are also described.
Design
The purpose of this study was to describe the relationship between access and
stage at diagnosis in African American and Caucasian women being diagnosed with breast
cancer within the DoD MHS. There was no experimental manipulation o f variables or
random assignment o f subjects, and the data were collected through secondary analysis.
The research design for this study was non-experimental, descriptive-comparative (Bums
& Grove, 1993).
Setting
The setting for this study was the Naval Medical Center, San Diego California
(NMCSD), a health care facility within the DoD MHS. Data were collected in the
NMCSD Tumor Board Registry, and the source of the data were tum or registry records
compiled and maintained at NMCSD. The following section provides an overview of: (a)
the structure o f the NMCSD, (b) the beneficiary population served by NMCSD, and (c)
the structure and functioning of the NMCSD Tumor Board Registry.
Overview o f NMCSD. The medical center is a 535 bed acute care military
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treatment facility with an occupancy rate o f 66.3 percent and an average daily census of
254 (Region Nine TRICARE, 1998). Constructed in 1987, NMCSD has the ability to
expand to 696 beds in contingency situations. In 1995, NMCSD had a total o f 1,014, 942
outpatient visits and filled 1,280,002 outpatient prescriptions. The medical center is
staffed by civilian and military personnel. In 1995, staffing included 707 clinician full time
equivalents (FTEs), 521 registered nurse FTEs, 226 allied health professional FTEs, 2103
para-professional FTEs, and 1095 administrative FTEs. The medical center is accredited
by the Joint Commission for Accreditation o f Hospital Organizations (JCAHO).
Beneficiary Demographics. There are a total of 257,658 beneficiaries eligible to
receive health care at NMCSD: 118, 065 females and 139,593 males (Defense Eligibility
Enrollment Report System [DEERS], 1997). Thirty-one percent o f the eligible
beneficiaries are family members o f active duty, 24 percent are active duty, 22 percent are
family members o f retired, 17 percent are retired, 4 percent are survivors of retired, 1
percent are guard reserve, and 1 percent are family members o f guard reserve. Thirty-nine
percent o f the females are ages 18 to 44, 35 percent are ages 45 and older, and 26 percent
are ages zero to 17. Forty-eight percent o f the males are ages 18 to 44, 29 percent are
ages 45 and older, and 23 percent are ages zero to 17. According to the DEERS (1997)
database, 26 percent of those beneficiaries eligible for care at NMCSD are of unknown
race. O f those beneficiaries with known race, 43 percent are White, 12 percent are
Asian/Pacific Islander, 11 percent are Black, 6 percent are Hispanic, 1 percent are Native
American, and 1 percent are of other racial origin.
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NMCSD Tumor Registry. The information included in this section was obtained
through observations at the NMCSD Tumor Registry, by review o f tumor registry
certification documents, and by interviewing the NMCSD Tumor Registrar and registrar
assistants.
The Tumor Registry for NMCSD is located on the medical center compound and
is staffed by a certified Tumor Registrar (NTRA) and five specially trained tumor registrar
assistants. The registry staff are responsible for performing a variety o f technical duties
necessary for the development and analysis o f diagnostic and therapeutic cancer data.
These duties include, but are not limited to, case finding, case accessioning, medical
record abstracting, patient indexing, quality control, and patient follow-up. A brief
overview of the processes supporting these duties is presented below.
Newly identified cancer cases are placed in the computerized numeric accession
register, and in the alphabetic master patient index. An abstract is completed for each
case, and the required follow-up data items are collected. The maximum delay for
abstracting cancer cases at NMCSD is six to eight months, calculated from the date of
initial diagnosis to the time the data are available for analysis. All NMCSD tumor registry
abstracts are computerized. Abstract summaries and supporting medical record and
follow-up data items are stored in registry files by year and accession number. Data
collected by the tumor registry are used for special in-house and national studies, and are
reported to the medical and administrative staff of NMCSD. A quality control plan is in
place with documentation of procedures to monitor case finding, data collection, accuracy,
and timeliness; and follow-up information is systematically obtained for patients in the data
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base to ensure that required follow-up rates are met. NMCSD registry data are submitted
to the National Cancer Data Base (NCDB) for the purpose o f continuous quality
improvement o f individual cancer programs, and evaluation o f cancer therapies and
outcomes. In addition, NMCSD cancer cases are recorded in the DoD Automated Tumor
Registry (ACTTJR) and state of California Tumor Registry Reporting Program (CNET).
The Tumor Registry at NMCSD is accredited by the American College o f Surgeons
Commission on Cancer.
Population and Sample
The target population for this study was all Caucasian and African American
women being diagnosed with breast cancer within the DoD MHS; and the accessible
population was all Caucasian and African American women being diagnosed with breast
cancer at Naval Medical Center San Diego between January 1, 1988 and December 31,
1997. The sampling design for this study was consecutive non-probability sampling
(Hulley & Cummings, 1988). The sample was composed o f two comparison groups, 573
Caucasian women and 62 African American women. Even though every subject who met
the selection criteria was included in this study, the minimum number of subjects (64)
required in each group to conduct the t test at a power of .80, medium effect size of .50,
and significance level of .05 (Cohen, 1988) were not obtained. In addition, the
assumptions for conducting the t test were not met. Therefore, the Mann Whitney U test
was used to detect a significant difference between the two groups, in the length of time in
days between discovery of breast abnormality and diagnosis of breast cancer, and in the
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length o f time in days between diagnosis o f breast cancer and initiation o f treatment
(Sheskin, 1997).
Instrumentation
The subject’s tumor registry record was the primary source o f data in this study.
The Breast Cancer Medical Record Data Collection sheet (Appendix A) was the
measurement instrument used to collect the data. In order to minimize variance and
increase the precision of measurement, all data were collected by the researcher (Hulley &
Cummings, 1988), and inter-rater reliability was used to test for equivalence in collection
o f the data (Brink & Wood, 1994; Polit & Hungler, 1995). Data collection procedures
and details relating to the conduction o f inter-rater reliability are presented in the data
collection and recording section o f this chapter.
Data Collection and Recording
A list o f African American and Caucasian women diagnosed with breast cancer
between January 1, 1988 and December 31, 1997 was drawn from the NMCSD Tumor
Board Registry computer data base. The list contained a total o f 714 records and was
used to select records for preliminary screening. All records on the list were initially
examined by the researcher to determine eligibility for inclusion in the study. Records
were selected for inclusion in the study based on the subject’s race being identified as nonHispanic African American, Black, Caucasian, or White; the subject’s patient status being
designated as active duty, retired, or family member; diagnosis o f breast cancer occurring
at NMCSD or at another MHS with referral to NMCSD for treatment, and the date of
diagnosis o f breast cancer being documented in the tumor registry record as occurring
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between January 1, 1988 and December 31, 1997. In addition, tum or registry records
were excluded from the study if the subject’s record contained an Hispanic surname
(maiden name), and if the diagnosis o f breast cancer occurred in a civilian health care
institution with referral to NMCSD after initiation o f treatment. Subjects with more than
one diagnosis o f breast cancer appearing on the list had only the first diagnosis included in
the analysis.
Finally, a total o f 635 records were selected for inclusion in the study, 573 records
o f Caucasian women and 62 records o f African American women. Identification numbers
were assigned to the data collection sheets to correspond to the subject’s tumor registry
number, and a log of identification numbers and corresponding tumor registry record
numbers was compiled and kept in a confidential file by the researcher. Names and tumor
registry numbers were not included on any o f the data collection tools.
Approximately three months were spent collecting the data, coding the data
collection sheets, and preparing the data for statistical analysis. Data collection sheets
were grouped by year and categorized within each year grouping by identification number.
Each data collection sheet was reviewed for accuracy and double checked with the
corresponding tumor registry record by the researcher. Double-checked data collection
sheets were numerically coded by the researcher, and the numerical codes were entered
into a computerized spreadsheet in preparation for statistical analysis.
Inter-rater reliability was performed by the five tumor registrar assistants on nine
percent o f the 635 records included in the study. Each assistant was assigned two years
between 1988 and 1997, and asked to select six records for review, for each year, from

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

the pre-screened list o f African American and Caucasian women. Three o f the 60 data
collection sheets submitted by the tumor registrar assistants were excluded because the
sheets reported data obtained from the tumor registry records o f women with a second
diagnosis o f breast cancer. There were a total o f 17 categories o f data on each data
collection sheet, resulting in a total of 969 categories for the 57 data collection sheets used
for inter-rater reliability. Of the 969 categories, there were 957 matches in each category
between the data recorded by the researcher and the data recorded by the tumor registrar
assistants. Inter-rater reliability results indicated that the total percentage of agreement
between the data recorded by the researcher and the data recorded by the tumor registrar
assistants was 98.76.
Data Analysis
The data analysis plan for this study involved descriptive and inferential statistics.
Prior to statistical analyses, the data collection sheets with missing data were identified
and coded (Norusis, 1997; Stevens, 1996). Missing data in the categories of marital
status, service branch, and stage at diagnosis were coded as unknown and excluded from
inferential statistical analysis. Missing data in the categories o f tumor size, number of
positive lymph nodes, and length of time between diagnosis and treatment were coded
with negative numbers and excluded from inferential statistical analysis. Because o f the
amount o f missing data within the category o f rank of sponsor, missing data were coded
as a separate category labeled unknown, and included in the data analysis as a separate
category (Cohen & Cohen, 1983). The categorical variables o f race, rank of sponsor, and
means o f discovery were dummy coded for the purposes of performing multiple and
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logistic regression (Cohen & Cohen, 1983; Daniel, 1995; Stevens, 1996; Tabachnick &
Fidell, 1996). Data analyses were performed using the Statistical Package for the Social
Sciences (SPSS) for Windows. A .05 level o f probability was considered to indicate
statistical significance for all inferential statistical procedures.
Descriptive statistics Descriptive statistics (mean, standard deviation, minimum,
maximum, frequency distributions) were utilized to summarize and describe the
demographic characteristics of the sample, and the variables o f the study (Hinkle,
Wiersma, & Jurs, 1994; Norusis, 1997).
Inferential statistics. The independent samples chi-square test was used to assess
the relationship between each stage and age, race, socioeconomic status, and the means o f
discovery o f breast cancer; to detect any differences in the distribution o f stage at
diagnosis by race; and to examine the relationship between potential (age, race,
socioeconomic status, means of discovery) and realized (length o f time between discovery
and diagnosis, length o f time between diagnosis and treatment) access (Fisher & Van
Belle, 1993; Hinkle, Wiersma & Jurs, 1994; Huck & Cormier, 1996; Sheskin, 1997). The
Mann Whitney U test was used to test for significant differences between the two groups
in the length of time between discovery o f breast abnormality and diagnosis, and the length
of time between diagnosis and initiation o f treatment (Daniel, 1995; Huck & Cormier,
1996; Sheskin, 1997). Analysis of variance (ANOVA) was used to test for differences
between the mean scores for age and the five stages o f breast cancer diagnosis, within the
two groups (Tabachnick & Fidell, 1996; Hinkle, Wiersma & Jurs, 1994) . Multiple
regression was used to examine the relationships between age and the length o f time
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between discovery o f breast abnormality and diagnosis, and the length o f time between
diagnosis and initiation o f treatment, between the two groups; and to examine the extent
to which the predictor variables o f age, race, socioeconomic status, and the means o f
discovery o f breast cancer predict utilization o f breast health services (Cohen & Cohen,
1983; Fisher & Van Belle, 1993; Grimm & Yamold, 1995, Tabachnick & Fidell, 1996).
Logistic regression was used to examine the extent to which the predictor variables o f age,
race, socioeconomic status, and the means o f discovery o f breast cancer predict early and
late stage at diagnosis o f breast cancer; and to examine the extent to which utilization of
health services predicts early and late stage at diagnosis o f breast cancer (Daniel, 1995;
Fisher & Van Belle, 1993; Grimm & Yamold, 1995; Tabachnick & Fidell, 1996).
Limitations
This study was limited by its methodological design in that it did not include
randomized selection o f subjects, control over the environment, or manipulation o f the
variables. Other threats to external validity, such as exclusive focus on women diagnosed
at Naval Medical Center San Diego, and restriction o f the race examined to African
American and Caucasian, limit the generalizability o f the study results. Threats to internal
validity related to the measurement approach include use of the medical record, compiled
and completed by various other individuals, as the source of data. In spite o f these
limitations, it is believed that some insight into the relationship between access and stage
at diagnosis o f breast cancer in African American and Caucasian women receiving care
inside the MHS has been gained by conducting this study.
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Human Subjects
In order to ensure protection of each subject’s freedom from intrinsic risk or
injury, and to ascertain rights to privacy and dignity, a variety of human subject protective
mechanisms were utilized in this study. To begin with, this proposal was submitted to
both the University o f San Diego and Naval Medical Center San Diego Institutional
Review Boards for approval. Appendices B and C are the approval letters received from
these review boards.
The Naval Medical Center San Diego Institutional Review board grants human use
exemption for research involving the collection or study of existing data, documents, or
records, if these sources are publicly available or if the information is recorded by the
investigator in such a manner that the subjects cannot be identified directly or through
identifiers linked to the subjects. In addition, the Privacy Act Statement, located in DoD
healthcare records, specifically allows information to be used for research purposes.
Therefore, written consent was not obtained from the subjects; however, confidentiality of
the subject’s data was maintained throughout the study. Identification numbers instead of
names or tumor board registry numbers were attached to the individual data collection
tools, and only the researcher had access to the data. Anonymity was maintained in that
individual names and individual characteristics are not presented, and data analysis
expresses group information, not individual information.
There were no perceived potential physical, psychological, or social risks to the
subjects in this study. The findings will be used to enhance current knowledge relating to
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the relationship between access, race, and stage at diagnosis of breast cancer in women
being diagnosed and treated within the DoD MHS.
Summary
The purpose of this study was to describe the relationship between access and
stage at diagnosis in African American and Caucasian women being diagnosed with breast
cancer within the DoD MHS. The data analysis plan described above is felt to have been
appropriate for the study’s purpose and methodology. It is hoped that this project has
provided insight into the role of access and its influence on participation in breast health
care programs and early diagnosis of breast cancer.
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CHAPTER IV
RESULTS
The results o f the data analysis are presented in four sections in this chapter.
Section one presents a description of the sample. Section two presents comparative
descriptive analysis of the study variables and selected demographic characteristics; and
section three presents the statistical analysis related to each research question. Section
four presents the results from supplemental data analysis.
Description o f the Sample
Table 5 provides a demographic profile of the subjects included in the study. Sixty
two of the women were African American (9.8%) and 573 (90.2%) were Caucasian. The
majority of the women were family members o f active duty or retired service members
(93.4%). Active duty women constituted 4.7 percent of the sample, and retired women
constituted 1.9 percent. O f the 635 women included in the analysis 78.9 percent were
married, and 70 percent were affiliated with the United States Navy. The largest rank of
sponsor grouping was E-7 (17.8%), followed by the unknown grouping in which the
sponsor’s rank could not be identified from the tumor registry record (16.1%). The mean
age of the sample was 58.03 (SD = 13.57).
The majority of the women included in the study were diagnosed at stage 1 (n =
274 or 43.1%). Stage 4 formed the smallest stage at diagnosis grouping (n = 29 or
4.6%), and 2.8 percent (n = 18) of the tum or registry records analyzed did not have a
88
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Table 5
Summary o f Demographic and Study Variable Characteristics
Characteristic

No. of cases

% o f total

573

90.2

62

9.8

593

93.4

Active duty

30

4.7

Retired

12

1.9

Married

501

78.9

Widowed

101

15.9

Single

15

2.4

Divorced

11

1.7

Separated

5

0.8

Unknown

2

0.3

445

70.1

Marine Corps

79

12.4

Air Force

55

8.7

Women with breast cancer
Caucasian
African American
Patient service status
Family member

Marital status

Branch o f service affiliation
Navy

(table continues)
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Characteristic

No. of cases

% o f total

Army

36

5.7

Unknown

15

2.4

Other

3

0.5

Coast Guard

2

0.3

E-7

113

17.8

Unknown

102

16.1

E-6

91

14.3

0-5

53

8.3

0-6

47

7.4

E-8

46

7.2

0-4

38

6.0

E-9

34

5.4

0-3

34

5.4

E-5

31

4.9

CWO

23

3.6

E-4

9

1.4

0-7

4

0.6

0-8

4

0.6

Rank o f sponsor

(table continues)
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Characteristic

No. o f cases

% o f total

0-2

3

0.5

E-l

1

0.2

0-9

1

0.2

0-10

1

0.2

1988

39

6.1

1989

55

8.7

1990

62

9.8

1991

65

10.2

1992

75

II.8

1993

71

11.2

1994

53

8.3

1995

68

10.7

1996

71

11.2

1997

76

12.0

: cancer diagnosis by year

Age at diagnosis (N = 635)
M:
58.03
SD:
13.57
minimum: 25
maximum: 97

(table continues)
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Characteristic

No. o f cases

% o f total

Stage 1

274

43.1

Stage 2

183

28.8

In Situ

76

12.0

Stage 3

55

8.7

Stage 4

29

4.6

Not staged

18

2.8

Routine mammogram

288

45.4

Incidental BSE

195

30.7

Stage at diagnosis

Tumor size in centimeters (N = 567)
M: 2.2
SD: 1.86
minimum: 0
maximum: 13

Number o f positive lymph nodes (N = 508)
M: 2.07
SD: 4.69
minimum: 0
maximum: 37
Means o f discovery

Intentional BSE

62

9.8

Routine CBE

37

5.8
(table continues)
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Characteristic

No. of cases

% of total

Secondary CBE

25

3.9

Secondary Mammogram

17

2.7

Unknown

11

1.7

Length o f time (in days) between discovery
and diagnosis
Exact length (N = 297)
M: 45.53
SD: 4.69
minimum: 0
maximum: 1825
In-exact Length (N= 292)
M: 76.49
SD: 157.11
minimum: 0
maximum: 1825

Length o f time (in categories) between
discovery and diagnosis

1 5 - 3 0 days

138

21.7

31 - 60 days

116

18.3

< 7 days

104

16.4

7 - 1 4 days

98

15.4

Unknown

47

7.4

61 - 90 days

38

6.0
(table continues)
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Characteristic

No. of cases

% of total

9 1 - 1 2 0 days

36

5.7

121 -240 days

36

5.7

22

3.5

Surgery after diagnosis

343

54

Surgery, concurrent with diagnosis

256

40.3

20

3.1

Radiation therapy

9

1.4

No treatment

5

0.8

Hormone therapy

2

0.3

536

84.4

Deceased, breast cancer

51

8.0

Deceased, unknown

37

5.8

Deceased, other cause

11

1.7

>

240 days

Length o f time (in days) between diagnosis
and treatment (N = 629)
M: 14.43
SD: 18.41
minimum: 0
maximum: 180
Means o f initial treatment

Chemotherapy

Survival status at the time o f data collection
Alive
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stage at diagnosis recorded. The mean tumor size was 2.2 centimeters (SD = 1.86), and
the mean number o f positive lymph nodes examined was 2.07 (SD = 4.69).
Forty-five percent o f the breast cancer cases were discovered by mammogram (n =
288), followed by incidental BSE (n = 195 or 30.7%). The means o f discovery could not
be determined from the tumor registry record in 1.7 percent o f the cases. The length of
time between discovery o f a breast abnormality ana diagnosis o f breast cancer could not
be calculated by examining the exact date of discovery in 292 o f the cases. In these cases,
the in-exact length of time in days was calculated by counting the number of days between
the 15th o f the month in which the breast abnormality was discovered and the exact date
o f diagnosis. The mean in-exact length of time between discovery and diagnosis (N =
292) was 76.49 days (SD = 157.11). The mean exact length o f time in days between
discovery and diagnosis (N = 297) was 45.53 (SD = 4.69). The length o f time between
discovery and diagnosis could not be identified from the tumor registry record in 46 o f the
cases. Twenty-two percent o f the cases included in the analysis had a length of time
between discovery and diagnosis which fell into the 15 to 30 day range, 18.3 percent fell
into the 31 to 60 day range, 14.4 percent had less than 7 days between discovery and
diagnosis, and 20.9 percent o f the cases fell into the greater than 60 day range. The mean
length o f time in days between diagnosis and treatment was 14.43 (SD = 18.41).
Surgery after diagnosis was the most frequently used means o f initial treatment (n
= 343 or 54%), and 40.3% (n = 256) of the women included in the study were treated
initially with surgery concurrent with diagnosis. Chemotherapy was the means of initial
treatment in 3.1 percent (n = 20) o f the cases, and 1.4 percent (n = 9) o f the women were
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treated initially with radiation therapy. At the time of data collection, the tumor registry
records indicated that 84.8 percent (n = 536) o f the women included in the study were
alive, 8 percent (n = 51) were deceased due to breast cancer, and 7.5 percent were
deceased due to other ( n= 11) or unknown causes (n = 37).
Descriptive Analysis o f the Study Variables
Comparative descriptive statistics o f the study variables and selected demographic
characteristics o f the African American and Caucasian women, included in the study are
presented in Table 6. T tests, Mann Whitney U tests, and independent samples chi-square
tests were used to examine differences in means and frequency distributions.
There was a significant difference in the mean ages for African American (M =
47.94) and Caucasian women (M = 59.13) (p = .000). Twenty-nine percent of the African
American women diagnosed with breast cancer were less than 40 years old, compared to
8.7 percent o f the Caucasian women; and 55.5 percent of the Caucasian women diagnosed
with breast cancer were 60 or older as compared to 19.3 percent o f the African American
women.
There was no significant difference between the two groups on marital status (p =
.495), but the groups differed significantly on patient service status (p = .000). Sixteen
percent o f the African American women were active duty, compared to 3.5 percent o f the
Caucasian women, and 94.8 percent o f the Caucasian women were family members,
compared to 80.6 percent of the African American women. The tw o groups also differed
significantly on the rank of the sponsor (p = .000). Twenty-eight percent o f the African
American women fell into the E l to E5 category as compared to 5.8 percent of the
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Table 6
Between Group Differences in Distribution o f Study Variables
Variable

African
American

Caucasian

p value

Age (years), % (no. o f cases)
<40

29

(18)

8.7

(50)

4 0 -4 9

24.2 (15)

17.3

(99)

50 -59

27.4 (17)

18.5 (106)

6 0 -6 9

14.5

(9)

33.7

(193)

> = 70

4.8

(3)

21.8

(125)

.000*

Marital status, % (no. o f cases)
Married

75.8 (47)

79.5 (454)

Unmarried

24.2(15)

20.5 (117)

Active duty

16.1 (10)

3.5 (20)

Retired

3.2

1.7 (10)

Family member

80.6 (50)

94.8 (543)

E l -E 5

27.7 (13)

5.8 (28)

E 6 -E 9

63.8 (30)

52.3 (254)

CWO - 0 4

4.3 (2)

19.8 (96)

0 5 -0 1 0

4.3 (2)

22.2 (108)

.495

Patient service status, % (no. of cases)

(2)

.000*

Rank of sponsor, % (no. of cases)

000*
(table continues)
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African
American

Caucasian

In Situ

14.8 (9)

12.1 (67)

Stage 1

26.2 (16)

46.4 (258)

Stage 2

42.6 (26)

28.2 (157)

Stage 3

13.1 (8)

8.5 (47)

Stage 4

3.3

4.9 (27)

Variable

p value

Stage at diagnosis, % (no. o f cases)

(2)

.029

Tumor size, % (no. o f cases)
0 - 1 cm

18.5 (10)

27.9 (143)

1 .1 -2 .0 cm

27.8 (15)

38.4 (197)

2 .1 -3 .0 cm

27.8 (15)

17.2 (88)

3 .1 -5 .0 cm

1 8 .5 (1 0 )

9 .2 (4 7 )

> 5.0 cm

7.4

(4)

7.4 (38)

.035

No. of lymph nodes, % (no. of cases)
0

58.3 (28)

66.5 (306)

1-3

22.9 (11)

14.3 (66)

4-10

10.4 (5)

13.5 (62)

>10

8.3 (4)

5.7 (26)

.336

Means o f discovery, % (no. of cases)
Intentional BSE
Incidental BSE

1 7 .5 (1 0 )
45.6 (26)

9 .2 (5 2 )
29.8 (169)
(table
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Variable

Caucasian

CBE

African
American
15.8 (9)

Mammogram

21.1 (12)

51.7 (293)

Surgery concurrent with
diagnosis

37.1 (23)

41.0(233)

Surgery after diagnosis

61.3 (38)

53.7(305)

1.6 (1)

5.3 (30)

Alive

77.4 (48)

85.2 (488)

Deceased, Breast Cancer

16.1 (10)

7.2 (41)

6.5 (4)

7.7 (44)

p value

9.3 (53)
.000*

Means o f initial treatment
% (no. of cases)

Other treatment

.311

Survival status at the time o f data
collection, % (no. o f cases)

Deceased (Unknown, Other)

Note. All p values are 2 sided. P values were derived from chi-square tests.
Other treatment includes chemotherapy, radiation therapy, and hormone therapy.
* significant at p < .001

** significant at p <.05
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Caucasian women; 63.8 percent of the African American women fell into the E6 to E 9
category, compared to 52.3 percent of the Caucasian women; 19.8 percent of the
Caucasian women fell into the CWO - 0 4 category compared to 4.3 percent o f the
African women; and 22.2 percent of the Caucasian women fell into the 0 5 to 0 10
category, compared to 4.3 percent of the African American women.
The two groups differed significantly on stage at diagnosis o f breast cancer (p =
.029), tumor size (p = .035), and means of discovery (p = .000). But there were no
significant differences between the two groups on number o f positive lymph nodes
examined (p = .336) or means of initial treatment (p = .311). At the time of data
collection, tumor registry records reflected that 16.1 percent o f the African American
women (n = 10) were deceased due to breast cancer as compared to 7.2 percent o f the
Caucasian women (n = 41).
The mean exact length of time in days between discovery and diagnosis o f breast
cancer was 45.15 for African American women (n = 20) and 45.55 for Caucasian women
(n = 277). The mean in-exact length o f time between discovery and diagnosis was 65.08
for African American women (n = 36) and 78.09 for Caucasian women (n =256); and the
combined exact and in-exact length of time between discovery and diagnosis was 57.96
for African American women and 61.29 for Caucasian women. The mean length o f time
in days between diagnosis and initiation of treatment was 13.26 for African American
women (n = 62) and 14.56 for Caucasian women (n = 567). Because o f sample size and
missing data on the length o f time between discovery and diagnosis, and the length o f time
between diagnosis and treatment variables, the minimum number o f subjects (64) required
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in each group to conduct the t test to detect differences between the two groups at a
power o f .80, medium effect size of, 50 and .05 significance level using Cohen’s method,
was not obtained. Therefore, the Mann Whitney test was used to detect differences
between the African American and Caucasian women included in the study, on length of
time between discovery and diagnosis, and length o f time between diagnosis and
treatment. There were no significant differences between the two groups on length o f
time in days between discovery and diagnosis (U = 14296, p = .620, two tailed) or length
of time in days between diagnosis and treatment (U = 17576.500, p = 1.000 two tailed).
Data Analysis Related to the Research Questions
Research Question 1: What are the relationships between age, race, socioeconomic status,
the means of discovery o f breast cancer, and stage at diagnosis of breast cancer in women
identifying their race as Caucasian or African American, and being diagnosed with breast
cancer at Naval Medical Center San Diego from January 1, 1988 to December 31, 1997?
Independent samples chi-square tests, to assess the relationship between each stage
and age, race, socioeconomic status, and the means o f discovery of breast cancer, and to
detect any differences in distribution by race; and one-way analysis of variance to test for
differences between the mean scores for the five stages o f breast cancer diagnosis between
the two groups, were obtained using the Statistical Package for the Social Sciences
(SPSS) for Windows.
Table 7 shows that a significant relationship was found between age at diagnosis
and each stage, X2 (16, N = 617) = 44.202, p = .000. Any standardized residual with an
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Table 7
Relationship Between Stage at Diagnosis and Age at Diagnosis

Age at diagnosis
< 40 vears

40- 49 vears

Stage at diagnosis

n

%

n

%

n

In situ

9

13.2

15

13.3

13

(Std. residual)

.2

Stage 1

19

(Std. residual)

-2.0

Stage 2

32

(Std. residual)

2.6

Stage 3

8

(Std. residual)

.8

.3
27.9

37

40

32.7

17
2.2

>70 vears

%

n

%

n

%

11.0

30

15.2

9

7.4

1.2

55

46.6

21.9

33

28.0

-.3
15.0

11
.1

93

-1.5
47.2

.6

.4

1.1
11.8

60--69 vears

-.4

-1.9
47.1

50- 59 vears

47

16
-.4

57.S

2.2
23.9

-1.5
9.3

70

31

25.6

-.8
8.1

3

2.5

.5
(table continues)
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absolute value greater than or equal to the tabled critical two-tailed .05 value z.os = 1.96
is significant at the .05 level and contributes significantly to the obtained chi-square value
(Sheskin, 1997). Based on the computation o f standardized residuals, the observed
frequency o f women less than 40 years old, diagnosed at stage 2 (47.1%, std. residual =
2.6), women 40 - 49 years old diagnosed at stage 3 (15%, std. residual = 2.2), and
women less than 40 years old diagnosed at stage 1 (27.9%, std. residual = -2.0) differed
significantly from the expected frequency, and contributed significantly to the obtained
chi-square value.
Table 8 shows that there were no significant differences between the mean scores
for age and the five stages o f breast cancer for African American women, F = 1.058, p =
.386; however, there were significant differences detected in the group o f Caucasian
women, F = 5.589, p = .000. Table 9 displays further analysis of the relationship between
stage at diagnosis and age, and shows the distribution o f age by early (in situ, stage 1) and
late (stage 2,3,4) stage at diagnosis, for African American and Caucasian women. In
support of the data analysis reported in Table 8, Table 9 shows that the distribution o f age
by early-late stage did not differ in the African American women included in the study, X2
(2, N = 61) =4.331, p = .115. The significant difference in distribution o f age by stage in
the Caucasian women, X2 (2, N = 556) = 14.902, p = .001, was contributed to by the
observed frequency o f Caucasian women less than 40 and diagnosed in late stage breast
cancer (14.7 %, std. residual = 2.1) differing significantly from the expected frequency.
As shown in Table 10, there was a significant relationship between race and stage
at diagnosis, X2 (4, N = 617) = 10.83, p = .029. The observed frequency o f African
American women diagnosed at stage 1 (26.2%, std. residual = -2.1) differed significantly
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Table 8
One-Wav Analysis o f Variance: Mean Age at Diagnosis and Stage at Diagnosis, bv Race
Source

SS

df

MS

p value

African American fa = 61)
Between Groups

156.065

624.259

Within Groups

8261.184

56

Total

8885.443

60

1.058

.386

147.521

Caucasian (n = 556)
Between Groups

943.886

3775.543

Within Groups

93051.090

551

Total

96826.633

555

5.589

168.877

Note. * significant atj> < .05
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Table 9
Relationship Between Stage at Diagnosis and Age at Diagnosis, bv Race
Stage
Late (Stage 2 ,; ,4 )

Early (In Situ, Stage 1)
Age at diagnosis

n

%

n

%

< = 40

9

African American3
36.0

10

27.8

(Std. residual)

.4

4 1 -6 0

10

(Std. residual)

-

6

(Std. residual)

1.2

Total

25

(Std. residual)

23
-

40.0

23

24

3
-

100
Caucasian
7.1

117

(Std. residual)

-.8

> = 61

185

(Std. residual)

1.5

Total

325

8.3

1.0

36

100

34

14.7

2.1

1. 8

4 1 -6 0

63.9

.8

1.0

> = 61

< = 40

-.4

36

99

42.9

1.0
56.9

98
-

100

42.4

1.8

231

Note. aX2(2, N = 61) = 4.331, p = .115
bX2(2, N = 556) = 14.902, p = .001
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Table 10
Relationship Between Stage at Diagnosis and Race
Race
African American

Caucasian

Stage at diagnosis

n

%

n

%

In situ

9

14.8

67

12.1

(Std. residual)

.5

Stage 1

16

(Std. residual)

-2.1

Stage 2

26

(Std. residual)

1.9

Stage 3

8

(Std. residual)

1.1

Stage 4

2

(Std. residual)

-.5

Total

61

Note. X2(4, N = 617)= 10.83,

-.2
26.2

258

46.4

.7
42.6

157

28.2

-.6
13.1

47

8.5

-.4
3.3

27

4.9

.2
100

e

556

= .029
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from the expected frequency, and contributed significantly to the obtained chi-square
value. Table 11 shows a significant relationship between stage at diagnosis and
socioeconomic status (rank of sponsor), X2 (12, N = 519) = 26.72, p = .008. The
obtained chi-square value was contributed to significantly by the observed frequency o f
women with a sponsor’s rank of E l - E5 and diagnosed at stage 2 (53.8%, std. residual =
2.7) differing significantly from the expected frequency.
Table 12 shows that a significant relationship was found between stage at
diagnosis o f breast cancer and the means of discovery, X2 (12, N = 606) = 134.46, p =
.000. The observed frequency of women with breast cancer discovered by mammogram
and diagnosed at stage 2 (15.8%, std. residual = -4.4), by mammogram and diagnosed at
in situ (20.9%, std. residual = 4.2), by incidental BSE and diagnosed at stage 2 (44.5%,
std. residual = 3.8), by CBE and diagnosed at stage 4 (15.5%, std. residual = 3.7), by
incidental BSE and diagnosed at in situ (3.7%, std. residual = - 3.4), by mammogram and
diagnosed at stage 1 (57.2%, std. residual = 3.4), and by incidental BSE and diagnosed at
stage 1 (21.3%, std. residual = -3.0), differed significantly from the expected frequency
and contributed significantly to the obtained chi-square value.
The distribution o f rank of sponsor (see Table 13) for African American women
was significantly different from the distribution for Caucasian women, X2 (3, N = 533) =
40.09, p = .000). The observed frequency o f African American women with a sponsor’s
rank of E l - E5 (27.7%, std. residual = 4.9), CWO - 0 4 (4.3%, std. residual = -2.3), and
05 - O10 (4.3%, std. residual = -2.5) differed significantly from the expected frequency
and contributed significantly to the obtained chi-square value. Table 14 shows that the
distribution of the means o f discovery for African American women was significantly
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Table 11
Relationship Between Stage at Diagnosis and Rank of Sponsor

Rank of Sponsor
El -E5

cwo

E6 -E9

05 -0 1 0

-0 4

Stage at diagnosis

n

%

n

%

n

%

n

%

In situ

2

5.1

32

11.5

12

12.6

16

15.1

(Std. residual)

-1.2

Stage 1

10

(Std. residual)

-1.8

Stage 2

21

(Std. residual)

2.7

Stage 3

6

(Std. residual)

1.4

-.2
25.6

122

.2
43.7

-.3
53.8

82

27
.6

45.3

.1
29.4

-.3
15.4

43

.9

31

5
-1.1

54.7

1.5
32.6

23

21.7

-1.6

.4
9,7

58

5.3

7

6.6

-.7
(table continues)
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Rank of Sponsor
El -E5
Stage at diagnosis

E 6-E 9
%

16

Stage 4
(Std. residual)

-1.3

Total

39

CWO - 04
%

%

5.7

4.2
.0

1.2

100

279

0 5 -0 1 0

100

95

%

-

100

1.2

106

100

Note. X2 (12, N = 519) = 26.72, p = . 008
Five cells (25%) have an expected count of less than 5. The minimum expected frequency is 1.65.
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Table 12
Relationship Between Stage at Diagnosis and Means of Discovery

Means of discovery
Intentional BSE

Incidental BSE

CBE

Mammogram

Stage at diagnosis

n

%

n

%

n

%

n

%

In situ

4

5

7

3.7

3

5.2

62

20,9

(Std. residual)

-1.6

Stage 1

20

(Std. residual)

-1.3

Stage 2

27

(Std. residual)

2.2

Stage 3

8

(Std. residual)

1.1

-3.4
33.3

57

-1.6
21.3

-3.0
45

85

29
2.9

36.2

-.9
44.5

3.8
13.3

21

4.2

21

4
-.5

57.2

3.4
36.2

.9
15.2

170

47

15.8

-4.4
6.9

13

4.4

-2.6
(table

continues)
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Table 13
Distribution o f Rank o f Sponsor Bv Race
Race
African American

Caucasian

Rank o f sponsor

n

%

n

%

El -E 5

13

27.7

28

5.8

(Std. residual)

4.9

E 6 -E 9

30

(Std. residual)

1.0

CWO - 0 4

2

(Std. residual)

-2.3

0 5 -0 1 0

2

(Std. residual)

-2.5

Total

47

-1.5
63.8

254

52.3

-.3
4.3

96

19.8

.7
4.3

108

22.2

.8
100

486

100

Note. X2(3, N = 533) = 40.09, E =.000
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Table 14
Distribution of Means o f Discovery. By Race
Race
African American

Caucasian

Means o f discovery

n

%

n

%

Intentional BSE

10

17.5

52

9.2

(Std. residual)

1.8

Incidental BSE

26

(Std. residual)

1.9

CBE

9

(Std. residual)

1.4

Mammogram

12

(Std. residual)

-3.0

Total

57

-.6
45.6

169

29.8

-.6
15.8

53

9.3

-.4
21.1

293

51.7

1.0
100

567

100

Note. X2(3, N = 624) = 19.90, j> = .000)
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different from the distribution for Caucasian women (X2 (3, N = 624) = 19.90, p = .000).
The observed frequency o f African American women with breast cancer discovered by
mammogram (21.1%, std. residual = -3.0) differed significantly from the expected
frequency and contributed significantly to the obtained chi-square value.
Research Question 2: What are the relationships between the length of time between
discovery and diagnosis o f breast cancer, and the length of time between diagnosis and
initiation of treatment of breast cancer, and stage at diagnosis of breast cancer in women
identifying their race as Caucasian or African American, and being diagnosed with breast
cancer at Naval Medical Center San Diego from January 1, 1988 to December 31, 1997?
Independent samples chi-square tests to assess the relationship between each stage
and the length o f time between discovery and diagnosis, and the length o f time between
diagnosis and treatment were obtained using SPSS.
Table 15 shows that a significant relationship was found between the length of
time between discovery and diagnosis and stage at diagnosis of breast cancer, X2(16, N =
572) = 35.834, p = .003. The observed frequency o f breast cancer cases diagnosed at
stage 3 and having greater than 91 days between discovery and diagnosis (18.9%, std.
residual = 3.2), and at stage 4 and having 61 to 90 days between discovery and diagnosis,
differed significantly from the expected frequency and contributed significantly to the
obtained chi-square value.
As shown in Table 16, there was also a significant relationship between stage at
diagnosis and the length o f time between diagnosis and treatment, X2(12, N = 617) =
53.330, p = .000. Length of time in days between diagnosis and treatment categories were
compressed to ensure that no more than 25 percent o f the cells had expected frequency
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Table 15
Relationship Between Stage at Diagnosis and Length of Time Between Discovery and Diagnosis

Length of time between discovery and diagnosis
0-■14 davs

15 -30 davs

31 - 60 davs

61 - 90 davs

>91 days

Stage at diagnosis

n

%

n

%

n

%

n

%

n

%

In situ

25

12.5

17

12.6

18

16,2

3

8.3

7

7.8

(Std. residual)

.1

Stage 1

97

(Std. residual)

.9

Stage 2

52

(Std. residual)

-.9

.1
48.5

62

45.9

.3
26.0

47
1.1

.5

1.2
52

46.8

30
-.5

41.7

-.2

.4
34.8

15

-1.2

27.0

11
.1

28

31.1

-1.9
30.6

29

32.2

.5
(table continues)
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Length of time between discovery and diagnosis
0 - 14 davs

15- 30 davs

31 - 60 davs

61 - 90 davs

> 91 davs

Stage at diagnosis

n

%

n

%

n

%

n

%

n

%

Stage 3

15

7.5

5

3.7

10

9.0

4

11.1

17

18.9

(Std. residual)

-.7

Stage 4

11

(Std. residual)

.4

Total

200

-2.0
5.5

4

.0
3.0

-1.0
100

135

1

.4
.9

-1.9
100

111

100

3.2

3

8.3

.9

2.2

36

100

9

10,0

90

100

Note. X2 (16, N = 572) = 35.834, g = .003
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Table 16
Relationship Between Stage at Diagnosis and Length of Time Between Diagnosis and Treatment

Length of time between diagnosis and treatment
0 -14 davs

15 -• 30 davs

31- 60 days

> 60 davs

Stage at diagnosis

n

%

n

%

n

%

n

%

In situ

50

14.4

12

5.9

11

23.4

3

15.8

(Std. residual)

1.1

Stage 1

147

(Std. residual)

-.6

Stage 2

101

(Std. residual)

-.2

-2.6
42.4

101

2.2
40.4

1.1
29.1

65
.6

19

.4
40.4

-.4
31.9

15
.3

7

36.8

-.5
31.9

2

29.7

-1.5
(table

continues)
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Length of time between diagnosis and treatment
0-■14 davs

15- 30 davs

31 - 60 davs

> 60 davs

Stage at diagnosis

n

%

n

%

n

%

n

%

Stage 3

34

9.8

20

9.8

0

0

1

5.3

(Std. residual)

.6

Stage 4

15

(Std. residual)

-.3

Total

347

.4
4.3

6

-2.0
2.9

-1.2
100

204

2

-.5
4.3

-.1
100

47

6

3.1

5.4
100

19

100

Note. X2 (12, N = 617) = 53.330, p. = .000
Five cells (25%) have an expected count of less than 5. The minimum expected frequency is .89.
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counts o f less than five (Daniel, 1995; Norusis, 1997). The observed frequency of breast
cancer cases diagnosed at stage 4 and having greater than 60 days between diagnosis and
treatment (3.1%, std. residual = 5.4), at in situ and having 15 to 30 days between
diagnosis and treatment (5.9%, std. residual = -2.6), at in situ and having 31 to 60 days
between diagnosis and treatment (23.4%, std. residual = 2.2), and at stage 3 and having 31
to 60 days between diagnosis and treatment, differed significantly from the expected
frequency, and contributed significantly to the observed chi-square value.
Research Question 3: To what extent do the variables age, race, socioeconomic status,
and the means o f discovery o f breast cancer predict the length o f time between discovery
and diagnosis o f breast cancer, and the length o f time between diagnosis and initiation o f
treatment o f breast cancer, in women identifying their race as Caucasian or African
American, and being diagnosed with breast cancer at Naval Medical Center San Diego
from January 1, 1988 to December 31, 1997.
Standard multiple regression analysis to examine the relationships between age and
the length o f time between discovery and diagnosis, and the length o f time between
diagnosis and treatment; and to examine the extent to which the predictor variables o f age,
race, socioeconomic status, and means of discovery o f breast cancer predict the length of
time between discovery and diagnosis, and the length o f time between diagnosis and
treatment was obtained using SPSS.
Table 17 shows that there were no significant relationships between age at
diagnosis o f breast cancer and the length o f time between discovery and diagnosis, and the
length o f time between diagnosis and treatment, F(2, 579) = 2.129, p = . 120.
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Table 17
Relationship Between Age at Diagnosis and Variables of Realized Access N = 582

Multiple R

=

0.085

R Square

=

0.007

Regression
Residual

Variable

df

F

U

2

2.129

0.120

579

B

SE

Beta

p value

DISDIAG

-5.139E-03

0.004

-0.055

0.189

DIAGTRT

4.799E-02

0.030

0.066

0.111

57.628

.744

Constant

Key:

DISDIAG
DIAGTRT

=
=

Length o f time between discovery and diagnosis
Length o f time between diagnosis and treatment
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Table 18 shows multiple R, R square, and the unstandardized regression
coefficients (B) for the regression model, and the standardized regression coefficients ((3),
the standard error (SE) for the unstandardized coefficients, and the p value, for each of the
predictor variables. The multiple R (.251) between the predictor variables (age, race,
rank o f sponsor, and means of discovery) and the outcome variable (length of time
between discovery and diagnosis), was statistically significant, F(9, 573) = 4.279, p =
.000. Six percent of the variance in the length of time between discovery and diagnosis
was explained by the predictor variables. When taken separately, only incidental BSE (3 =
.255, p = .000) and CBE (3 = .091, p = .033) were found to be significant predictors of
the length o f time in days between discovery and diagnosis o f breast cancer.
Multicollinearity and singularity occur when variables are too highly correlated and
can cause problems with interpretation o f partial coefficients, sampling stability, and
computational accuracy (Cohen & Cohen, 1983). In order to eliminate high correlation
and redundancy among variables, bivariate correlations greater than or equal to .70 should
not be included in the analysis (Tabachnick & Fidell, 1996).
Tolerance statistics can also be computed to assess multicollinearity among
predictor (independent) variables. Tolerance is the proportion o f variability of a predictor
variable that is not explained by its relationships with the other predictor variables.
Multicollinearity is a problem if tolerances are less than 0.1 (Norusis, 1997).
To assess the extent to which the predictor variables were independent of each
other, tolerance statistics were calculated and an intercorrelation matrix was obtained (see
Table 19). Tolerances ranged from .46 to .90 and were well above the 0.1 level, and none
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Table 18
General Regression of Age at Diagnosis. Race. Socioeconomic Status, and Means o f
Discovery on Length of Time Between Discovery and Diagnosis N = 583

Multiple R

=

0.251

R Square

=

0.063

Regression
Residual

df

F

9

4.279

£
0.000

573

B

SE

Beta

p value

Age at diagnosis

-0.119

0.472

-0.011

0.801

Race3

-21.442

21.504

-0.043

0.319

Rank (E l - E5)b

-40.699

28.183

-0.069

0.149

Rank (E6 - E 9 )b

-18.177

17.455

-0.062

0.298

Rank (CWO - 0 4 ) b

-7.612

21.341

-0.019

0.721

Rank (0 5 - O 10)b

-22.691

20.501

-0.060

0.269

Intentional B S E C

20.250

21.369

0.041

0.344

Incidental B S E C

79.852

13.866

0.255

0.000*

CBEC

44.061

20.625

0.091

0.033**

Constant

54.748

34.021

Variable

Note. 3 Reference category - African American
bReference Category - Unknown
c Reference category - Mammogram

* significant at p < .001

** significant at p < .05
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Table 19
Intercorrelation Matrix of the Variables of Potential Access (Length of Time Between Discovery and Diagnosis)
N = 583
Variable

Age

Rank 1

Race

Rank 2

Rank 3

Rank 4

INTBSE

INCBSE

Age

1.000

Race

-0.231*

1.000

Rank 1

-0,223*

0.189*

1.000

Rank 2

-0.016

0.036

-0.239*

1.000

Rank 3

0.024

-0.104

-0.111**

-0.385*

1.000

Rank 4

0.071**

-0.119**

-0.122*

-0.424*

-0.197*

1.000

INTBSE

-0.171*

0.080*

0.043

-0.012

-0.006

-0.043

INCBSE

-0.155

0.099*

0.078**

0.025

0.035

-0.076**

-0.225*

CBE

0.059

0.065

0.025

-0.046

-0.017

-0.024

-0.110** -0.221*

Note.

Key:

* p_< .001 one tailed

Rank 1
Rank 3
INTBSE

=
=
=

E1- E5
CWO - 04
Intentional BSE

Rank 2
Rank 4
INCBSE

=
=
=

MAMM

1.000
1,000
1,000

E6 - E9
05-010
Incidental BSE

** g < .05 one tailed
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of the correlations in Table 19 were greater than .70. Therefore multicollinearity was not
considered a problem for these analyses.
Table 20 shows the multiple R, R square, and the unstandardized regression
coefficients (B) for the regression model, and the standardized regression coefficients (3),
the standard error (SE) for the unstandardized regression coefficients, and the p value, for
each o f the predictor variables. The multiple R (. 161) between the predictor variables
(age, race, rank of sponsor, and means of discovery) and the outcome variable (length of
time between diagnosis and treatment), approached the accepted .05 level o f significance,
F(9, 608) = 1.793, p =.067. Taken separately, age at diagnosis was found to be a
significant predictor of the length o f time between diagnosis and treatment (3 = . 110, p =
.011). Rank of E l - E5 (3 = .090, p = .058), intentional BSE (3 = .079, p = .067), and
CBE (3 = .078, p = .065) approached the .05 significance level as predictors of the
length of time between diagnosis and treatment. Table 21 is an intercorrelation matrix of
the predictor variables. All correlations were less than .70 and tolerances ranged from .45
to .90, therefore multicollinearity was not considered a problem for these analyses.
Research Question 4: To what extent do the variables age, race, socioeconomic status,
and the means of discovery o f breast cancer predict stage at diagnosis o f breast cancer in
women identifying their race as Caucasian or African American, and being diagnosed with
breast cancer at Naval Medical Center San Diego from January 1, 1988 to December 31,
1997.
A direct logistic regression analysis was performed on stage at diagnosis (early vs.
late) as an outcome, and age, race, SES, and means of discovery as predictor variables
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Table 20
General Regression o f Age at Diagnosis. Race. Socioeconomic Status, and Means of
Discovery on Length of Time Between Diagnosis and Treatment N = 618

Multiple R

=

0.161

R Square

=

0.026

df
Regression
Residual

9

F
1.793

p
0.067

608

B

SE

Beta

p value

0.151

0.059

0.110

0.011*

Race3

-0.982

2.707

-0.015

0.717

Rank (El - E5)b

6.796

3.576

0.090

0.058

Rank (E6 - E 9)b

2.100

2.210

0.057

0.342

Rank (CWO - 0 4 ) b

4.161

2.709

0.081

0.125

Rank ( 0 5 - 0 1 0 ) b

0.178

2.613

0.004

0.946

Intentional B SE C

4.848

2.639

0.079

0.067

Incidental B S E C

2.477

1.745

0.062

0.156

CBEC

4.857

2.628

0.078

0.065

Constant

2.080

4.323

Variable
Age at Diagnosis

Note. a Reference category - African American
bReference Category - Unknown
c Reference category - Mammogram

* significant at p < .05
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Table 21
Intercorrelation Matrix of the Variables of Potential Access (Length of Time Between Diagnosis and Treatment) N = 618
Variable

Age

Race

Rank 1

Rank 2

Rank 3

Rank 4

INTBSE

INCBSE MAMM

Age

1.000

Race

-0.231*

1.000

Rank 1

-0.223*

0.189*

1.000

Rank 2

-0.016

0.036

-0.239*

1.000

Rank 3

0.024

-0.104**

-0.111**

-0.385*

1.000

Rank 4

0.071**

-0.119**

-0,122*

-0.424*

-0.197*

1.000

INTBSE

-0.171*

0,080**

0.043

-0.012

-0.006

-0.043

INCBSE

-0.155*

0.099**

0.078**

0.025

0.035

-0.076**

-0.225*

1.000

0.065

0.025

-0.046

-0.017

0.024

-0.110**

-0.221*

CBE
Note. Key:

0.059
Rank 1
Rank 3
INTBSE

* g < .001 one tailed

= El -E5
= CWO - 04
= Intentional BSE

1.000

1.000

Rank 2
E 6 -E 9
Rank 4
=
0 5 -0 1 0
INCBSE = Incidental BSE

** g < .05 one tailed
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using SPSS. After deletion of 18 cases with missing values, data from 617 women were
available for analysis: 61 African American and 556 Caucasian.
A test o f the fiill model with all o f the predictors against a constant only model was
statistically reliable, X2(10, N = 617) = 126.358, p = .000, indicating that the predictors as
a set, reliably distinguished between early (in situ, stage I) and late (stages 2,3,4) stage at
diagnosis. In regard to prediction success, 70.57 percent o f the early stage and 73.41
percent o f the late stage breast cancer was correctly predicted, for an overall success rate
of 71.80 percent.
Table 22 shows regression coefficients, Wald statistics, odds ratios and 95 percent
confidence intervals for odds ratios, for each o f the variables. Means of discovery was the
only grouping which reliably predicted late stage at diagnosis, z = 88.0578, p = .0000.
The odds for African American women (OR = 1.06, 95% C l .57 - 2.00) being
diagnosed with late stage breast cancer were slightly higher than the odds for Caucasian
women (OR = 1.00). Women with a sponsor’s rank of E l to E5 (OR = 2.11, 95% Cl .87
- 5.08) were three times more likely to be diagnosed at late stage breast cancer than
women whose sponsor’s rank was 0 5 - O10 (OR = .68, 95% Cl .36 - 1,29), and twice as
likely to be diagnosed in late stage breast cancer than any o f the other rank o f sponsor
groupings. Women who had their breast cancer discovered by incidental BSE ( OR =
3.79, 95% C l 1.02 - 14.13) were almost six times more likely to be diagnosed at late stage
breast cancer than women who had their breast cancer discovered by mammogram (OR =
.68, 95% C l = .3 6 - 1.29).
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Table 22
Logistic Regression Analysis o f Late Stage at Diagnosis as a Function o f Variables of
Potential Access N = 617
95% Confidence
Interval for Odds Ratio
Variables
Age

B

Odds
Ratio
0.99

Lower

-0.0092

Wald Test
(z - ratio)
1.6803

Upper

0.98

1.00

0.0626

0.0381

1.06

0.57

2.00

Race
African American
Caucasian3

1.00

Rank o f sponsor
E l -E 5

0.7447

2.7457

2.11

0.87

5.08

E 6 -E 9

0.0906

0.1182

1.09

0.65

1.83

CWO - 0 4

-0.0608

0.0353

0.94

0.50

1.77

0 5 -0 1 0

-0.3844

1.3869

0.68

0.36

1.29

Unknown Rank3

1.00

Means o f discovery
Intentional BSE

1.0740

2.3313

2.93

0.74

11.62

Incidental BSE

1.3319*

3.9338

3.79

1.02

14.13

CBE

-0.0608

0.0353

2.93

0.74

11.65

Mammogram

-0.3844

1.3869

0.68

0.36

1.29

Unknown means3

Note. a Reference Category

1.00

* £ < .05
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Research Question 5: To what extent do the variables length o f time between discovery
and diagnosis o f breast cancer, and length o f time between diagnosis and initiation of
treatment o f breast cancer, predict stage at diagnosis of breast cancer in women
identifying their race as Caucasian or African American, and being diagnosed with breast
cancer at Naval Medical Center San Diego from January 1, 1988 to December 31, 1997.
A direct logistic regression analysis was performed on stage at diagnosis (early vs.
late) as an outcome and the length o f time between discovery and diagnosis, and the
length of time between diagnosis and treatment as predictors using SPSS. After deletion
of 67 cases with missing values, data from 568 women were available for analysis.
A test o f the frill model with all o f the predictors against a constant only model was
statistically reliable, X2(2, N = 568) = 28.928, p = .000, indicating that the predictors as a
set, reliably distinguished between early (in situ, stage 1) and late (stages 2,3,4) stage at
diagnosis. In regard to prediction success, 90.74 percent o f the early stage and 20.49
percent o f the late stage breast cancer was correctly predicted for an overall success rate
of 60.56 percent.
Table 23 shows regression coefficients, Wald statistics, odds ratios and 95 percent
confidence intervals for odds ratios for each o f the variables. Only length o f time between
discovery and diagnosis reliably predicted late stage diagnosis, z = 17.3248, p = .0000.
Presentation of Results from Supplemental Data Analysis
In order to examine: (a) the relationship between means o f discovery and variables
of potential access (race, age, SES); (b) the distribution o f variables o f potential access by
age, (c) differences in age, tumor size, length o f time between discovery and diagnosis,
and length o f time between diagnosis and treatment, by means o f discovery (self
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Table 23

Realized Access N = 568
95% Confidence Interval
for Odds Ratio
Upper

B

Wald Test
(z - ratio)

Odds
Ratio

Lower

Variables
DISDIAG

0.0058*

17.3248

1.006

1.003

1.009

DIAGTRT

-0.0029

0.3705

0.997

0.988

1.007

Note. Key:

DISDIAG
DIAGTRT

=

Length o f time between discovery and diagnosis
Length o f time between diagnosis and treatment

£ < .001
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discovered, provider discovered); (d) the extent to which age, race, marital status, patient
service status, and SES (rank o f sponsor), predict self discovered (intentional and
incidental BSE) and provider discovered (CBE, mammogram) breast cancer; and (e) the
distribution o f race, age, SES, means of discovery, and stage at diagnosis by year of
diagnosis, additional data analyses were performed.
Relationship between means o f discovery and variables of potential access.
Comparative analyses o f means of discovery and race, age, and SES are presented in
Table 24. Independent samples chi-square tests were used to examine differences in
frequency distributions, and standardized residuals were calculated to determine which
cells contributed to any obtained significant p values.
As shown earlier in table in Table 14, and repeated in Table 24 for illustrative
purposes, there was a significant difference in the distribution o f means of discovery by
race (p = .000). Fifty-two percent of the Caucasian women included in the study had
breast abnormalities discovered by mammogram, as compared to 21 percent o f the African
American women; and 46 percent of the breast abnormalities in the African American
women were discovered by incidental BSE, as compared to 30 percent o f the Caucasian
women.
There was a significant difference in the means o f discovery by age (p = .000).
Fifty-six percent o f the women less than 40 years old had their cancers discovered by
incidental BSE, as compared to 20 percent who had cancers discovered by intentional
BSE, 17 percent by mammogram, and 6 percent by CBE. Women 40 -49 years old had
almost equal percentages o f their cancers discovered by incidental BSE (37.2%) and
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Table 24
Relationship Between Variables of Potential Access (Race. Age. SES) and Means of Discovery
Characteristic/ Variable

Intentional BSE

Incidental BSE

CBE

Mammogram

African American

17.5(10)

45.6 (26)

15.8 (9)

21.1 (12)***

Caucasian

9.2 (52)

29.8(169)

9.3 (53)

51.7 (293)

<40

20.3 (13)***

56.3 (36)***

6.3 (4)

17.2(11)***

4 0 -4 9

17.7(20)***

37.2 (42)

8.8 (10)

36.3 (41)

50-59

6.6 (8)

28.9(35)

10.7(13)

53.7 (65)

6 0 -6 9

7.0 (14)

22.0 (44)***

9.0 (18)

62.0(124)***

70 and above

5.6 (7)

30.2 (38)

13.5(17)

50.8 (64)

p value

Race, % (no. of cases)

. 000 *

% (no. of cases)

. 000 *

(table continues)

133

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Characteristic/ Variable

Intentional BSE

Incidental BSE

CBE

Mammogram

El -E5

15.0(6)

45.0 (18)

12.5 (4)

27.5 (10)

E 6-E 9

9.6 (27)

32.6 (92)

8.2 (23)

49.6 (140)

CWO - 04

9.4 (9)

34.4 (33)

9.4 (9)

46.9 (45)

0 5 -0 1 0

7.3 (8)

23.6 (26)

8.2 (9)

60.9 (67)

Unknown

12.5 (12)

27.1 (26)

16.7 (16)

43.8 (42)

p value

Rank of sponsor, % (no. of cases)

.043**

Note. All p values are 2 sided and were derived from chi-square tests.
* significant at p < .001

** significant at p < .05
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mammogram (36.3); and women 50 years and older had greater than 50 percent o f their
cancers discovered by mammogram.
The four means o f discovery groupings differed significantly on the distribution by
rank of sponsor (p = .043). Forty-five percent o f the discoveries in the E l - E5 sponsor
rank group occurred by incidental BSE, as compared to 34 percent in the CWO - 0 4
group, 33 percent in the E6 - E9 group, and 24 percent in the 05 - 010 group. Sixty-one
percent o f the discoveries in the 0 5 - 010 sponsor’s rank group occurred by
mammogram, as compared to 50 percent in the E6 - E9 group, 47 percent in the CWO 0 4 group, and 28 percent in the E l - E5 group.
Distribution o f variables o f potential access bv age. Comparative frequencies of
the distribution of race, SES and means of discovery, by age categories, are presented in
Table 25. Thirty-one percent o f the African American women included in the study were
less than 40 years old as compared to 10 percent o f the Caucasian women. Within the
rank o f sponsor grouping, 39.1 percent of the women in the E l -E5 category were less
than 40 years old, as compared to 9.8 percent o f the E6 through E9, 10.2 percent o f the
CWO - 0 4 , and less than one percent of the 0 5 through 010. Eighty-two percent of the
incidental BSE cancer discoveries occurred in women 40 years or older. Within the
intentional BSE means o f discovery, 79.9 percent of the women were 40 years and older,
and 96.4 percent of the mammogram discovered cancers occurred in women 40 years and
older.
Differences in mean scores o f selected study variables bv means o f discovery.
Means o f discovery was recoded into self discovered means (intentional and incidental
BSE) and provider discovered means (CBE and mammogram) and the t-test for
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Table 25
Distribution o f Variables o f Potential Access (Race. SES. Means of Discovery). Bv Age
(<40 and > = 40)
< 40 Years Old

> = 40 Years Old

African American

30.6(19)

69.4 (43)

Caucasian

9.9 (57)

90.1 (516)

El -E 5

39.1 (16)

60.9 (25)

E 6 -E 9

9.8 (28)

90.2 (256)

CWO - 0 4

10.2 (10)

89.8 (88)

.9 (1)

99.1 (109)

Intentional BSE

20.1(13)

79.9 (49)

Incidental BSE

18.5(36)

81.5(159)

CBE

6.5 (4)

93.5 (58)

Mammogram

3.6(11)

96.4 (294)

Variable
Race %(no. of cases)

Rank of Sponsor

%(no. o f cases)

0 5 -0 1 0
Means of Discovery

%(no. o f cases)
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independent samples was used to test for significant differences between the mean scores
of the two groups on age, tumor size, length o f time between discovery and diagnosis, and
length o f time between diagnosis and treatment. A minimum sample size o f a least 200
was achieved for all groups, therefore a power o f greater than .995 was obtained using a
medium effect size o f .50 and a significance level o f .05 (Cohen, 1988). Unequal
variances, as determined by calculating the F test, were treated by using the separate
variance formula (Hinkle, Wiersma, & Jurs, 1994).
Table 26 displays a summary o f differences in mean scores of selected study
variables, by self and provider discovered means. There were significant differences in
means between the self discovered and provider discovered breast abnormalities on age at
diagnosis (t = -6.096; p = .000), size of tumor in centimeters (t = 6.820; p = .000), and
length o f time in days between discovery and diagnosis (t = 4.321; p = .000). There were
no significant differences in the means between self discovered and provider discovered
abnormalities on length o f time in days between diagnosis and treatment (t = 1.047; p =
.295).
Extent to which age, race, patient service status, marital status, and SES predict
self or provider discovered means. Means of discovery was recoded into self discovered
means (intentional and incidental BSE) and provider discovered means (CBE and
mammogram), and age at diagnosis was categorized into five nominal groups. Marital
status and patient service status were included as additional demographic descriptors o f
the women in this study. A direct logistic regression analysis was performed on means o f
discovery (self vs. provider) as an outcome, and age, race, marital status, patient service
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Table 26
T-Test Summary Table of Selected Study Variables by Means of Discovery

Variable

Self Discovered
(BSE)
SD
M

N

N

Provider Discovered
(CBE and Mammogram)
SD
M

t

df

p value

AGE

257

54.15

14.90

367

60.91

11.58

-6.096

461

.000*

SIZE

237

2.839

2.007

320

1.755

1.626

6.820

444

.000*

DISDIAG

236

94.62

179.94

347

37.94

109.94

4.321

354

.000*

DIAGTRT

255

15.47

18.75

363

13.88

18.32

1.047

539

.295

Note.
Key:

* g < .001 two tailed
AGE
SIZE
DISDIAG
DIAGTRT

=
=
=
=

Age at Diagnosis
Size of Tumor in Centimeters
Length of time in days between discovery and diagnosis
Length of time in days between diagnosis and treatment
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status, and SES as predictor variables, using SPSS. After deletion o f 13 cases with
missing values, data from 622 women were available for analysis.
A test o f the full model with all o f the predictors against a constant only model was
statistically reliable, X2(12, N = 622) = 64.992, p = .000, indicating that the predictors as
a set, reliably distinguished between self (intentional and incidental BSE) and provider
(CBE, mammogram) discovered means. In regard to prediction success, 41.80 percent o f
the self discovered abnormalities, and 83.06 percent of the provider discovered
abnormalities were correctly predicted, for an overall success rate o f 66.08 percent.
Table 27 shows regression coefficients, Wald statistics, odds ratios and 95 percent
confidence intervals for odds ratios, for each of the variables. Age (z = 36.4114, p =
.0000) and race (z = 3.8065, p = .0511) reliably predicted provider discovered breast
abnormalities.
Women 60 to 69 years old (OR = 1.36, 95% Cl .84 - 2.21) were seven times more
likely to have provider discovered breast abnormalities, than were women less than 40
years old (OR = .20, 95% Cl .091 - .42); and three times more likely than women 40 to
49 years old (OR = .46, 95% Cl .27 - .80). The odds for women 60 to 69 years old
having provider discovered breast abnormalities were also higher than for women 50 to
59 years old (OR = 1.02, 95% Cl .59 - 1.77), and for women 70 years and older (OR =
1.00 ).

Caucasian women (OR = 1.00) were more likely to have provider discovered
breast abnormalities than were African American women (OR = .54, 95% Cl .29 - 1.00).
The odds for married women (OR = 1.14, 95% Cl = .73 - 1.77) having provider
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Table 27
Logistic Regression Analysis o f Provider Discovered Breast Abnormality as a Function o f
Variables of Selected Demographic Variables N = 622
95% Confidence
Interval for Odds
Ratio
Variables

B

Wald Test
(z - ratio)

Odds
Ratio

Lower

Upper

Age
<40

-1.6283*

17.3136

.20

.091

.42

4 0 -4 9

-.7723**

7.4602

.46

.27

.80

5 0 -5 9

.0230

.0068

1.02

.59

1.77

6 0 -6 9

.3077

1.5375

1.36

.84

2.21

.29

1.00

.73

1.77

1.00

_> 70a
Race
African American

-.6183**

3.8065

.54
1.00

Caucasian*
Marital Status
Married

.1280

.3226

1.14
1.00

Unmarried*
Patient Service Status
Active Duty
Retired
Family Member*

.0886

.0319

1.09

.41

2.89

-.1279

.0388

.88

.25

3.14

1.00
(table continues)
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95% Confidence
Interval for Odds
Ratio
B

Variables

Wald Test
(z - ratio)

Odds
Ratio

Lower

Upper

Rank of sponsor
E l -E 5

-.2232

.2716

.80

.35

1.85

E 6 -E 9

-.1175

.2104

.89

.54

1.47

CWO - 0 4

-.1937

.3860

.82

.45

1.52

.2183

.4881

1.24

.67

2.30

0 5 -0 1 0
Unknown Rank3

1.00

Note. a Reference
* p <.001

* * p < .05
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discovered breast abnormalities were higher than the odds for unmarried women (OR =
1.00); and active duty women (OR = 1.09, 95% Cl .41 - 2.89) were more likely to have
provider discovered breast abnormalities than were women who were family member
beneficiaries (OR = 1.00), or women who were retired from active duty (OR = .88, 95%
Cl .25 - 3.14). The odds for women with a sponsor’s rank o f 0 5 to O10 (OR= 1.24,
95% Cl .67 - 2.30) having provider discovered breast abnormalities were higher than the
odds for women with a sponsor’s rank o f E l to E5 (OR = .80, 95% Cl .35 - 1.85), CWO
to 0 4 (OR = .82, 95% Cl .45 - 1.52), and E6 to E9 (OR = .89, 95% Cl .54 - 1.47).
Distribution o f race, age. SES. means o f discovery, and stage at diagnosis by year
of diagnosis. Independent samples chi-square tests were used to examine differences in
distributions o f race, age at diagnosis, rank o f sponsor, stage at diagnosis (early versus
late), and means o f discovery, by year. There were no significant differences in
distributions o f race X2 (9, N = 635) = 5.388, £ = .799, age X2 (36, N = 635) = 36.616, £
= .440, rank o f sponsor X2 (27, N = 533) = 32.096, £ = .229, or stage at diagnosis X2 (9,
N = 617) = 15.392, £ = .081, by year. There was a significant difference in the
distribution o f means o f discovery by year X2 (27, N = 624) = 56.817, £ = .001. Table 28
displays the trends in means of discovery from 1988 through 1997. In 1988 and 1989, the
percentage o f incidental BSE and mammogram discoveries were both 34.2 and 38.2
percent respectively. From 1992 through 1996, the percentage o f mammogram
discoveries consistently increased from 43.2 to 64.2 percent. Incidental BSE discoveries
were at 39.2 percent in 1992, 20.6 percent in 1993, 35.8 percent in 1994, 25.4 percent in
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Table 28
Distribution of Means of Discovery bv Year

Means of Discovery
Intentional BSE

Incidental BSE

CBE

Mammogram

Year of Diaanosis

n

%

n

%

n

%

n

%

1988

6

15.8

13

34.2

6

15,8

13

34.2

1989

7

12.7

21

38.2

6

10.9

21

38.2

1990

7

11.5

17

27.9

6

9.8

31

50.8

1991

5

7.7

15

23.1

10

15.4

35

53.8

1992

6

8.1

29

39.2

7

9.5

32

43.2

1993

16

23.5

14

20.6

4

5.9

34

50.0

1994

4

7.5

19

35.8

1

1.9

29

54.7

1995

3

4.5

17

25.4

9

13.4

38

56.7

1996

1

1.5

15

22.4

8

11.9

43

64.2
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Means of Discovery
Intentional BSE

Incidental BSE

CBE

Mammogram

Year of Diagnosis

n

%

n

%

n

%

n

%

1997

7

9.2

35

46.1

5

6.6

29

38.:

Total

62

195

62

305

Note. X2 (27, N = 624) = 56.817, p = . 001
Percentage displayed within the % category is the percent within the year of diagnosis.
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1995, and 22.4 percent in 1996. Mammogram discoveries were at 38.2 percent in 1997,
as compared to 46.1 percent for incidental BSE discoveries.
Summary
This chapter presented the results o f the data analysis for this study in four
sections. The first section presented a description o f the sample, and was followed by
presentation o f comparative descriptive analysis o f the study variables and selected
demographic characteristics, in section two. The third section presented statistical analysis
related to each o f the research questions, and the results of supplemental statistical
analysis were presented in section four.
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CHAPTER V
SUMMARY, DISCUSSION, IMPLICATIONS, AND CONCLUSION
This chapter includes: a summary of the research design and method, discussion o f
the research findings, implications for nursing practice, education, and research, and the
conclusion o f the research study.
Summary of the Research Design and Method
The purpose of this descriptive comparative study was to examine the relationship
between access and stage at diagnosis o f breast cancer in African American and Caucasian
women diagnosed with breast cancer at NMCSD between January 1, 1988 and December
31, 1997. The conceptual framework for this study: (a) was based on the Aday/Andersen
Framework for the Study of Access, (b) asserted that in addition to economic access,
there are additional delineators o f access to breast health care; and (c) theorized that there
are influential relationships between potential access, realized access, and stage at
diagnosis o f breast cancer, within an equal economic access health care system. Indicators
of potential access were defined as race, age, socioeconomic status, and means of
discovery o f breast cancer. Indications o f realized access were defined as the length o f
time between discovery of breast abnormality and diagnosis, and the length o f time
between diagnosis and treatment.

146
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The following research questions were addressed:
1. What are the relationships between age, race, socioeconomic status, the means
of discovery o f breast cancer, and stage at diagnosis of breast cancer in women identifying
their race as Caucasian or African American, and being diagnosed with breast cancer at
Naval Medical Center San Diego from January 1, 1988 to December 31, 1997.
2. W hat are the relationships between the length of time between discovery and
diagnosis o f breast cancer, and the length of time between diagnosis and initiation of
treatment o f breast cancer, and stage at diagnosis o f breast cancer in women identifying
their race as Caucasian or African American, and being diagnosed with breast cancer at
Naval Medical Center San Diego from January 1, 1988 to December 31, 1997.
3. To what extent do the variables age, race, socioeconomic status, and the
means of discovery o f breast cancer predict the length of time between discovery and
diagnosis o f breast cancer, and the length o f time between diagnosis and initiation of
treatment o f breast cancer, in women identifying their race as Caucasian or African
American, and being diagnosed with breast cancer at Naval Medical Center San Diego
from January 1, 1988 to December 31, 1997.
4. To what extent do the variables age, race, socioeconomic status, and the means
of discovery o f breast cancer predict stage at diagnosis of breast cancer in women
identifying their race as Caucasian or African American, and being diagnosed with breast
cancer at Naval Medical Center San Diego from January 1, 1988 to December 31, 1997.
5. To what extent do the variables length o f time between discovery and diagnosis
of breast cancer, and length o f time between diagnosis and initiation of treatment of breast
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cancer, predict stage at diagnosis o f breast cancer in women identifying their race as
Caucasian or African American, and being diagnosed with breast cancer at Naval Medical
Center San Diego from January 1, 1988 to December 31, 1997.
Data were collected from the tumor registry records o f 573 Caucasian and 62
African American women, and were analyzed using SPSS for Windows. Descriptive
statistics were used to summarize and describe the demographic characteristics of the
sample and the study variables; and inferential statistics were used to examine the
relationships between the study variables. The results o f the study confirm the existence
of non-economic delineators o f access to breast health care, support the influential
relationships between potential access, realized access, and stage at diagnosis of breast
cancer, and provide some new insights into the disparity in stage at diagnosis of breast
cancer between African American and Caucasian women. Discussion o f the results o f the
study are presented in the next section o f this chapter.
Discussion
Descriptive Characteristics of the Sample and Study Variables
The racial distribution o f African American (9.8%) and Caucasian (90.2%) women
in this study is representative of the racial distribution o f African Americans (12%) and
Caucasians (84%) in the United States population. In addition, the racial distribution o f
women included in the DoD MHS wide studies o f breast cancer conducted by Zaloznik
(1995; African American women 10.41 %; Caucasian women 89.58%), and Wojcik,
Spinks, and Optenberg (1998; African American women 10.6%; Caucasian women
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89.4%) is consistent with the distribution o f African American and Caucasian women in
this study.
The significant difference in the mean age at the time o f diagnosis of breast cancer,
between the African American and Caucasian women in this study, concurs with studies
conducted both within and outside o f the DoD MHS. In this study, the mean age for
African American women was 47.94 years as compared to 59.13 for Caucasian women,
and 29 percent o f the African American women were diagnosed at an age less than 40
years as compared to 8.7 percent of the Caucasian women. In the DoD-wide study
conducted by Zaloznik (1995), 24 percent o f the African American women were
diagnosed at an age less than 40 years old as compared to 9 percent o f the Caucasian
women; and in the DoD-wide study conducted by Wojcik, et al. (1998), the mean age for
African American women was 50 years as compared to 57.1 years for Caucasian women,
and 22.8 percent o f the African American women were diagnosed at an age less than 40
years as compared to 9.2 percent of the Caucasian women. In a study conducted outside
of the DoD by Newman and Alfonso (1997), the mean age for African American women
was 56 years as compared to 63 years for Caucasian women, and approximately one third
of the African American women were diagnosed at an age less than 50 years, as compared
to one fifth o f the Caucasian women.
In relation to patient service status, the results of this study correspond to the
results o f the study conducted by Wojcik, et al. (1998). In the Wojcik et al. study, 90
percent o f the women were family members o f active duty members or retirees, and 4.9
percent o f the women were active duty. Within the group o f active duty women, 10.3
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percent were African American, as compared to 4.3 percent Caucasian. In this study, 93.4
percent o f the women were family members, 4.7 percent active duty, and 16.1 percent of
the women within the active duty group were African American as compared to 3.5
Caucasian.
African American women in this study were diagnosed at significantly later stages
than were Caucasian women. Forty-one percent of the African American women in this
study were diagnosed with tumors confined to the breast (early stage breast cancer), as
compared to 58.5 percent of the Caucasian women. This finding is consistent with the
percentages reported by other studies (Coates et al., 1990; Eley et al., 1994; Hunter et al.,
1993; Mandelblatt et al., 1995; Roach et al., 1997; Simon & Severson, 1996; Wojcik et
al., 1998). Specifically, Landis, Murray, Bolden and Wingo (1999) reported that from
1989 to 1994, 50 percent of the African American women diagnosed with breast cancer
presented with tumors confined to the breast, as compared to 62 percent of the Caucasian
women. Wells and Horm (1992) reported that 45.7 percent of the African American
women they studied were diagnosed in early stage breast cancer, as compared to 52.1
percent of the Caucasian women; and Newman and Alfonso (1997) found that 21.3
percent o f the African American women in their study presented at early stage breast
cancer as compared to 49 percent of the Caucasian women.
In this study, African American women tended to have larger tumors at the time o f
diagnosis. This significant difference in tumor size is in keeping with the findings o f other
studies. Roach et al. (1997), Wojcik et al. (1998), and Zaloznik (1995), all reported that
African American women had significantly larger tumors at the time o f diagnosis, when
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compared to Caucasian women. However, neither this study, nor any o f the studies
presented in chapter two reported significant differences in the number o f positive lymph
nodes between the two groups o f women.
The primary means o f discovery for the women in this study was mammogram
(45.4%). The significant difference in mammogram discovered breast cancers, for the
African American (21.1% mammogram) and Caucasian (51.7% mammogram) women in
this study, will be discussed in detail under research question one.
The mean exact length o f time in days between discovery and diagnosis o f breast
cancer was 45.15 for African American women and 45.55 for Caucasian women. When
the exact length o f time was combined with the calculated in-exact length o f time between
discovery and diagnosis, the mean for African American women became 57.96, as
compared to a mean o f 61.29 for Caucasian women. In keeping with the findings o f
studies reported in chapter two and conducted outside o f the DoD MHS, there were no
significant differences between African American and Caucasian women on length o f time
between discovery and diagnosis of breast cancer. However, neither the study by
Zaloznik (1995), nor the study by Wojcik et al. (1998), conducted within the DoD MHS,
investigated the length o f time between discovery o f breast abnormality and diagnosis of
breast cancer.
The mean length o f time in days between diagnosis and treatment for African
American women in this study was 13.26 as compared to 14.56 for Caucasian women, and
there were no significant differences between the tw o groups. The mean length o f time
between diagnosis and treatment for the African American and Caucasian women in this
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study, was however, shorter than the mean time reported by Wojcik et al.(1998), in which
African American women were found to have a significantly shorter length o f time
between diagnosis and treatment (21.15 days), than were Caucasian women (29.51 days).
Surgery was the means of initial treatment in 94.3 percent o f the women in this
study, and there were no significant differences between African American (98.4%) and
Caucasian (94.7%) women. This finding is consistent with the DoD wide study finding o f
Wojcik et al. (1998) in which surgery was the means o f initial treatment for 93.8 percent
of the African American women and for 90.3 percent o f the Caucasian women.
In keeping with the finding that African American women are more likely to die
from breast cancer than Caucasian women (Chaulk, Kazandijan, & Pipesh, 1995; Coates
et al., 1990; Eley et al., 1994; Wagner & Schatzkin, 1994; Wojcik et al., 1998), 16.1
percent of the African American women in this study were deceased due to breast cancer
at the time o f data collection, as compared to 7.2 percent of the Caucasian women.
Research Question 1: What are the relationships between age, race,
socioeconomic status, the means of discovery o f breast cancer, and stage at diagnosis of
breast cancer in women identifying their race as Caucasian or African American, and being
diagnosed with breast cancer at Naval Medical Center San Diego from January 1, 1988 to
December 31, 1997.
The significant finding in this study, regarding the relationship between late age
and early stage at diagnosis, is in keeping with the finding of Newman and Alfonso (1997).
In both studies, women 50 years o f age and older were diagnosed at in situ (stage 0) and
stage 1 at a higher percentage than women less than 50 years old. On the other hand, the
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finding relating to the distribution of stage by age and race in this study, was different
from the finding in Newman and Alfonso’s study. Both studies reported detecting a
significant difference in stage at diagnosis between African American and Caucasian
women, and in the distribution of stage by age within the group of Caucasian women.
However, while Newman and Alfonso reported a significant difference in the distribution
of stage at diagnosis between African American women less than 50 years old, and African
American women 50 years o f age and older, this study found that there was no significant
difference in the distribution of stage by age in the group African American women.
The finding o f a significant difference in the stage at diagnosis of breast cancer
between the African American and Caucasian women in this study, echo the results o f
other studies examining the relationship between race and stage at diagnosis of breast
cancer. In studies conducted by Hunter et al. (1993) Mandelblatt et al. (1995), and
Newman and Alfonso (1997), African American women were found to be diagnosed at
significantly later stages than Caucasian women. Hunter et al. attributed this disparity to
access to health care, lifestyle, and antecedent medical experiences in the African
American women, and suggested that higher stage at diagnosis was related to poorer
access to health care and lower socioeconomic status (SES). Mandelblatt et al. also
attributed the disparity in stage at diagnosis to health care access and SES. Mandelblatt et
al. found that the odds for being diagnosed with late stage breast cancer were higher for
women living in areas with low SES rankings, and that mammography capacity was a
significant independent predictor of stage at diagnosis. On the other hand, Newman and
Alfonso reported that the disparity in stage at diagnosis o f breast cancer in the African
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American and Caucasian women in their study, did not appear to be related to economic
access to health care. The majority of the African American women in the Newman and
Alfonso study had access to and used private medical care; and the distribution o f stage at
diagnosis in African American women receiving care through the public clinic was similar
to the distribution o f those receiving care through the private practice setting.
Zaloznik (1995) reported finding no significant difference in stage at diagnosis
between African American and Caucasian women receiving care in the DoD MHS. In a
study conducted using the tumor registry records o f 6414 Caucasian and 746 African
American women entered in the DoD Automated Tumor Registry from 1976 to 1992,
Zaloznik reported that African American women were significantly younger than
Caucasian women, had significantly larger tumors than Caucasian women, but were not
diagnosed at significantly later stages than Caucasian women. This finding is interesting in
light of the results o f the study by Wojcik et al. reported in 1998. Wojcik et al. examined
the breast cancer survival status of 698 African American and 5879 Caucasian women
with records entered in the DoD central tumor registry from 1975 to 1994 and found that
African American women were significantly younger than Caucasian women at the time o f
diagnosis, had significantly larger tumors than Caucasian women, and were diagnosed at
significantly later stages than Caucasian women. Neither o f the studies conducted inside
the DoD MHS examined the effects of SES, or means o f discovery on stage at diagnosis,
but Wojcik et al. asserted that factors other than economic access may contribute to
diagnosis o f African American women at younger ages and later stages of breast cancer.
The findings o f this study, relating to the relationship between age, race, and stage at
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diagnosis support the assertion made by Wojcik et al., and indicate that in this sample,
delineators o f access, other than economic, appear to be related to the disparity in age,
race, and stage at diagnosis.
Approximately 93 percent of the women included in this study were family
members o f active duty members or retirees. Therefore, the rank o f the sponsor is not
considered to be an effective measure o f military rank or educational level for 93 percent
of the women in this study. However, the rank o f the sponsor is viewed as an appropriate
measure o f the SES of the household o f the woman being diagnosed with breast cancer,
and is supported as an effective means o f comparing and contrasting the SES o f the
women included in this study.
The relationship between SES and stage at diagnosis was significant. Junior
enlisted (lower pay level than senior enlisted, junior officer, senior officer) were diagnosed
at stages 2 and 3 at a higher percentage than senior enlisted, junior officers, and senior
officers. This finding of late stage at diagnosis o f breast cancer at lower SES rankings is
consistent with other studies reported in chapter two (Franzini et al., 1997; Wagner &
Schatzkin, 1994; Wells & Horm, 1992). However, prior studies on the relationship
between SES and stage at diagnosis o f breast cancer, within an equal economic access
system, were not available for comparison. In addition, this disparity in stage at diagnosis
could be related to age at diagnosis, since junior enlisted and their spouses are frequently
younger than senior enlisted, junior officers and senior officers. Furthermore, the
significantly higher percentage o f African American women with a sponsor’s rank o f
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junior enlisted, as compared to Caucasian women, could also be related to the disparity in
stage at diagnosis by SES.
The percentage o f women diagnosed in early stage breast cancer, by mammogram,
is significantly higher than the percentage o f women diagnosed in early stage breast cancer
by any other means. Forty-five percent o f the stage 2 cancers were diagnosed by
incidental BSE, as compared to 16 percent diagnosed by mammogram, and 21 percent o f
the stage 0 breast cancers were diagnosed by mammogram, as compared to five percent
diagnosed by intentional BSE, and four percent diagnosed by incidental BSE. These
findings support the existing literature on breast cancer screening which reports that early
stage diagnosis is more likely to be associated with mammogram than with any other
means.
The finding relating to the distribution o f means o f discovery by race was
significant. Fifty-two percent of the Caucasian women in this study had their breast
cancers discovered by mammogram as compared to 21 percent of the African American
women; and 30 percent of the Caucasian women discovered their breast cancers by
incidental BSE as compared to 46 percent o f the African American women. Nine percent
o f the Caucasian women discovered their breast cancers by intentional BSE as compared
to 18 percent o f the African American women; and 9 percent of the cancers in the group
o f Caucasian women were discovered by CBE, as compared to 16 percent in the group o f
African American women. Only one study examining the relationship between stage at
diagnosis and means o f discovery in African American and Caucasian women could be
located for comparison with the findings o f this study. However, the available studies on
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the breast cancer screening behaviors and practices o f African American and Caucasian
women provide an additional avenue for discussion o f this study’s findings, in relation to
the means o f discovery. Vernon et al. (1992), O’Malley, Earp, and Harris (1997), and
Roberson (1997) found, when examining breast cancer screening behaviors in African
American and Caucasian women, that Caucasian women were more likely to participate in
mammography than African American women. In these studies, the difference in
screening practice was attributed to cost and lack of physician referral. On the other hand,
Douglass, Bartolucci, Waterbor, and Sirles (1995), and Michels, Carter, Taplin, and
Kugler (1995) reported finding no significant difference in mammography participation
between African American and Caucasian women.
In the one study located examining the relationship between means of discovery
and stage at diagnosis, Benedict, Williams, and Hoomani (1996) found that 55.6 percent
o f the African American women had cancers discovered by mammogram as compared to
31.7 percent o f the Caucasian women; even though the Caucasian women had higher rates
for annual CBE and mammogram, than the African American women. In addition,
Benedict et al. reported that 33.3 percent of the cancers in African American women were
discovered by accident, as compared to 7.35 in the Caucasian women; and that 11.1
percent o f the cancers in African American women were discovered by BSE as compared
to 34.1 in the Caucasian women. Benedict et al. did not include stage 0 in their analysis,
and stage at diagnosis, in relation to means of discovery, was not stratified by race. In
addition, inferential statistics were not conducted because o f sample size. Therefore, even
though the study conducted by these investigators offers some insight into the relationship
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between stage at diagnosis and means o f discovery for women receiving care outside o f an
equal economic access system, the comparability of the results with this study’s findings is
difficult because o f research design and methodology.
The results o f these studies both support and contrast the findings o f this study.
The majority o f the studies available on means of discovery relate to self reported breast
cancer screening behaviors and activities o f women who have not had breast cancer; and
the one study located on means o f discovery in women diagnosed with breast cancer did
not provide optimal comparability. Nevertheless, the significant difference in stage at
diagnosis in the African American and Caucasian women in this study appears to be
related to the means of discovery.
Research Question 2 . What are the relationships between the length of time
between discovery and diagnosis o f breast cancer, and the length o f time between
diagnosis and initiation of treatment o f breast cancer, and stage at diagnosis o f breast
cancer in women identifying their race as Caucasian or African American, and being
diagnosed with breast cancer at Naval Medical Center San Diego from January 1, 1988 to
December 31, 1997.
The finding of a significant relationship between length o f time in days between
discovery and diagnosis, and stage at diagnosis supports that increased length o f time
between discovery and diagnosis is associated with late stage at diagnosis. Women with
greater than 90 days between discovery and diagnosis seemed to have poorer outcomes in
relation to stage at diagnosis. Sixty-one percent o f the women with greater than 90 days
between discovery and diagnosis were diagnosed in late stage breast cancer. Women with
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61 to 90 days between discovery and diagnosis were equally distributed (50%) between
early and late stage at diagnosis; and women with 0 to 60 days between discovery and
diagnosis were diagnosed at late stage breast cancer at a range o f 37 to 42 percent. Even
though there are no prior studies which specifically examine the relationship between stage
at diagnosis and length of time between discovery and diagnosis, available for comparison
with the findings o f this study, the existing literature on breast cancer maintains that late
stage diagnosis o f breast cancer is associated with prolonged time between discovery and
diagnosis; occurs more frequently in African American women; and is a result of lack o f
economic access to care. However, the existence o f economic access to health care within
the group o f women in this study renders economic access barriers irrelevant as the
primary cause o f diagnosis delay, and support the existence o f other access barriers to
care. Furthermore, the African American women in this study were diagnosed at
significantly later stages than the Caucasian women, yet there was no significant difference
between the two groups on length o f time between discovery and diagnosis.
The relationship between length o f time between diagnosis and treatment and stage
at diagnosis was significant. This finding is interesting in light o f the fact that diagnosis,
and assignment o f stage, occur primarily before the period o f time between diagnosis and
treatment commences. This finding will be discussed further under research question
number three.
Research Question 3. To what extent do the variables age, race, socioeconomic
status, and the means of discovery o f breast cancer predict the length o f time between
discovery and diagnosis of breast cancer, and the length o f time between diagnosis and
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initiation o f treatment of breast cancer, in women identifying their race as Caucasian or
African American, and being diagnosed with breast cancer at Naval Medical Center San
Diego from January 1, 1988 to December 31, 1997.
The group of variables comprising potential access accounted for six percent o f the
variance in length of time between discovery and diagnosis. Incidental BSE emerged as
the variable explaining the greatest amount o f variance, followed by CBE; and none o f the
other variables of potential access contributed significantly to the variance in this model.
The amount o f explained variance is low, and there are no prior studies available for
comparison. Still, one interpretation of the low explained variance might be the existence
o f several other undefined variables o f potential access, which influence both means o f
discovery of breast cancer, and the length o f time between discovery and diagnosis. In
addition, unidentified personal and health care delivery system factors related to length o f
time between discovery o f breast abnormality and initial contact with the health care
delivery system might also impact length o f time between discovery and diagnosis.
The findings of this study did not support the variables o f potential access (age,
race, SES, means of discovery), as a group, as significant predictors o f the length o f time
between diagnosis and treatment o f breast cancer. The regression model did approach the
level o f significance, and age at diagnosis, when taken separately was found to be a
significant predictor of the length o f time between diagnosis and treatment. However, in
the regression model examining the relationship between age and realized access, age at
diagnosis was not found to be significantly related to the length o f time between diagnosis
and treatment.
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The results discussed thus far in this chapter support that stage at diagnosis is
significantly related to the variables o f potential access. While Aday and Anderson (1974)
maintain that potential access can be conceptualized as characteristics o f the individual
and/or the health care delivery system, in this study, potential access has been supported as
a characterization o f the individual. Even though statistical analyses have also
demonstrated the existence o f significant relationships between the variables o f realized
access and stage at diagnosis, length of time between discovery and diagnosis appears to
be a characteristic of the individual related to the means o f discovery, while length o f time
between diagnosis and treatment appears to be a characteristic o f the health care
institution related to economic access to health care. If this conjecture is true, variables of
potential access, which define characteristics of the individual, would not be expected to
significantly predict length of time between diagnosis and treatment within an equal
economic access system; and variables defining means o f discovery would be expected to
significantly predict the length o f time between discovery and diagnosis. Given the
findings of this study, it can be posited that the results relating to the extent to which
variables of potential access predict the length of time between diagnosis and treatment,
are consistent with the other results o f this study.
Research Question 4 . To what extent do the variables age, race, socioeconomic
status, and the means of discovery o f breast cancer predict stage at diagnosis o f breast
cancer in women identifying their race as Caucasian or African American, and being
diagnosed with breast cancer at Naval Medical Center San Diego from January 1, 1988 to
December 31, 1997.
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Means o f discovery was the only potential access variable which reliably predicted
late stage diagnosis o f breast cancer. Within the means o f discovery grouping, incidental
BSE was the strongest predictor, and women with breast cancers discovered by incidental
BSE were almost six times more likely to be diagnosed at late stage than were women
with breast cancers discovered by mammogram. This finding supports study results
discussed earlier relevant to the significant relationship between stage at diagnosis and
means o f discovery, in that mammogram appears to be related to early stage diagnosis,
while incidental BSE seems to be related to late stage diagnosis. Both intentional BSE
and CBE were four times more likely to result in late stage diagnosis, when compared to
mammogram. Therefore, overall, the results o f this study confirm that early stage
diagnosis is more likely to be associated with mammogram than with any other means o f
discovery.
African American women, in this study, were slightly more likely to be diagnosed
with late stage breast cancer, when compared to the Caucasian women. This odds ratio
supports this study’s finding of a significant difference between the two groups on stage
at diagnosis o f breast cancer. In addition, the increased likelihood of African American
women being diagnosed at a later stage seems to be related to a higher percentage o f
African American women having breast cancers discovered by incidental BSE, the means
of discovery most associated with late stage diagnosis; and a higher percentage o f
Caucasian women having cancers discovered by mammogram, the means of discovery
most associated with early stage diagnosis.
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Women with a sponsor’s rank of E l to E5 were three times more likely to be
diagnosed with late stage breast cancer than were women with a sponsor’s rank o f 0 5 to
010, and were twice as likely to be diagnosed in late stage than any o f the other rank o f
sponsor groupings. These findings support the discussion presented earlier in this chapter,
and reiterate the assertion that the stage at diagnosis disparity in SES may be related to
stage at diagnosis disparities within the age and race variables.
According to the results discussed above, late stage diagnosis is more likely to be
associated with African American women from low SES (sponsor’s rank o f E l to E5),
with their breast cancers discovered by some means other than mammogram. Once again,
this study’s findings confirm the association between potential access and stage at
diagnosis, and echo the findings of much of the breast cancer disparity literature, which
reports that late stage breast cancer is more likely to be diagnosed in African American
women from low SES and with low mammogram usage. But if economic access is the
primary cause o f late stage diagnosis in African American women, the profile for women
diagnosed with late stage breast cancer within an equal economic access system should be
different, and it appears to be the same. Even though the finding o f significant
relationships between age, race, SES and stage at diagnosis has been repeatedly reported
in the literature (Coates, et al., 1990; Eley, et al., 1994; Hunter, et al., 1993; Mandelblatt,
et al., 1995; Newman & Alfonso, 1997; Wojcik, et al., 1998), studies specifically
investigating and reporting the relationship between means o f discovery and stage o f
diagnosis are not available in the literature. In this study, significant findings involving the
relationship between means of discovery and stage at diagnosis appear to have an
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underlying association with significant findings relating to race, age, SES and length o f
time between discovery and diagnosis. Therefore, additional studies are needed to explore
the relationships between age, race, SES, means o f discovery, and stage at diagnosis, both
inside and outside of the DoD. Discussion relating to additional statistical analyses
conducted with these variables, in this study, is presented later in this chapter.
Research Question 5. To what extent do the variables length of time between
discovery and diagnosis of breast cancer, and length o f time between diagnosis and
initiation o f treatment of breast cancer, predict stage at diagnosis o f breast cancer in
women identifying their race as Caucasian or African American, and being diagnosed with
breast cancer at Naval Medical Center San Diego from January 1, 1988 to December 31,
1997.
Within the group of realized access variables, only the length o f time between
discovery and diagnosis reliably predicted late stage at diagnosis. This finding supports
the discussion presented earlier under research question number 3.
Supplemental Data Analysis
The findings of this study: (a) identify significant relationships between age, race,
SES, means o f discovery and stage at diagnosis; (b) identify significant differences in age,
SES, and means of discovery by race; (c) identify significant relationships between length
of time between discovery and diagnosis, and length o f time between diagnosis and
treatment, and stage at diagnosis; (d) identify means o f discovery (incidental BSE and
CBE) as a significant predictor o f length of time between discovery and diagnosis; (e)
identify means o f discovery as a reliable predictor o f late stage diagnosis; and (f) identify
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the length of time between discovery and diagnosis as a reliable predictor of late stage
breast cancer. Furthermore, the disparity in stage at diagnosis, between the African
American and Caucasian women in this study, and the significant relationship between
length o f time between discovery and diagnosis and stage at diagnosis, seem to both be
related to means o f discovery. In light o f these findings, and the suggestion o f underlying
relationships to means of discovery, supplemental data analyses were conducted.
Discussion relevant to these supplemental findings are presented below.
Comparative analyses reflect a significant difference in the distribution of means o f
discovery by race, age, and SES. Previous discussions have identified the significant
difference in distribution o f means o f discovery by race, and supplemental analyses reflect
similar differences in the distribution of means of discovery by age and sponsor’s rank.
The American Cancer Society (ACS) and the DoD MHS breast cancer screening
guidelines recommend annual mammography for women age 40 and older (American
Medical Women’s Association [AMWA], 1997). Therefore, the percentage o f women
less than 40 years old, having their cancers discovered by mammogram, is expected to be
significantly less than those 40 years and older. But the ACS and DoD MHS also
recommend monthly BSE, and CBE at least every 3 years for women 20 to 39 years old.
Thus, age can be supported as a possible influencer o f low mammography percentages in
the women less than 40, but the high percentage of incidental discoveries in women less
than 40, as compared to intentional BSE and CBE, can not be readily related to age.
Previous discussions have already identified the significant difference in mean age
at diagnosis between African American and Caucasian women. Therefore, the disparity in
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stage at diagnosis between the two groups might be related to this significant difference in
age, which might be related to the significant difference in mammogram discovered breast
cancers in the two groups, which might be related to the DoD MHS age guidelines for
annual screening mammography. However, the number o f African American women 40
years and older is almost four times the number having breast cancers discovered by
mammogram, so age may be one influencer o f the number o f mammogram discovered
breast cancers diagnosed in the African American women in this study, but additional
influencers exist and must be identified. This assertion is supported by the finding that
while 516 o f the Caucasian women in the study were 40 years and older, only 293 of the
breast cancers discovered in this group o f women occurred by mammogram. In addition,
within the 40 to 49 year old age group 37.2 percent of the cancers were discovered by
incidental BSE as compared to 36.3 by mammogram, and 8.8 percent by CBE.
Mammography is the optimal secondary prevention strategy for breast cancer, but some
cancers palpated on CBE and/or BSE, may not be detected on mammography (AMWA,
1997). As a result, a certain percentage o f cancers may only be found by CBE or BSE.
However, the large percentage o f cancers discovered by incidental BSE raise questions
about routine breast cancer screening practices in all age groups.
The disparity in stage at diagnosis o f breast cancer by sponsor’s rank, may also be
related to age. Women with a sponsor’s rank of E l through E5 were diagnosed at
significantly later stages than any o f the other groupings, and 39.1 percent o f the women
in the E l to E5 group were less than 40 years old, as compared to 10.2 percent for the
CWO through 0 4 group, 9.8 percent for the E6 to E9 group, and less than one percent
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for the 0 5 to OlO group. But, there were 25 women with a sponsor’s rank of E l to E5
40 years o f age and older, and only 10 had cancers discovered by mammogram. Of the
women falling into the E l to E5 category, 16 were less than 40 years old, however, 18 of
the women in the E l to E5 category had cancers discovered by incidental BSE, 6 by
intentional BSE, and 4 by CBE. The disparity in stage at diagnosis within the sponsor’s
rank group may be related to race, but 63.8 percent of the African American women in the
study had a sponsor’s rank of E6 to E9, as compared to 27.7 percent for E l to E5; and
women in the E l to E5 group were twice as likely to be diagnosed at late stage breast
cancer, when compared to women in the E6 to E9 group.
In this study, breast cancers discovered by intentional BSE had the same odds for
being diagnosed at late stage as those discovered by CBE. But the odds for cancers
discovered by incidental BSE being diagnosed at late stage were almost six times the odds
for mammogram discovered cancers. In addition, self discovered (BSE) breast cancers
were diagnosed at a significantly earlier age, when compared to provider discovered (CBE
and mammogram) cancers. While there was no significant difference in mean length of
time between diagnosis and treatment between self discovered and provider discovered
breast cancers, women who had self discovered cancers had significantly larger tumors,
and a significantly higher mean length o f time between discovery and diagnosis.
Furthermore, supplemental logistic analysis supported that Caucasian women, 50 years of
age and older, with a sponsor’s rank o f 0 5 through OlO, were most likely to have
provider discovered breast cancers.
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Improvements in the diagnosis and treatment of breast cancer have emerged over
the past 20 years (Chu et al., 1996), and the findings of significant relationships between
the variables o f potential access and stage at diagnosis may be influenced by significant
differences in the distribution of these variables across the years. However supplemental
analysis revealed that there were no significant differences in the distribution o f race, age,
SES, or stage, by year; and even though chi-square analysis demonstrated a significant
difference in the distribution of means o f discovery by year, the trends in mammography
and incidental BSE discoveries appear to be inconsistent.
The additional analyses conducted in this study have confirmed means of discovery
as a major influencer o f the significant differences in stage at diagnosis by race, age, and
SES, and have demonstrated that the women with self discovered breast cancers had
poorer stage at diagnosis outcomes. Nevertheless, additional study is needed to explore
the relationship between means o f discovery and stage at diagnosis in other races, and in
other health care institutions inside and outside o f the DoD.
The existence o f significant differences in means o f discovery by race, age, and
SES, within an equal economic access health care system, provide support for the theory
that a woman’s participation in breast health care is influenced by the perception o f the
availability, necessity, and appropriateness o f care. Knowledge o f the “need” for breast
health care and the existence of the “economic means” to obtain that care may have little
or no influence on a woman’s expediency in seeking care, if the care is not perceived as
necessary, appropriate, or available. A perception o f the availability o f breast health care
is influenced by economic factors as well as location of care, fit with time schedules, fit
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with family and personal responsibilities, and fit with cultural beliefs, values, and
expectations. A perception of the necessity o f breast health care is influenced by
incorporation o f health promotion and disease prevention into definitions o f health,
symptomatology and cultural definitions o f severity, and personal and family priorities. A
perception o f appropriateness of care is influenced by the fit o f breast health care with
cultural values, beliefs, and practices, interactions and relationships with providers o f care,
and previous experience associated with breast cancer and breast health care. These
perceptions are generated through experiences resulting from the interaction o f cultural,
structural, and social factors, and assessment o f these perceptions can provide insight into
differences in means o f discovery by age, race and SES. Therefore, additional studies are
also needed to evaluate the knowledge o f the “need” for breast health care, and the
perception o f access appropriateness, necessity, and availability.
In addition, studies are needed: to evaluate adherence to breast cancer screening
guidelines by women receiving care within the DoD MHS; to identify other elements o f
potential access which may influence participation in breast cancer screening programs and
care seeking behaviors; to explore differences in the length o f time between discovery o f
breast abnormality and contact with the health care delivery system, and length of time
between discovery o f abnormality and diagnosis o f breast cancer; and to explore factors
associated with the length of time between first medical consultation and diagnosis of
breast cancer.
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Implications for Nursing
The implications of the findings o f this study for nursing practice, education, and
research, along with recommendations for further research, are presented in this section.
Nursing Practice
The results o f this study confirm the existence o f non-economic access barriers to
participation in breast cancer screening programs for some women. Within the DoD
MHS, “easy” access did not exist for all women receiving breast health care, and while the
African American women in this study seemed to have poorer stage at diagnosis
outcomes, the implications of this study impact women o f all ethnicities and age groups,
and provide opportunities for improvement o f nursing practice in all clinical settings.
Early detection is the best defense against late stage breast cancer diagnosis.
Therefore, every effort should be employed to ensure that women inside and outside of the
DoD MHS are aware of, and participate in health promotion and disease prevention
activities related to breast health care. Existence o f economic access to care, did not
translate into utilization of care in this study. Variables o f potential access, such as age,
race, SES, and means of discovery, were significantly related to stage at diagnosis, and
explained a small amount of the variance in length of time between discovery and
diagnosis. Therefore, breast health promotion and disease prevention programs should
focus on being economically available, perceptually necessary, and culturally appropriate.
In this study, there was no significant difference in the length of time between
diagnosis and treatment, by race, or by means o f discovery. These findings support the
existence o f equal economic access to “ superior medical and diagnostic technology” for all
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eligible DoD MHS beneficiaries. But diagnosis and treatment cannot be initiated if the
health care system is not utilized. Therefore, breast health care programs must also
emphasize utilization o f health care resources, and the steps to be taken when breast
abnormalities are discovered.
The results o f this study confirmed findings o f other studies investigating the
disparity in stage at diagnosis between African American and Caucasian women.
According to this study, late stage breast cancer was more likely to be diagnosed in
African American women, from low SES, and with low mammogram usage. Even though
the implications presented above apply to all age groups and ethnicities, the observation
that the profile for women with delayed diagnosis within this equal economic access health
care system reflects the profile for women outside o f this system has specific implications
for provision of breast health care and education to African American women. The
percentage o f incidental discoveries of breast cancer for African American women was
significantly high, when compared to Caucasian women; and since African American
women were diagnosed at younger ages and with larger tumors, emphasis on practicing
monthly BSE and routine CBE and mammogram, in this population of women, is
essential. If late stage diagnosis and mortality are to be decreased, BSE instruction must
include “the how to” and “the what to do”, and nurses must incorporate assessment o f the
woman’s definition o f health, and attitudes about seeking care into this breast health care
instruction. In addition, African American women must be consistently encouraged to
seek out breast health care, and to participate in CBE, BSE, and mammogram, even in
the absence of symptoms.
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This study has provided new insights into the relationship between access to care
and stage at diagnosis, and has tremendous implications for nursing practice. Even though
additional study and exploration is needed to further identify, describe, and verify non
economic access barriers to breast health care, incorporation o f the implications discussed
above, into current nursing practice, will enhance the success o f breast health care
programs targeting women o f all ethnicities and ages.
Nursing Education
Nursing education programs must continue to make health promotion and disease
prevention an integral part o f their curriculums. Approaches to teaching health promotion
and disease prevention should promote breast health care; and breast health care
curriculums should emphasize the impact of non-economic access barriers on participation
in breast cancer screening.
In addition, nursing education programs should expand their perceptions of
culturally appropriate care, and begin to view each nurse-client encounter as an
opportunity for increasing cultural awareness, and gaining insight into client’s definitions
of health, and care seeking behaviors. In this study, characteristics of the individual (such
as age, race, and SES) had significant relationships to both means o f discovery and stage
at diagnosis. Therefore, non-economic access barriers to participation in breast health
care might be more readily identified by assessing the client’s cultural perception o f health
care necessity, appropriateness, and availability.
Finally, educators o f nurses should emphasize the importance of breast cancer
screening in students o f nursing, at all levels. Educational programs should help students
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evaluate their own adherence to ACS recommendations for breast cancer screening, and
identify personal barriers to accessing breast health care. Enhancing awareness o f the
relationship between access and stage at diagnosis, and increasing personal participation in
breast health care, through nursing education, will contribute significantly to decreasing
the percentage o f incidental breast cancer discoveries, and subsequent late stage
diagnoses.
Nursing Research
The findings of this study suggest a revised conceptual model (Figure 2). Within
this equal economic access system, the identified variables o f potential access influenced
length of time between discovery and diagnosis, but did not influence length o f time
between diagnosis and treatment. Both the variables of potential access and length of time
between discovery and diagnosis influenced stage at diagnosis, but length of time between
diagnosis and treatment, although a measure o f realized access, seemed to be influenced
primarily by stage at diagnosis o f breast cancer.
The revised conceptual model for the study o f access to breast health care for
women within the MHS should be tested with other races serviced by NMCSD, and with
African American and Caucasian populations at other DoD MHS institutions. Although
studies conducted using an automated data base, across a number o f institutions
simultaneously, provide generalizability, studies focusing on means o f discovery and
length of time between discovery and diagnosis will be best conducted by the review o f
actual tumor registry records. Since the findings from this study relating to means of
discovery and length of time between discovery and diagnosis were most significant, it is
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Figure 2. REVISED Framework for the Study of Access to Breast Health Care for Women in the Military Health System
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recommended that these findings be confirmed by conducting studies within the MHS,
using tumor registry records in conjunction with data bases.
Within the equal economic access health care system focused on in this study,
barriers to access seemed to occur at the individual level (versus health care system level).
The means o f discovery influenced the timeliness o f diagnosis, and questions surrounding
the individual’s ability and willingness to participate in health care arise from the poorer
stage at diagnosis outcomes associated with self discovered breast cancer. In addition, the
group of potential access variables identified in this study were only able to explain a small
amount o f the variance in length o f time between discovery and diagnosis. Therefore,
additional studies using the access framework and examining additional variables of
potential and realized access are recommended. Within the potential access variable,
additional predisposing factors such as family history o f breast cancer and health
promotion practices (alcohol use, tobacco use; body mass index) could be added, as well
as other enabling factors such as geographic proximity to the health care institution, and
transportation availability. Within the realized access variable, length o f time between
discovery and contact with the health care system should be evaluated in conjunction with
length of time between discovery and diagnosis.
Stage at diagnosis influences both treatment and survival outcomes, and although
this study did not examine treatment or survival outcomes in relation to stage at diagnosis,
early stage diagnosis was associated primarily with mammogram, while late stage
diagnosis was associated primarily with incidental BSE. Questions arise surrounding both
o f these means o f discovery, but because mammogram discovered breast cancers were
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associated primarily with early stage diagnosis, it is recommended that additional studies
be conducted within the DoD MHS describing the demographic characteristics and
diagnostic outcomes of women receiving mammograms.
Even though this study was conducted with a sample o f women at one institution,
the demographic characteristics o f this sample correspond to the demographic
characteristics o f studies conducted with populations o f African American and Caucasian
women both inside and outside o f the DoD MHS. Therefore, it is recommended that the
findings o f this study be used to guide exploratory studies o f a qualitative nature, inside
and outside o f the DoD, to identify other variables o f potential access.
In addition, it is recommended that additional exploratory studies be conducted to
further examine the significant relationship between age, race, SES, means of discovery,
and stage at diagnosis. These studies should be conducted both inside and outside o f the
DoD MHS, and should explore these relationships in regard to potential access need
factors such as health beliefs, health practices, and perceptions about the necessity,
appropriateness, and availability o f care.
Although this study added foundational knowledge on the relationship between
access and stage at diagnosis o f breast cancer, the additional studies discussed above are
needed to substantiate the findings o f this study, and develop hypotheses to be tested in
future breast health care research. A summary of the recommendations for further study is
presented below.
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Summary o f recommendations for further study.
1.

Conduct an expanded study, using the revised conceptual model, and comparing

the findings o f this study on African American and Caucasian women with data collected
from the tum or registry records o f Asian women, diagnosed with breast cancer at
NMCSD.
2.

Using the revised model, replicate this study at another large DoD MHS

institution.
3.

Conduct a study of the relationship between access and stage at diagnosis between

African American and Caucasian women within the DoD MHS, using a revised framework
which includes additional variables o f potential and realized access.
4.

Conduct a descriptive study o f the demographic characteristics and diagnostic

outcomes o f women receiving mammograms within the DoD MHS.
5.

Conduct qualitative exploratory studies inside and outside o f the DoD MHS to

identify other variables of potential access.
6.

Conduct qualitative exploratory studies inside and outside o f the DoD MHS to

explore the relationships between potential access and stage at diagnosis, as they relate to
health beliefs, health practices, and perceptions o f access.
Conclusion
The findings of this study support the theorized relationships between the study
variables. As in other studies examining the relationship between economic access and
stage at diagnosis o f breast cancer, the existence of economic access to care in this
sample, did not always result in early diagnosis, and other factors such as age, race, SES,
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and means o f discovery influenced diagnosis outcomes. Within this study, length o f time
between discovery and diagnosis was a function of means o f discovery; and even though
length of time between diagnosis and treatment was not predicted by potential access, this
variable seemed to be a measure o f equal access to treatment within this DoD MHS.
In this equal economic access system, there was a significant difference in stage at
diagnosis between the African American and Caucasian women. Delayed diagnosis was
the cause o f this significant difference. African American women were diagnosed at later
stages and with larger tumors, as compared to Caucasian women. However, this
diagnosis delay did not appear to be related to economic access, in that there was no
significant difference between the African American and Caucasian women in the length o f
time between diagnosis and treatment. The disparity in diagnosis delay between the
African American and Caucasian women, and within the age and rank of sponsor
categories, seemed to be related to the means of discovery. Self discovered breast cancers
were associated primarily with late stage diagnosis, while provider discovered cancers
were associated with early stage; and while intentional BSE and CBE had similar
diagnostic outcomes, late diagnosis was most strongly associated with incidental BSE,
while mammogram was most strongly associated with early diagnosis.
The results of this study clearly indicate that interventions aimed at increasing
participation in breast health care programs among African American women, women o f
color, and all other categories o f women, must focus on all aspects o f access to health
care. Economic access makes the difference from diagnosis to treatment, but treatment
cannot be initiated until diagnosis occurs, and diagnosis cannot occur until access is
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realized. Therefore, breast health care interventions should be directed towards increasing
awareness, increasing discovery, and decreasing the length o f time between discovery and
diagnosis, especially in women ages 2 0 - 4 0 .
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Breast Cancer Medical Record Data Collection Sheet
Identification Num ber:________________________________
Race:____________________________________
Patient Status:

Active Duty

Marital Status:

Married

Branch o f Service Affiliation:

Date o f Birth:____________________
R etired

Single

Divorced

Family Member

Separated

Widowed

______________________

Rate/Rank: _______________________________________ _
Date o f Diagnosis:_____________________________________
Stage at D iagnosis:

0

1

II

HI

Age at Diagnosis:_________________
IV

Tumor Size in centimeters:_______________________________________________
Number o f Positive Lymph N o d e s : _____________________________________________
Means o f Discovery:
Intentional Breast S elf Exam

Incidental Breast S elf Exam

Routine C linical Breast Exam

Secondary C linical Breast Exam

Routine Mammogram

Secondary Mammogram

Length o f tim e in days between discovery o f breast abnorm ality and diagnosis:___________________
Date D iscovered:______________________
Length o f tim e in days between diagnosis o f breast cancer and initiation o f treatment:_____________
Date Treatment Initiated:__________________________
Means o f Treatment:

Surgery at the Tim e o f D iagnosis

Surgery after D iagnosis

Radiation Therapy

Chemotherapy

Hormone Therapy

No Treatment

Survival Status at the Tim e o f Data Collection:
A live
Deceased Due to Other Cause

Deceased Due to Breast Cancer
Deceased Due to Unknown Cause
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From:
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Via:

Chairman, Scientific Review Committee (SRC)
Chairman, Committee for the Protection of Human Subjects
Commander
Deputy Commander

Subj :

EXPEDITED R EVIEW OF CIP STUDY #S-98-107, “FACTORS RELATED
TO STAGE AT DIAGNOSIS OF AFRICAN AMERICAN AND CAUCASIAN
WOMEN DIAGNOSED WITH BREAST CANCER IN THE MILITARY HEALTH
SYSTEM"

Ref:

(a) NSHSBETHINST 6000.41A
(b) NAVMEDCEN SDIEGOINST 6500.4D

1.
The subject study was reviewed by members of the respective
committees.
In accordance with references (a) and (b), local
expedited approval of the above protocol is requested effective
the date of your endorsement below.
2.
Local expedited approval was authorized for the above
research project by two members of the SRC on 11 June 1998.
The
signature below is provided to reflect the approval by the
committee members.
This protocol was processed in accordance
with part 2, section A(i) of reference (a). This protocol is a
retrospective chart review.
3.
The Chairman, CPHS determined that the study is exempt from
CPHS review.
The signature below is provided to reflect that
exemption.

D . L . REEVES
CDR, M S C , USN
Chairman, Scientific Review
Committee

K. DEAN GUBLER
CDR, MC, USN
Chairman, Committee for the
Protection of Human Subjects

4.
This expedited approval will allow the investigator to begin
the study as soon as the minor changes requested by the reviewers
have been submitted.
An administrative entry will be included in
the next set of committee minutes.
5.

Approved/ Bi 3 app Lnoved
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(1) Approved version, of CIP Study
(2) Travel information
(3) Revisions to the protocol

1. Your research protocol (enclosure (1))
initiation as of this date.
Your protocol
requirements of references (a) and (b) and
the Scientific Review Committee (SRC). A n
required in May 1999.

has been approved for
has met the
has been approved by
annual review will be

2. Requests for travel funds for presentations related to your
protocol must be processed through Medical Editing and include
your CIP #.
Travel funds are allocated by Naval School of Health
Sciences (NSHS), Bethesda, MD and are available on a first come
first served basis.
The information needed to apply for TAD
funded by NSHS is in enclosure (2).
3. Articles/abstracts for publications must be submitted to the
DCR Medical Editing staff.
They will assist in the preparation,
ensure proper acknowledgment of BUMED as sponsor, obtain command
approval and submit them to journals and publications.
4. Changes to the protocol (i.e., increasing/decreasing subjects
or budget, addition/deletion of investigators, and changes in
protocol procedures) must be submitted to DCR for approval
(enclosure (3)) prior to initiation.
5.
Sincere best wishes for a successful research project.
For
assistance, please contact the Research Program Administration
office at 532-8125/36.
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University of San Diego
P h ilip Y. H a h n S c h o o l o f N u rs in g

July 18,1998

Sandra Bibb DNSc (c)
Doctoral Student
Philip Y. H ahn School of N ursing
Dear Sandra:
I have received and review ed your application to the USD Committee for the
Protection of H um an Subjects for your doctoral dissertation proposal. On July
17, 1998, I consulted w ith Dr. Gary Schneider, Chairperson of the Committee
regarding the status of your application.
Both Dr. Schneider and I concur that your proposal as described is exem pt
from review by the Committee for the Protection of H um an Subjects under
the guidelines stipulated in the USD Faculty Handbook. Therefore, you may
now proceed w ith the conduct of your dissertation.
I wish you success in your research endeavors. Please contact me if your
require any additional information.
Sincerely,

Jane Georges, PhD, RN
Assistant Professor
School of N ursing Representative
Committee for the Protection of Human Subjects

5998 Alcala Park, San Diego, California 9 211 0-2 492
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